United States Patent: 7781162

[US Patent & Trademark Office, Patent Full Text and Image Database]

( 1 of 1 )

United States Patent	7,781,162
Ecker , et al.	August 24, 2010

Methods for rapid identification of pathogens in humans and animals

Abstract

The present invention provides methods of: identifying pathogens in biological samples from humans and animals, resolving a plurality of etiologic agents present in samples obtained from humans and animals, determining detailed genetic information about such pathogens or etiologic agents, and rapid detection and identification of bioagents from environmental, clinical or other samples.

Inventors:	Ecker; David J. (Encinitas, CA), Griffey; Richard H. (Vista, CA), Sampath; Rangarajan (San Diego, CA), Hofstadler; Steven A. (Oceanside, CA), McNeil; John (La Jolla, CA), Crooke; Stanley T. (Carlsbad, CA)
Assignee:	Ibis Biosciences, Inc. (Carlsbad, CA)
Family ID:	32512832
Appl. No.:	10/660,122
Filed:	September 11, 2003

Prior Publication Data


	Document Identifier	Publication Date
	US 20040219517 A1	Nov 4, 2004

Related U.S. Patent Documents


Application Number	Filing Date	Patent Number	Issue Date
10323233	Dec 18, 2002
10326051	Dec 18, 2002
10325526	Dec 18, 2002
10325527	Dec 18, 2002
09798007	Mar 2, 2001
60431319	Dec 6, 2002
60443443	Jan 29, 2003
60443788	Jan 30, 2003
60447529	Feb 14, 2003

Current U.S. Class: 435/6.12; 435/91.2; 536/24.33; 435/6.18

Current CPC Class: C12Q 1/686 (20130101); C12Q 1/689 (20130101); C12Q 1/686 (20130101); C12Q 2565/627 (20130101); Y10T 436/24 (20150115)

Current International Class: C12Q 1/68 (20060101); C07H 21/04 (20060101); C12P 19/34 (20060101)

References Cited [Referenced By]

U.S. Patent Documents


4075475	February 1978	Risby et al.
4683195	July 1987	Mullis et al.
4683202	July 1987	Mullis et al.
4965188	October 1990	Mullis et al.
5015845	May 1991	Allen et al.
5072115	December 1991	Zhou
5213961	May 1993	Bunn et al.
5219727	June 1993	Wang et al.
5436129	July 1995	Stapleton
5451500	September 1995	Stapleton
5472843	December 1995	Milliman
5476774	December 1995	Wang et al.
5484908	January 1996	Froehler et al.
5502177	March 1996	Matteucci et al.
5503980	April 1996	Cantor
5504327	April 1996	Sproch et al.
5504329	April 1996	Mann et al.
5523217	June 1996	Lupski et al.
5527669	June 1996	Resnick et al.
5527675	June 1996	Coull et al.
5547835	August 1996	Koster
5567587	October 1996	Kohne
5576204	November 1996	Blanco et al.
5580733	December 1996	Levis et al.
5605798	February 1997	Koster
5608217	March 1997	Franzen et al.
5612179	March 1997	Simons
5622824	April 1997	K oster
5625184	April 1997	Vestal et al.
5639606	June 1997	Willey
5645985	July 1997	Froehler et al.
5683869	November 1997	Ramsay Shaw et al.
5686242	November 1997	Bruice et al.
5691141	November 1997	Koster
5700642	December 1997	Monforte et al.
5702895	December 1997	Matsunaga et al.
5707802	January 1998	Sandhu et al.
5712125	January 1998	Sandhu et al.
5716825	February 1998	Uhlen
5727202	March 1998	Kucala
5745751	April 1998	Nelson et al.
5747246	May 1998	Pannetier et al.
5747251	May 1998	Carson et al.
5753489	May 1998	Kistner et al.
5759771	June 1998	Tilanus
5763169	June 1998	Sandhu et al.
5763588	June 1998	Matteucci et al.
5770367	June 1998	Southern et al.
5777324	July 1998	Hillenkamp
5814442	September 1998	Natarajan et al.
5828062	October 1998	Jarrell et al.
5830653	November 1998	Froehler et al.
5830655	November 1998	Monforte et al.
5832489	November 1998	Kucala
5834255	November 1998	vanGemen et al.
5845174	December 1998	Yasui et al.
5849492	December 1998	Rogan
5849497	December 1998	Steinman
5849901	December 1998	Mabilat et al.
5851765	December 1998	Koster
5856174	January 1999	Lipshutz et al.
5864137	January 1999	Becker et al.
5866429	February 1999	Bloch
5869242	February 1999	Kamb
5871697	February 1999	Rothberg et al.
5872003	February 1999	Koster
5876936	March 1999	Ju
5885775	March 1999	Haff et al.
5900481	May 1999	Lough et al.
5928905	July 1999	Stemmer et al.
5928906	July 1999	Koster et al.
5965363	October 1999	Monforte et al.
5976798	November 1999	Parker et al.
5981176	November 1999	Wallace
5981190	November 1999	Israel
5994066	November 1999	Bergeron et al.
6001564	December 1999	Bergeron et al.
6005096	December 1999	Matteucci et al.
6007690	December 1999	Nelson et al.
6007992	December 1999	Lin et al.
6015666	January 2000	Springer et al.
6018713	January 2000	Coli et al.
6024925	February 2000	Little et al.
6028183	February 2000	Lin et al.
6043031	March 2000	Koster et al.
6046005	April 2000	Ju et al.
6051378	April 2000	Monforte et al.
6054278	April 2000	Dodge et al.
6055487	April 2000	Margery et al.
6060246	May 2000	Summerton et al.
6061686	May 2000	Gauvin et al.
6063031	May 2000	Cundari et al.
6074823	June 2000	Koster
6074831	June 2000	Yakhini et al.
6090558	July 2000	Butler et al.
6104028	August 2000	Hunter et al.
6110710	August 2000	Smith et al.
6111251	August 2000	Hillenkamp
6133436	October 2000	Koster et al.
6140053	October 2000	Koster
6146144	November 2000	Fowler et al.
6146854	November 2000	Koster et al.
6153389	November 2000	Haarer et al.
6159681	December 2000	Zebala
6180339	January 2001	Sandhu et al.
6180372	January 2001	Franzen
6194144	February 2001	Koster
6197498	March 2001	Koster
6214555	April 2001	Leushner et al.
6218118	April 2001	Sampson et al.
6221587	April 2001	Ecker et al.
6221598	April 2001	Schumm et al.
6221601	April 2001	Koster et al.
6221605	April 2001	Koster
6225450	May 2001	Koster
6235476	May 2001	Bergmann et al.
6235478	May 2001	Koster
6235480	May 2001	Shultz et al.
6238871	May 2001	Koster
6238927	May 2001	Abrams et al.
6239159	May 2001	Brown et al.
6258538	July 2001	Koster et al.
6261769	July 2001	Everett et al.
6265716	July 2001	Hunter et al.
6268129	July 2001	Gut et al.
6268131	July 2001	Kang et al.
6268144	July 2001	Koster
6268146	July 2001	Shultz et al.
6270973	August 2001	Lewis et al.
6270974	August 2001	Shultz et al.
6274726	August 2001	Laugharn, Jr. et al.
6277573	August 2001	Koster
6277578	August 2001	Shultz et al.
6277634	August 2001	McCall et al.
6300076	October 2001	Koster
6303297	October 2001	Lincoln et al.
6312893	November 2001	Van Ness et al.
6312902	November 2001	Shultz et al.
6322970	November 2001	Little et al.
6361940	March 2002	Van Ness et al.
6372424	April 2002	Brow et al.
6389428	May 2002	Rigault et al.
6391551	May 2002	Shultz et al.
6393367	May 2002	Tang et al.
6419932	July 2002	Dale
6423966	July 2002	Hillenkamp et al.
6428955	August 2002	Koster et al.
6428956	August 2002	Crooke et al.
6432651	August 2002	Hughes et al.
6436635	August 2002	Fu et al.
6436640	August 2002	Simmons et al.
6453244	September 2002	Oefner
6458533	October 2002	Felder et al.
6468743	October 2002	Romick et al.
6468748	October 2002	Monforte et al.
6475143	November 2002	Iliff
6475736	November 2002	Stanton, Jr.
6479239	November 2002	Anderson et al.
6500621	December 2002	Koster
6553317	April 2003	Lincoln et al.
6558902	May 2003	Hillenkamp
6563025	May 2003	Song et al.
6566055	May 2003	Monforte et al.
6582916	June 2003	Schmidt et al.
6586584	July 2003	McMillian et al.
6589485	July 2003	Koster
6602662	August 2003	Koster
6605433	August 2003	Fliss et al.
6610492	August 2003	Stanton et al.
6613509	September 2003	Chen
6613520	September 2003	Ashby et al.
6623928	September 2003	Van Ness et al.
6638714	October 2003	Linnen et al.
6680476	January 2004	Hidalgo et al.
6682889	January 2004	Wang et al.
6705530	March 2004	Kiekhaefer
6706530	March 2004	Hillenkamp
6716634	April 2004	Myerson
6783939	August 2004	Olmsted et al.
6800289	October 2004	Nagata et al.
6813615	November 2004	Colasanti et al.
6836742	December 2004	Brekenfeld
6852487	February 2005	Baraney et al.
6856914	February 2005	Pelech
6875593	April 2005	Froehler et al.
6906316	June 2005	Sugiyama et al.
6906319	June 2005	Hoyes
6914137	July 2005	Baker
6977148	December 2005	Dean et al.
6994962	February 2006	Thilly
7022835	April 2006	Rauth et al.
7024370	April 2006	Epler et al.
7108974	September 2006	Ecker et al.
7198893	April 2007	Koster et al.
7217510	May 2007	Ecker et al.
7226739	June 2007	Ecker et al.
7255992	August 2007	Ecker et al.
7285422	October 2007	Little et al.
7312036	December 2007	Sampath et al.
7321828	January 2008	Cowsert et al.
7349808	March 2008	Kreiswirth et al.
7390458	June 2008	Burow et al.
7419787	September 2008	Koster et al.
7501251	March 2009	Koster et al.
2002/0006611	January 2002	Portugal et al.
2002/0042112	April 2002	Koster et al.
2002/0042506	April 2002	Krstyanne et al.
2002/0045178	April 2002	Cantor et al.
2002/0055101	May 2002	Bergereon et al.
2002/0120408	August 2002	Kreiswirth et al.
2002/0137057	September 2002	Wold et al.
2002/0138210	September 2002	Wilkes et al.
2002/0150903	October 2002	Koster
2002/0150927	October 2002	Matray et al.
2002/0168630	November 2002	Fleming et al.
2003/0017487	January 2003	Xue et al.
2003/0027135	February 2003	Ecker et al.
2003/0039976	February 2003	Haff
2003/0050470	March 2003	An et al.
2003/0064483	April 2003	Shaw et al.
2003/0073112	April 2003	Zhang et al.
2003/0082539	May 2003	Ecker et al.
2003/0101172	May 2003	Ecker et al.
2003/0104410	June 2003	Mittmann
2003/0113745	June 2003	Monforte et al.
2003/0119018	June 2003	Omura et al.
2003/0124556	July 2003	Ecker et al.
2003/0129589	July 2003	Koster et al.
2003/0134312	July 2003	Burgoyne
2003/0148284	August 2003	Vision et al.
2003/0167133	September 2003	Ecker et al.
2003/0167134	September 2003	Ecker et al.
2003/0175695	September 2003	Ecker et al.
2003/0175696	September 2003	Ecker et al.
2003/0175697	September 2003	Ecker et al.
2003/0175729	September 2003	Van Eijk et al.
2003/0186247	October 2003	Smarason et al.
2003/0187588	October 2003	Ecker et al.
2003/0187593	October 2003	Ecker et al.
2003/0190605	October 2003	Ecker et al.
2003/0190635	October 2003	McSwiggen
2003/0194699	October 2003	Lewis et al.
2003/0203398	October 2003	Bramucci et al.
2003/0220844	November 2003	Mamelkos et al.
2003/0224377	December 2003	Wengel et al.
2003/0225529	December 2003	Ecker et al.
2003/0228571	December 2003	Ecker et al.
2003/0228613	December 2003	Bornarth et al.
2004/0005555	January 2004	Rothman et al.
2004/0014957	January 2004	Eldrup et al.
2004/0023207	February 2004	Polansky
2004/0023209	February 2004	Jonasson
2004/0029129	February 2004	Wang et al.
2004/0038206	February 2004	Zhang et al.
2004/0038234	February 2004	Gut et al.
2004/0038385	February 2004	Langlois et al.
2004/0081993	April 2004	Cantor et al.
2004/0101809	May 2004	Weiss et al.
2004/0110169	June 2004	Ecker et al.
2004/0111221	June 2004	Beattie et al.
2004/0117129	June 2004	Ecker et al.
2004/0121309	June 2004	Ecker et al.
2004/0121310	June 2004	Ecker et al.
2004/0121311	June 2004	Ecker et al.
2004/0121312	June 2004	Ecker et al.
2004/0121313	June 2004	Ecker et al.
2004/0121314	June 2004	Ecker et al.
2004/0121315	June 2004	Ecker et al.
2004/0121329	June 2004	Ecker et al.
2004/0121335	June 2004	Ecker et al.
2004/0121340	June 2004	Ecker et al.
2004/0122598	June 2004	Ecker et al.
2004/0122857	June 2004	Ecker et al.
2004/0126764	July 2004	Lasken et al.
2004/0137013	July 2004	Katinger et al.
2004/0161770	August 2004	Ecker et al.
2004/0180328	September 2004	Ecker et al.
2004/0185438	September 2004	Ecker et al.
2004/0191769	September 2004	Marino et al.
2004/0202997	October 2004	Ecker et al.
2004/0209260	October 2004	Ecker et al.
2004/0219517	November 2004	Ecker et al.
2005/0026147	February 2005	Walker et al.
2005/0026641	February 2005	Hokao
2005/0027459	February 2005	Ecker et al.
2005/0065813	March 2005	Michelevich et al.
2005/0130196	June 2005	Hofstadler
2005/0130216	June 2005	Becker et al.
2005/0142584	June 2005	Willson et al.
2005/0250125	November 2005	Novakoff
2005/0266397	December 2005	Ecker et al.
2006/0020391	January 2006	Kreiswirth et al.
2006/0057605	March 2006	Sampath et al.
2006/0121520	June 2006	Ecker et al.
2006/0172330	August 2006	Osborn et al.
2006/0205040	September 2006	Sampath et al.
2006/0240412	October 2006	Hall et al.
2006/0259249	November 2006	Sampath et al.
2006/0275788	December 2006	Ecker et al.
2007/0218467	September 2007	Ecker et al.
2009/0004643	January 2009	Ecker et al.
2009/0023150	January 2009	Koster et al.
2009/0042203	February 2009	Koster et al.
2009/0092977	April 2009	Koster et al.

Foreign Patent Documents


1202204	Dec 1998	CN
19732086	Jan 1999	DE
19802905	Jul 1999	DE
19824280	Dec 1999	DE
19852167	May 2000	DE
19943374	Mar 2001	DE
10132147	Feb 2003	DE
0281390	Sep 1988	EP
0633321	Nov 1995	EP
0620862	Apr 1998	EP
1035219	Sep 2000	EP
1138782	Oct 2001	EP
1234888	Aug 2002	EP
1308506	May 2003	EP
1310571	May 2003	EP
1333101	Aug 2003	EP
1365031	Nov 2003	EP
02709785	Nov 2005	EP
1748072	Jan 2007	EP
2811321	Jan 2002	FR
2325002	Nov 1998	GB
2339905	Feb 2000	GB
IN200301136	Oct 2005	IN
5-276999	Oct 1993	JP
2004-200	Jan 2004	JP
2004-24206	Jan 2004	JP
2004-201641	Jul 2004	JP
2004-201679	Jul 2004	JP
WO 88/03957	Jun 1988	WO
WO 90/15157	Dec 1990	WO
WO 92/08117	May 1992	WO
WO 92/09703	Jun 1992	WO
WO 92/05182	Nov 1992	WO
WO 92/19774	Nov 1992	WO
WO 93/03186	Feb 1993	WO
WO 93/08297	Apr 1993	WO
WO 94/16101	Jul 1994	WO
WO 94/19490	Sep 1994	WO
WO 94/21822	Sep 1994	WO
WO 95/04161	Feb 1995	WO
WO 95/11996	May 1995	WO
WO 95/13395	May 1995	WO
WO 95/13396	May 1995	WO
WO95/31997	Nov 1995	WO
WO 96/16186	May 1996	WO
WO 96/29431	Sep 1996	WO
WO 96/32504	Oct 1996	WO
WO 96/35450	Nov 1996	WO
WO 96/37630	Nov 1996	WO
WO97/33000	Sep 1997	WO
WO 97/34909	Sep 1997	WO
WO97/37041	Oct 1997	WO
WO 97/47766	Dec 1997	WO
WO 98/03684	Jan 1998	WO
WO98/12355	Mar 1998	WO
WO 98/12355	Mar 1998	WO
WO 98/14616	Apr 1998	WO
WO 98/15652	Apr 1998	WO
WO 98/20020	May 1998	WO
WO 98/20157	May 1998	WO
WO98/20166	May 1998	WO
WO 98/26095	Jun 1998	WO
WO 98/31830	Jul 1998	WO
WO 98/35057	Aug 1998	WO
WO 98/40520	Sep 1998	WO
WO98/54751	Dec 1998	WO
WO 99/05319	Feb 1999	WO
WO 99/12040	Mar 1999	WO
WO 99/13104	Mar 1999	WO
WO99/14375	Mar 1999	WO
WO 99/29898	Jun 1999	WO
WO99/31278	Jun 1999	WO
WO 00/63362	Oct 1999	WO
WO 99/57318	Nov 1999	WO
WO 99/58713	Nov 1999	WO
WO 99/60183	Nov 1999	WO
WO 00/66789	Nov 2000	WO
WO 01/07648	Feb 2001	WO
WO 01/12853	Feb 2001	WO
WO 01/23604	Apr 2001	WO
WO 01/23608	Apr 2001	WO
WO 01/32930	May 2001	WO
WO 01/40497	Jun 2001	WO
WO 01/46404	Jun 2001	WO
WO 01/51661	Jul 2001	WO
WO 01/51662	Jul 2001	WO
WO 01/57263	Aug 2001	WO
WO 01/57518	Aug 2001	WO
WO 01/73119	Oct 2001	WO
WO 01/73199	Oct 2001	WO
WO 01/77392	Oct 2001	WO
WO 02/02811	Jan 2002	WO
WO 02/10186	Feb 2002	WO
WO 02/10444	Feb 2002	WO
WO 02/18641	Mar 2002	WO
WO 02/21108	Mar 2002	WO
WO 02/22873	Mar 2002	WO
WO 02/24876	Mar 2002	WO
WO 02/50307	Jun 2002	WO
WO 02/57491	Jul 2002	WO
WO 02/070728	Sep 2002	WO
WO 02/077278	Oct 2002	WO
WO 02/099034	Dec 2002	WO
WO 02/099095	Dec 2002	WO
WO 02/099129	Dec 2002	WO
WO 02/099130	Dec 2002	WO
WO 02070664	Dec 2002	WO
WO 03/002750	Jan 2003	WO
WO 03/008636	Jan 2003	WO
WO 03/012058	Feb 2003	WO
WO 03/012074	Feb 2003	WO
WO 03/014382	Feb 2003	WO
WO 03/016546	Feb 2003	WO
WO 03/020890	Mar 2003	WO
WO 03/033732	Apr 2003	WO
WO 03/054162	Jul 2003	WO
WO 03/054755	Jul 2003	WO
WO 03/060163	Jul 2003	WO
WO 03/075955	Sep 2003	WO
WO 03/088979	Oct 2003	WO
WO 03/093506	Nov 2003	WO
WO 03/097869	Nov 2003	WO
WO 03/100035	Dec 2003	WO
WO 03/100068	Dec 2003	WO
WO 03/102191	Dec 2003	WO
WO 03/104410	Dec 2003	WO
WO 2004/003511	Jan 2004	WO
WO 2004/011651	Feb 2004	WO
WO 2004/013357	Feb 2004	WO
WO 2004/040013	May 2004	WO
WO 2004/044123	May 2004	WO
WO 2004/044247	May 2004	WO
WO 2004/052175	Jun 2004	WO
WO 2004/053076	Jun 2004	WO
WO 2004/053141	Jun 2004	WO
WO 2004/053164	Jun 2004	WO
WO 2004/060278	Jul 2004	WO
WO 2004/070001	Aug 2004	WO
WO 2004/072230	Aug 2004	WO
WO 2004/072231	Aug 2004	WO
WO 2004/101809	Nov 2004	WO
WO 2005/003384	Jan 2005	WO
WO 2005/012572	Feb 2005	WO
WO 2005/024046	Mar 2005	WO
WO 2005/053141	Jun 2005	WO
WO 2005/054454	Jun 2005	WO
WO 2005/075686	Oct 2005	WO
WO 2005/091971	Oct 2005	WO
WO 2005/098047	Oct 2005	WO
WO 2006/089762	Aug 2006	WO
WO 2006/094238	Sep 2006	WO
WO 2006/116127	Nov 2006	WO
WO 2007/086904	Aug 2007	WO
WO 2008/118809	Oct 2008	WO
WO 98/54571	Dec 2008	WO

Other References

Figueiredo et al (Am. J. Trop. Med. Hyg. (1998) 59(3):357-362). cited by examiner .
Fujioka et al (J. Virol. Meth. (1995) 51:253-258). cited by examiner .
Jurinke et al (Genetic Analysis: Biomolecular Engineering (1996) 13:67-71). cited by examiner .
Campbell et al (J. Virol. Methods (1996) 57:175-179. cited by examiner .
Kilpatrick et al (J. Clin. Microbiol. (1996) 34(12):2990-2996). cited by examiner .
BLAST Search results (Mar. 2006). cited by examiner .
Norder et al (J. Med. Virol. (1990) 31:215-221). cited by examiner .
Fuerstanau et al (Rapid Communications in Mass Spectrometry (1995) 9:1528-1538). cited by examiner .
Vanderhallen et al (J. Clin. Microbiol. (1998) 36(12):3463-3467). cited by examiner .
Muddiman et al., "Characterization Of PCR Products From Bacilli Using Electrospray Ionization FTICR Mass Spectrometry," Anal Chem., 1996, vol. 68, No. 21, pp. 3705-3712. cited by other .
Hurst et al., "Maldi-Tof Analysis Of Polymerase Chain Reaction Products From Methanotrophic Bacteria," Anal. Chem., 1998, vol. 70, No. 13, pp. 2693-2698. cited by other .
Lacroix et al., "PCR-Based Technique For The Detection Of Bacteria In Semen And Urine," J. Microbiol. Meth., 1996, vol. 26, pp. 61-71. cited by other .
Yao et al., "Mass Spectrometry Based Proteolytic Mapping For Rapid Virus Identification," Anal. Chem., 2002, vol. 74., No. 11, pp. 2529-2534. cited by other .
Van Baar et al., "Characterization Of Bacteria By Matrix Assisted Laser Desorption/Ionisation And Electrospray Mass Spectrometry," FEMS Microbiol. Reviews, 2000, vol. 24, pp. 195-219. cited by other .
Aaserud, et al., "Accurate base composition of double-strand DNA by mass spectrometry," J. Am. Soc. Mass Spec. (1996) 7:1266-1269. cited by other .
Muddiman, et al., "Length and base composition of PCR-amplified nucleic acids using mass measurements from electrospray ionization mass spectrometry," Anal. Chem. (1997) 69:1543-1549. cited by other .
Wunschel, et al., "Heterogeneity in bacillus cereus PCR products detected by ESI-FTICR mass spectrometry," Anal. Chem. (1998) 70:1203-1207. cited by other .
Muddiman, et al., "Sequencing and charaterization of larger oligonucleotides by electrospray ionization fourier transform ion cyclotron resonance mass spectrometry," Rev. Anal. Chem. (1998) 17:1-68. cited by other .
Hurst, et al., "Detection of bacterial DNA polymerase chain reaction products by matrix-assisted laser desorption/ionization mass spectrometry," Repid. Comm. Mass. Spec. (1996) 10:377-382. cited by other .
Muddiman, et al., "Precise mass measurement of a double-stranded 500 base-pair (309 kDa) polymerase chain reaction product by negative ion electrospray ionization fourier transform ion cyclotron resonance mass spectrometry," Rapid Comm. Mass Spec. (1999) 13:1201-1204. cited by other .
Baker, et al., "Review and re-analysis of domain-specific 16S primers," J. Microbiol. Methods (2003) 55:541-555. cited by other .
Benson, et al., "Advantages of Thermococcus kodakaraenic (KOD) DNA polymerase for PCR-mass spectrometry based analyses," J. Am. Soc. Mass Spectrom. (2003) 14:601-604. cited by other .
Black. et al., "Detection of trace levels of tricothecene mycotoxins in human urineby gas chromatography-mass spectrometry," J. Chromatog. (1986) 367:103-115. cited by other .
Campbell and Huang, "Detection of California serogroup Bunyavirus in tissue culture and mosquito pools by PCR," J. Virol. Methods (1996) 57:175-179. cited by other .
Chen, et al., "A universal PCR primer to detect members of the Potyviridae and its use to examine the taxonomic status of several members of the family," Arch. Virol. (2001) 146:757-766. cited by other .
Conrads, et al., "16S-23S rDNA internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Fusobacterium," Intl. J. System. Evol. Micrbiol. (2002) 52:493-499. cited by other .
Dasen, et al., "Classification and identification of Propioibacteria based on ribosomal RNA genes and PCR," System. Appl. Microbiol. (1998) 21:251-259. cited by other .
Deforce, et al., "Characterization of DNA oligonucleotides by coupling of capillary zone electrophoresis to electrospray ionization Q-TOF mass spectrometry," Anal. Chem. (1998) 70:3060-3068. cited by other .
Demesure, et al., "A set of universal primers for amplification of polymorphic non-coding regions of mitochondrial and chloroplast DNA in plants," Mol. Ecol. (1995) 4:129-131. cited by other .
Flora, et al., "Dual-micro-ESI source for precise mass determination on a quadrupole time-of-flight mass spectrometer for genomic and proteomic applications," Anal. Bioanal. Chem. (2002) 373:538-546. cited by other .
Fox, et al., "Identification of Brucella by ribosomal-spacer-region PCR and differentiation of Brucell canis from other Brucella spp. pathogenic for humans by carbohydrate profiles," J. Chil. Microbiol. (1998) 36:3217-3222. cited by other .
Fox et al., "Report of the `Bioterrorism Workshop`", J. Microbol. Methods (2002) 51:247-254. cited by other .
Griffey and Greig, "Detection of base pair mismatches in duplex DNA and RNA oligonucleotides using electrospray mass spectrometry," SPIE (1997) 2985:82-86. cited by other .
Griffin, et al., "Direct genetic analysis by matrix-assisted laseer desorption/ionization mass spectrometry," proc. Natl. Acad. Sci. USA (1999) 96:6301-6306. cited by other .
Hannis and Muddiman, "Accurate characterization fo the tyrosine hydroxylase forensic allele 9.3 through development of electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry," Rapid. Comm. Mass Spectrom. (1999) 13:954-962. cited by other .
Hannis and Muddiman, "Genotyping short tandem repeats using flow injection and electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry," Rapid. Comm. Mess Spectrom. (2001) 15:348-350. cited by other .
Hannis and Muddiman, "Detection of double-stranded PCR amplicons at the attomole level electrosprayed from low nanomolar solutions using FT-ICR mass spectrometry," Fresenius J. Anal Chen. (2001) 369:246-251. cited by other .
Hayashi, et al., "Phylogenetic analysis of the human guy microbiota using 16S rDNA close libraries and strictly anaerobic culture based methods," Microbiol. Immunol. (2002) 46:535-548. cited by other .
Hoffmann, et al., "Universal primer set for the full-length amplification of all infulenza A viruses," Arch. Virol. (2001) 146:2275-2289. cited by other .
Isola, et al., "Maldi-Tof mass spectrometric method for detection of hybridized DNA oligomers," Anal. Chem. (2001) 73:2126-2131. cited by other .
Jakowski and Soler, "Mass spectrometry of DNA: Part 2.sup..cndot.Quantitative estimation of base composition," Eur. J. Mass Spectrom. Biochem. Med. Environ. Res. 1980) 1:45-52. cited by other .
Kageyama and Benno, "Rapid detection f human fecal Eubacterium species and related genera by tested PCR method," Microbiol. Immunol. (2001) 45:315-318. cited by other .
Little, et al., "Rapid sequencling of oligonucleotides by high-resolution mas sspectrometry," J. Am. Chem. Soc. (1994) 116:4893-4897. cited by other .
Liu, et al., "Improving the microdialysis procedure for electrospray ionization mass spectrometry of biological samples," J. Mass. Spectrom. (1997) 32:425-431. cited by other .
Mangrum, et al., "Solution composition and thermal denaturation for the production of single-stranded PCR amplicons: piperidine-induced destabilization of the DNA duplex," J. Am. Soc. Mass Spectrom. (2002) 13:232-240. cited by other .
McCabe, et al., "Bacterial species identification after DNA amplification with a universal primer pair," Mol. Genet. Metab. (1999) 66:205-211. cited by other .
Meiyu, et al., "Detection of flaviviruses by reverse transcriptase-polymerase chain reaction with the universal primer set," Microbiol. Immunol. (1997) 41:209-213. cited by other .
Moricca, et al., "Detection of Fusarium oxysporum f.sp. vasinifectum in cotton tissue by polymerase chain reaction," Plant Pathol. (1998) 47:486-494. cited by other .
Muddiman, et al., "Characterization of PCR products for Bacilli using electrospray ionization FTICR mass spectrometry," Anal Chem. (1996) 68:3705-3712. cited by other .
Nagpal, et al., "Utility of 16S-23S rRNA spacer region methodology: how similar are interspace regions within a genome and between strains for closely related organisms?," J. Microbiol. Methods (1998) 33:211-219. cited by other .
Null, et al., "Preparation of single-stranded PCR products for electrospray ionization mass spectrometry using the DNA repair enzyme lambda exonuclease," Analyst (2000) 125:619-626. cited by other .
Null, et al., "Evaluation of sample preparation technique for mass measurements of PCR products using ESI-FT-ICR mass spectrometry," Am Soc. Mass Speectrom. (2002) 13:338-344. cited by other .
Null and Muddiman, "Determination of a correction to improve mass measurement accuracy of isotopically unresolved polymerase chain reaction amplicons by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry," Rapid Comm. Mass Spectrom. (2003) 17:1714-1722. cited by other .
Null and Muddiman, "Perspectives on the use of electrospray ionization Fourier transform ion ion cyclotron resonance mess spectrometry for short tandem repeat genotyping in the post genome era," J. Mass Spectrom. (2001) 36:589-606. cited by other .
Null, et al., "Genotyping of simple and compound short tandem repear loci using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry," Anal. Chem. (2001) 73:4514-4521. cited by other .
Null, et al., "Implications of hydrophobicity and free energy of solvation for characterization of nucleic acids by electrospray ionization mass spectrometry," Anal. Chem. (2003) 75:1331-1339. cited by other .
Peng, et al., "Rapid detection of Shigella species in environmental sewage by an immunocapture PCR with universal primers," App. Environ. Microbiol. (2002) 68:2580-2583. cited by other .
Pomerantz, et al., "Determination of oligonucleotide composition from mass spectrometrically measured molecular weight," J. Am. Soc. Mass Spectrom. (1993) 4:204-209. cited by other .
Ross, et al., "Discrimination of single-nucleotide polymorphisms in human DNA using peptide nucleic acid probes detected by MALDI-TOF mass spectrometry," Anal. Chem. (1997) 69:4197-4202. cited by other .
Scaramozzino, et al., "Comparison of Flavivirus universal primer pairs and development of a rapid, highly sensitive heminested reverse transcription-PCR assay for detection of flaviviruses targeted to a conserved region of the NS5 gene sequences," J. Clin. Microbiol. (2001) 39:1922-1927. cited by other .
Shaver, et al., "Restriction fragment length polymorphism of rRNA operons for discrimination and intergenic spacer sequences for cataloging of Bacilus subtilis sub-groups," J. Microbiol. Methods (2002) 50:215-223. cited by other .
Srinivasan, et al., "Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry as a rapid screening method to detect mutations causing Tay-Sachs disease," Rapid Comm. Mass Spectrom. (1997) 11:1144-1150. cited by other .
Steffens and Roy, "Sequence analysis of mitochondrial DNA hypervariable regions using infrared fluorescence detection," Bio/Techniques (1998) 24:1044-1046. cited by other .
Wunschel. et al., "Mass spectrometric characterization of DNA for molecular biological applications: advances using MALDI and ESI," Adv. Mass Spectrom., vol. 14, Karjalainen, et al., (eds.) 1998. Elsevier, Amsterdam. cited by other .
Bahrmand, A. R. et al., "Use of restriction enzyme analysis of amplified DNA coding for the hsp65 gene and polymerase chain reaction with universal primer for rapid differentiation of mycobacterium species in the clinical laboratory," Scand. J. Infect. Diseases (1998) 30(5):477-80. cited by other .
Bahrmand, A.R. et al., "Polymerase chain reaction of bacterial genomes with single universal primer: application to distinguishing mycobacteria species," Mol. Cell. Probes (1996) 10(2):117-122. cited by other .
Bastia, T. et al., "Organelle DNA analysis of Solanum and Brassica somatic hybrids by PCR with `universal primers`," Theoretical and Applied Genetics (2001) 102(8):1265-1272. cited by other .
Biovin-Jahns, V. et al., "Bacterial Diversity in a Deep-Subsurface Clay Environment," Appl. Environ. Micrbiol. (1996) 62(9):3405-3412. cited by other .
Bowen, J. et al., "The native virulence plasmid combination affects the segregational stability of a theta-replicating shuttle vector in Bacillus anthracis var. New Hampshire," J Appl Microbiol. (1999) 87(2):270-278. cited by other .
Cespedes, A. et al., "Polymerase chain reaction restriction fragment length polymorphism analysis of a short fragment of the cytochrome b gene for identification of flatfish species," J. Food Protection (1998) 61(12):1684-1685. cited by other .
Chen, C. A. et al., "Universal primers for amplification of mitochondrial small subunit ribosomal RNA-encoding gene in scleractinian corals," Marine Biotech. (2000) 2(2):146-153. cited by other .
Cho, M. et al., "Application of the ribonuclease P (RNaseP) RNA gene sequence for phylogenetic analysis for the gene Saccharomonospora," Internat. J. of Sys. Bacteriol. (1998) 48:1223-1230. cited by other .
Cornel, A. J. et al., "Polymerase chain reaction species diagnostic assay for Anopheles quadrimaculatus cryptic species (Diptera: Cuclicidae) based on ribosomal DNA ITS2 sequences," Journal of Medical Entomology (1996) 33(1):109-116. cited by other .
Crain, P. F. et al., "Applications of mass spectrometry tot he characterization of oligonucleotides and nucleic acids," Curr Opin Biotechnol (1998) 9(1):25-34. cited by other .
Crespillo, M. et al., "Mitochondrial DNA sequences for 118 individuals from northeaster Spain," Int. J. Legal Med. (2000) 114:130-132. cited by other .
Deforce, D. L. et al., "Analysis of oligonucleotides by ESI-MS," Advances in Chromatography (2000) 40:539-566. cited by other .
Dias Neto, E. et al., "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags," PNAS (2000) 97(7):3491-3496. cited by other .
Dinauer, D. M. et al., "Sequence-based typing of HLA class II DQB1," Tissue Antigens (2000) 55(4):364-368. cited by other .
Dubernet, S. et al., "A PCR-based method for identification of Lactobacilli at the genus level," FEMS Microbiology Letters (2002) 214(2):271-275. cited by other .
Fox, A. et al., "Identification and detection of bacteria: electrospray MS-MS versus derivatization/GC-MS," Proceedings of the ERDEC Scientific Conference on Chemical and Biological Defense Research (1996) Aberdeen Proving Ground, Md., Nov. 15-18, 1994: p. 39.44. cited by other .
Gattermann, N. et al., "Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients with Acquired Idiopathic Siderblastic Anemia," Blood (1997) 90(12):4961-4972. cited by other .
Griffin, T. J. et al., "Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry," Trends in Biotechnology (2000) 18(2):77-84. cited by other .
Hahner, S. et al., "Analysis of short tandem repeat polymorphisms by electrospray ion trap mass spectrometry," Nucleic Acids Res. (2000) 28(18):E82. cited by other .
Hannis, J. C. et al., "Genotyping complex short tandem repeats using electrospray ionization Fourier transform ion cyclotron resonance multistage mass spectrometry," Proceedings of SPIE- The International Society for Optical Engineering (2000) 3926:36-47. cited by other .
Henchal, E. A. et al., "Sensitivity and specificity of a universal primer set for the rapid diagnosis of dengue virus infections by polymerase chain reaction and nucleic acid hybridization," American Journal of Tropical Medicine and Hygiene (1991) 45(4):418-428. cited by other .
Herrmann, B. et al., "Differentiation of Chlamydia spp. by Sequence Determination and Restriction Endonuclease Clevage of RNase P RNA Genes," J. Clin. Microbiol. (1996) 34(8):1897-1902. cited by other .
Higgins, G. S. et al., "Competitive oligonucleotide single-base extension combined with mass spectrometric detection for mutation screening," BioTechniques (1997) 23(4):710-714. cited by other .
Honda, K. et al., "Universal method of hypersensitive nested PCR toward forensic DNA typing," International Congress Series (1998) 7:28-30. cited by other .
Johnson, Y. A. et al., "Precise molecular weight determination of CPR products of the rRNA intergenic spacer region using electrospray quadrupole mass spectrometry for differentiation of B. subtilis and B. atrophaeus, closely related species of bacilli," J. Microbiol. Methods (2000) 40(3):241-254. cited by other .
Krahmer, M. T. et al., "Electrospray quadrupole mass spectrometry analysis of model olignucleotides and polymerase chain reaction products: determination of base substitutions, nucleotide additions/deletions, and chemical modifications," Anal. Chem. (1999) 71(14):2893-2900. cited by other .
Krahmer, M. T. et al., "MS for identification of single nucleotide polymorphisms and MS/MS for discrimination of isomeric PCR products," Anal. Chem. (2000) 72(17):4033-4040. cited by other .
Leif, H. et al., "Isolation and characterization of the proton-translocating NADH: ubiquinone oxidoreductase from Escherichia coli," Eur. J. Biochem. (1995) 230(2):538-548. cited by other .
Li, J. et al., "Single nucleotide polymorphism determination using primer extension and time-of-flight mess spectrometry," Electrophoresis (1999) 20(6):1258-1265. cited by other .
Liu, Y. et al., "An unusual gene arrangement for the putative chromosome replication origin and circadian expression of dnaN in Synechococcus sp. strain PCC 7942," Gene (1996) 172(1):105-109. cited by other .
Loakes, D. et al., "Nitroindoles as Universal Bases," Nucleosides Nucleotides (1995) 14:1001-1003. cited by other .
Love, B. C. et al., "Cloning and sequence of the groESL heat-shock operon of Pasteurella multocida," Gene (1995) 166(1):179-180. cited by other .
Maiwald, M. et al., "Characterization of contaminating DNA in Taq polymerase which occurs during amplification with a primer set for Legionella 5S ribosomal RNA," Mol. Cell. Probes (1994) 8(1):11-14. cited by other .
Martemyanov, K. A. et al., "Extremely Thermostable Elongation Factor G from Aquifex aeolicus: Cloning, Expression, Purification, and Characterization in a Heterologous Translation System," Protain Expr. Purif. (2000) 18(3):257-261. cited by other .
Matray, T. J. et al., "Synthesis and properties of RNA analogs--oligoribonucleotide N3'.fwdarw.P5' phosphoramidates," Nucleic Acids Res. (1999) 27(20):3976-3985. cited by other .
Messmer, T. O. et al., "Discrimination and Streptococcus pneumoniae from other upper respiratory tract strepococci by arbitarily primed PCR," Clin. Biochem. (1995) 28(6):567-572. cited by other .
Morse, R. et et al., "Nucleotide Sequence of part of the ropC Gene Encoding the .beta.' Subunit of DNA-Dependent RNA Polymerase from some Gram-Positive Bacteria and Comparative Amino Acid Sequence Analysis," System Appl. Microbiol. (1996) 19:150-157. cited by other .
Muddiman, D. C. et al., "Application of secondary ion and matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for the quantitative analysis of biological molecules," Mass Spectrometry Reviews (1995) 14(6):383-429. cited by other .
Muddiman, D. C. et al., "Important aspects concerning the quantification of biomolecules by time-of-flight secondary-ion mass spectrometry," Applied Spectroscopy (1996) 50(2):161-166. cited by other .
Muddiman, D. C. et al., "Precise mass measurement of a double-stranded 500 base-pair (309kDa) polymerase chain reaction product by negative ion eletrospray ionization fourier transform ion cyclotron resonance mass spectrometry," Rapid Commun. Mass Spec. (1999) 13:1201-1204. cited by other .
Muhammad, W. T. et al., "Electrospray ionization quadrupole time-of-flight mass spectrometry for genotyping single nucleotide substitutions in intact polymerase chain reaction products in K-ras and p53," Rapid Commun. Mass Spectrom. (2002) 16(24):2278-2285. cited by other .
Mushegian, A. R. et al., "A minimal gene set for cellular life derived by comparison of complete bacterial genomes," Proc. Natl. Acad. Sci. USA (1996) 93(19):10268-10273. cited by other .
Nakao, H. et al., "Development of a Direct PCR Assay for Detection of the Diphtheria Toxin Gene," J. Clin. Microbiol. (1997) 35(7):1651-1655. cited by other .
Naumov, G. I. et al., "Discrimination between the soil yeast spices Williopsis saturnus and Williopsis suaveolens by the polymerase chain reaction with the universal primer N21," Microbiology (Moscow)(Translation of Mikrobiologiya) (2000) 69(2):229-233. cited by other .
Nishikawa, T. et al., "Reconstruction of active recombinant Shiga toxin (Stx) from recombinant Stx1-A and Stx1-B subunits independently produced by E coli clones," FEMS Microbiol Lett. (1999) 178:13-18. cited by other .
Reid, S. M. et al., "Primary diagnosis of foot-and-mouth disease by reverse transcription polymerase chain reaction," Journal of Virological Methods (2000) 89(1-2):167-176. cited by other .
Reilly, K. et al., "Design and use of 16S ribosomal DNA-directed primers in competitive PCRs to enumerate proteolytic bacteria in the rumen," Microbiol. Ecol. (2002) 43(2):259-270. cited by other .
Ross, P. L. et al., "Analysis of DNA fragments from conventional and microfabricated PCR devices using delayed extraction MALDI-TOF mass spectrometry," Anal. Chem. (1998) 70(10):2067-2073. cited by other .
Sala, M. et al., "Ambiguous base pairing of the purine analogue 1-(2-deoxy-.beta.D-ribofuranosyl)-imidazole-4-carboxamide during PCR," Nucleic Acids Res. (1996) 24(17):3302-6. cited by other .
Sauer, S. et al., "A novel procedure for efficient genotyping of single nucleotide polymorphisms," Nucleic Acids Res. (2000) 28(5):E13. cited by other .
Schram, K. H., "Mass Spectrometry of Nucleic Acid Components," Biomedical Applications of Mass Spectrometry (1990) 34:203-280. cited by other .
Schultz, J. C. et al., "Polymerase chain reaction products analyzed by charge detection mass spectrometry," Rapid Communications in Mass Spectrometry (1999) 13(1):15-20. cited by other .
Seshadri, R. et al., "Differential Expression of Translational Elements by Life Cycle Variants of Coxiella burnetii," Infect. Immun. (1999) 67(11):6026-6033. cited by other .
Shaver, Y. J. et al., "Variation in 16S-23S rRNA intergenic spacer regions among Bacillus subtilis," Molecular Microbiology (2001) 42(1):101-109. cited by other .
Takahashi, H. et al., "Characterization of gyrA, gyrB, grlA and grl B mutations in fluoroquinolone-resistant clinical isolates of Staphylococcus aureus," J. Antimicrob. Chemother. (1998) 41(1):49-57. cited by other .
Tong, J. et al., "Ligation reaction specificities of and NAD.sup.+-dependent DNA ligase from the hyperthermophile Aquifex aeolicus," Nucleic Acids Res. (2000) 28(6):1447-1454. cited by other .
Van Aerschot, A. et al., "In search of acyclic analogues as universal nucleosides in degenerate probes," Nucleosides & Nucleotides (1995) 15(3-5):1053-1056. cited by other .
Van Camp, G. et al., "Amplification and sequencing of variable regions in bacterial 23S ribosomal RNA genes with conserved primer sequences," Curr. Microbiol. (1993) 27(3):147-151. cited by other .
Van Ert, M. N. et al., "Mas spectrometry provides accurate characterization of two genetic marker types in Bacillus anthracis," Biotechniques (2004) 37(4):642-651. cited by other .
Walters, J. J. et al., "Genotyping single nucleotide polymorphisms using intact polymerase chain reaction products by electrospray quadrupole mass spectrometry," Rapid Commun. Mass Spectrom. (2001) 15(18):1752-1759. cited by other .
Welham, K. J. et al., "The Characterization of Micro-organisms by Matrix-assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry," Rapid Commun. Mass Spec. (1988) 12:176-180. cited by other .
Widjojoatmodjo, M. N. et al., "Rapid identification of bacteria by PCR-single-strand conformation polymorphism," J. Clin. Microbiol. (1994) 32(12):3002-3007. cited by other .
Wolter, A. et al., "Negative Ion FAB Mass Spectrometric Analysis of Non-Charged Key Intermediates in Olihonucleotide Synthesis: Rapid Identification of Partially Protected Dinucleoside Monophosphates," Biomed. Environ. Mass Spectrom. (1987) 14:111-116. cited by other .
Woo. T. H. S. et al., "Identification of Leptospira inadai by continuous monitoring of fluorescence during rapid cycle PCR," Systematic and Applied Mirobiology (1998) 21(1):89-96. cited by other .
Wunschel, D. et al., "Discrimination among the B. cereus group, in comparison to B. subtilis, by structural carbohydrate profiles and ribosomal RNA spacer region PCR," Systematic and Applied Microbiology (1994) 17(4):625-635. cited by other .
Wunschel, D. S. et al., "Analysis of double-stranded polymerase chain reaction products from the Bacillus cereus group by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry," Rapid Communications in Mass Spectrometry (1996) 10(1):29-35. cited by other .
Yasui, T. et al., "A specific oligonucleotide primer for the rapid detection of Lactobacillus lindneri by polymerase chain reaction," Can. J. Microbiol. (1997) 43(2):157-163. cited by other .
U.S. Appl. No. 09/798,007, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/156,608, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/318,463, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/318,881, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/319,290, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/319,342, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/326,047, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/435,307, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/430,253, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/660,122, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/660,996, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/660,997, Ibis Biosciences. cited by other .
U.S. Appl. No. 10/660,998, Ibis Biosciences. cited by other .
U.S. Appl. No. 11/233,630, Ibis Biosciences. cited by other .
U.S. Appl. No. 11/331,978, Ibis Biosciences. cited by other .
U.S. Appl. No. 11/331,987, Ibis Biosciences. cited by other .
Alves-Silva, J. et al., "The Ancestry of Brazilian mtDNA Lineages," Am. J. Hum. Genet. (2000) 67:444-461. cited by other .
Anderson et al., "Sequence and organization of the human mitochondrial genome," Nature (1981) 290:457-465. cited by other .
Andreasson et al., "Mitochondrial Sequence Analysis for Forensic Identification Using Pyrosequencing Technology" BioTechniques (2002) 32:124-133. cited by other .
Borrow et al., "SiaD PCR Elisa for confirmation and identification of serogroup Y and W135 meningococcal infections" FEMS Microbiological Letters (1998) 159:209-214. cited by other .
Carracedo et al., "DNA commission of the international society for forensic genetics: guidelines for mitochondrial DNA typing" Forensic Science International (2000) 110:79-85. cited by other .
Case et al., "Maternal inheritance of mitochondrial DNA polymorphisms in cultured human fibroblasts," Somatic Cell Genetics (1981) 7:103-108. cited by other .
Chang, P.-K. et al., "aflT, a MFS transporter-encoding gene located in the aflatoxin gene cluster, does not have a significant role in aflatoxin secretion," Fungal Genet.Biol. (2004) 41:911-920. cited by other .
Chen, N. et al., "The genomic sequence of ectromelia virus, the causative agent of mousepox," Virology (2003) 317:165-186. cited by other .
EMBL Accession No. S90302, Human, Muscle, Mitochondrial Mutant, 22 nt, segment 2 of 2 (XP002436791) Nov. 26, 1993. cited by other .
Esmans et al., "Liquid Chromatography-Mass Spectrometry in Nucleoside, nucleotide and modified nucleotide characterization" J. of Chromatography A (1998) 794:109-127. cited by other .
European Search Report for 02709785.6 dated Oct. 10, 2005. cited by other .
Figueiredo et al., "Identification of Brazilian flaviviruses by a simplified reverse transcription-polymerase chain reaction method using Flavivirus universal primers" Am J of Trop Med & Hygiene (1998) 59:357-362. cited by other .
Fox et al., "Report of the `Bioterrorism Workshop` Duke University Thomas Center on Apr. 24, 2002 organized by US Army Research Office" Journal of Microbiological Methods (2002) 51:247-254. cited by other .
Fuerstenau et al., "Molecular Weight Determination of Megadalton DNA Electrospray Ions Using Charge Detection Time-of-flight Mass Spectrometry" Rapid Comm. Mass Spec. (1995) 9:1528-1538. cited by other .
Fujioka et al., "Analysis of enterovirus genotypes using single-strand conformation polymorphisms of polymerase chain reaction products" J. Virol. Meth. (1995) 51:253-258. cited by other .
Gabriel et al., "Improved mtDNA sequence analysis of forensic remains using a "mini-primer set" amplification strategy" Journal of Forensic Sciences (2001) 46:247-253. cited by other .
Ginther et al., "Identifying individuals by sequencing mitochondrial DNA from teeth," Nature Genetics (1992) 2:135-138. cited by other .
Giles et al., "Maternal inheritance of human mitochondrial DNA," PNAS (1980) 77:6715-6719. cited by other .
Greenberg et al., "Intraspecific nucleotide sequence variability surrounding the origin of replication in human mitochondrial DNA," Gene (1983) 21:33-49. cited by other .
Grzybowski "Extremely high levels of human mitochondrial DNA heteroplasmy in single hair roots" Electrophoresis (2000) 21:548-553. cited by other .
Holland et al., "Mitochondrial DNA Sequence Analysis of Human Skeletal Remains: Identification of Remains from the Vietnam War," Journal of Forensic Sciences (1993) 38:542-553. cited by other .
Hutchison et al., "Maternal inheritance of mammalian mitochondrial DNA," Nature (1974) 251:536-538. cited by other .
Ingman et al., "Mitochondrial genome variation and the origin of modern humans" Nature (2000) 408:708-713. cited by other .
Isola et al., "MALDI-TOF mass spectrometric method for detection of hybridized DNA oligomers" Analytical Chemistry (2001) 73:2126-2131. cited by other .
Jankowski et al., "Mass spectrometry of DNA. Part 2. Quantitative estimation of base composition" European Journal of Mass Spectrometry in Biochemistry, Medicine, and Environmental Research (1980) 1:45-52. cited by other .
Jiang et al., "Multiple Trait Analysis of Genetic Mapping for Quantitative Trait Loci Genetics" Genetics (1995) 140:1111-1127. cited by other .
Jiang et al., "A highly efficient and automated method of purifying and desalting PCR products for analysis by electrospray ionization mass spectrometry." Anal. Biochem. (2003) 316:50-57. cited by other .
Jurinke et al., "Detection of hepatitis B virus DNA in serum samples via nested PCR and MALDI-TOF mass spectrometry" Genetic Analysis: Biomolecular Engineering (1996) 13:67-71. cited by other .
Ke et al., "Development of a PCR Assay for Rapid Detection of Enterococci" Journal of Clinical Microbiology (1999) 37:3497-3503. cited by other .
Kilpatrick et al., "Group-Specific Identification of Polioviruses by PCR Using Primer Containing Mixed-Base or Deoxyinosine Residues at Positions of Codon Degeneracy" J. Clin. Microbiol. (1996) 34:2990-2996. cited by other .
Kupke et al., "Molecular Characterization of Lantibiotic-synthesizing Enzyme EpiD Reveals a Function for Bacterial Dfp Proteins i Coenzyme a Biosynthesis" Journal of Biological Chemistry (2000) 275:31838-31846. cited by other .
Lebedev, Y. et al "Oligonucleotides containing 2-aminoadenine and 5-methycytosine are more effective as primers for PCR amplification than their nonmodified counterparts" Genetic Analysis: Biomolecular Engineering (1996) 13:15-21. cited by other .
Lewers et al., "Detection of Linked QTL for Soybean Brown Stem Rot Resistance in `BSR 101` as Expressed in a Growth Chamber Environment" Molecular Breeding (1999) 5:33-42. cited by other .
Little et al., "MALDI on a Chip: Analysis of Arrays of Low-Femtomole to Subfemtomole Quantities of Synthetic Oligonucleotides and DNA Diagnostic Products Dispensed by a Piezoelectric Pipet" Analytical Chemistry (1997) 69:4540-4546. cited by other .
Miller et al., "A compendium of human mitochondrial DNA control region: development of an international standard forensic database," Croat Med. J. (2001) 42:315-327. cited by other .
Nilsson et al., "Evaluation of mitochondrial DNA coding region assays for ncreased discrimination in forensic analysis" Forensic Science International: Genetics (2008) 2:1-8. cited by other .
Norder et al., "Typing of Hepatitis B Virus Genomes by a Simplified Polymerase Chain Reaction" J. Med. Virol. (1990) 31:215-221. cited by other .
Paterson et al., "Fine Mapping of Quantitative Trait Loci Using Selected Overlapping Recombinant Chromosomes, in an Interspecies Cross of Tomato" Genetics (1990) 124:735-742. cited by other .
Raaum, R. L. et al., "Catarrhine primate divergence dates estimated from complete mitochondrial genomes: concordance with fossil and nuclear DNA evidence," J. Hum. Evol. (2005) 48:237-257. cited by other .
Schena M. "Genome analysis with gene expression microarrays" Bioessays (1996) 18:427-431. cited by other .
Senko et al., "Determination of Monoisotopic Masses and Ion Populations for Large Biomolecules from Resolved Isotopic Distributions," J. Am. Soc. Mass Spectrom. (1995) 6:229. cited by other .
Stoneking et al., "Population variation of human mDNA control region sequences detected by enzymatic amplification and sequence-specific oligonucleotide probes," American Journal of Human Genetics (1991) 48:370-382. cited by other .
Tatuch et al., "Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high" Am. J. Hum. Genet. (1992) 50:852-858. cited by other .
Vanderhallen et al., "Identification of Encephalomyocarditis Virus in Clinical Samples by Reverse Transcription-PCR Followed by Genetic Typing Using Sequence Analysis" J. Clin. Microbiol. (1998) 36:3463-3467. cited by other .
Zeng et al., "Precision Mapping of Quantitative Trait Loci" Genetics (1994) 136:1457-1468. cited by other .
Table listing related applications and file history excerpts from those related applications. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Jan. 8, 2003. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Jan. 31, 2003. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed May 20, 2003. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Sep. 22, 2003. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Aug. 10, 2004. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Aug. 10, 2004. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Dec. 9, 2004. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed May 18, 2004. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Jul. 19, 2005. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Sep. 15, 2005. cited by other .
U.S. Appl. No. 10/660,997 Office Communication Mailed Nov. 21, 2006. cited by other .
U.S. Appl. No. 10/660,122 Office Communication Mailed Sep. 19, 2007. cited by other .
U.S. Appl. No. 10/660,996 Office Communication Mailed Jul. 12, 2006. cited by other .
U.S. Appl. No. 10/660,996 Office Communication Mailed Nov. 22, 2006. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Dec. 18, 2002. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Nov. 13, 2003. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Jul. 13, 2004. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Aug. 10, 2004. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed May 19, 2005. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Aug. 11, 2005. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Jul. 12, 2006. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Nov. 20, 2006. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Nov. 17, 2006. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Oct. 10, 2007. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed Jan. 17, 2008. cited by other .
International Search Report for PCT/US02/20336 dated Feb. 3, 2003. cited by other .
International Preliminary Examination Report for PCT/US02/20336 dated May 12, 2004. cited by other .
International Search Report for PCT/US2005/000386 dated May 9, 2006. cited by other .
International Search Report for PCT/US03/38761 dated Dec. 30, 2005. cited by other .
International Search Report for PCT/US2004/011877 dated Apr. 20, 2006. cited by other .
Supplemental European Search Report for EP 03796752.8 dated Aug. 14, 2007. cited by other .
U.S. Appl. No. 90/010,209, filed Jun. 27, 2008, Ecker et al., Re-exam. cited by other .
U.S. Appl. No. 90/010,210, filed Jun. 27, 2008, Ecker et al., Re-exam. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Jun. 2, 2005 with associated Information Disclosure Statement filed Nov. 28, 2005. cited by other .
U.S. Appl. No. 10/660,997 Office Communication Mailed Apr. 26, 2007 with associated Information Disclosure Statement filed Feb. 20, 2007. cited by other .
U.S. Appl. No. 10/660,996 Office Communication Mailed Jul. 10, 2007 with associated Information Disclosure Statement filed Feb. 21, 2007. cited by other .
U.S. Appl. No. 11/233,630 Office Communication Mailed Apr. 16, 2008. cited by other .
U.S. Appl. No. 11/331,987 Office Communication Mailed Jul. 9, 2008. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Jun. 12, 2008. cited by other .
U.S. Appl. No. 10/418,514 Office Communication Mailed Apr. 15, 2008. cited by other .
U.S. Appl. No. 10/418,514 Office Communication Mailed Jul. 1, 2008. cited by other .
U.S. Appl. No. 90/010,209 Office Communication Mailed Jun. 27, 2008. cited by other .
U.S. Appl. No. 90/010,209 Office Communication Mailed Jul. 22, 2008. cited by other .
U.S. Appl. No. 90/010,210 Office Communication Mailed Jun. 27, 2008. cited by other .
U.S. Appl. No. 90/010,210 Office Communication Mailed Jul. 22, 2008. cited by other .
European Patent Office Communication 96(2) EPC for 02709785.6 dated Nov. 20, 2006. cited by other .
European Supplemental Search Report for 03810055.8 dated Jul. 9, 2007. cited by other .
Gendel et al., "Computational analysis of the specificity of 16S rRNA-derived signature sequences for identifying food-related microbes" Food Microbiology (1996) 13:1-15. cited by other .
International Search Report for PCT/US03/38795 dated Apr. 19, 2004. cited by other .
International Search Report for PCT/US03/38757 dated Jun. 24, 2004. cited by other .
International Search Report for PCT/US03/38505 dated Apr. 12, 2005. cited by other .
International Search Report for PCT/US2005/018031 dated Jun. 28, 2006. cited by other .
Jackson et al., "Mass spectrometry for genotyping: an emerging tool for molecular medicine" Molecular Medicine Today (2000) 6:271-276. cited by other .
Table listing related applications and office actions and rejections from those related applications, 2008. cited by other .
U.S. Appl. No. 10/660,998 Office Communication Mailed Sep. 19, 2008. cited by other .
U.S. Appl. No. 11/233,630 Office Communication Mailed Oct. 2, 2008. cited by other .
U.S. Appl. No. 90/010,209, filed Mar. 25, 2008, Kreiswirth et al. cited by other .
U.S. Appl. No. 90/010,210, filed Jun. 27, 2008, Ecker et al. cited by other .
Aaserud et al., "DNA sequencing with balckbody infrared radioactive dissociation of electrosprayed ions" Int. J. Mass. Spectrom. Ion Processes, (1997) 167-168: 705-712 (Reference not found in. cited by other .
Adam et al., Molecular structure of the two-dimensional hexon crystalline array and of adenovirus capsid: Acta Microbiol. Immuno. Hung. (1998) 45:305-310. cited by other .
Adam et al., "Intertype specific epitope structure of adenovirus hexon" Acta Microbiol. Immuno. Hung. (1998) 45:311-316. cited by other .
Adam et al., "Characterization of intertype specific epitopes on adenovirus hexons" Arch. Virol. (1998) 143:1669-1682. cited by other .
Adrian et al., "DNA restriction analysis of adenovirus prototypes 1 to 41" Arch. Virol. (1986) 91:277-290. cited by other .
Adzhar et al., "Universal oligonucleotides for the detection of infectious bronchitis virus by the polymerase chain reaction" Avian Pathology (1996) 25:817-836. cited by other .
Akalu et al., "Rapid identification of subgenera of human adenovirus by serological and PCR assays" J. Virol Methods (1998) 71:187-196. cited by other .
Allaouchiche et al., "Clinical Impact of Rapid Oxacillin Susceptibility Testing Using a PCR Assay in Staphylococcus aureus Bactaeremia" J. Infect. (1999) 39(3):198-204. cited by other .
Allawi, H.T. & Santa Lucia J., Jr. Thermodynamics and NMR of internal G.T. mismatches in DNA, Biochemistry, 36, 10581-94 (1997). cited by other .
Altschuel et al., J. Mol. Biol., 215, 403-410 (1990). cited by other .
Altschul et al., Nucl. Acid Res., 25:3389-3402 (1997). cited by other .
Amano et al., "Detection of influenza virus: traditional approaches and development of biosensors" Anal. Bioanal. Chem. (2005) 381:156-164. cited by other .
Amexis et al., "Quantitiative mutant analysis of viral quasispecies by chip-based matrix-assisted laser desorption/ionization of time-of-flight mass spectrometry" PNAS (2001) 98(21):12097-12102; Correction: 98(24):14186. cited by other .
Anderson and Young, Quantitative Filter Hybridization in Nucleic Acid Hybridization (1985), pp. 73-111. cited by other .
Anthony et al., "Use of the Polymerase Chain Reaction for Rapid Detection of High-Level Mupirocin Resistance in Staphylococci" Eur. J. Clin. Microbiol. Infect. Dis. (1999) 18(1):30-34. cited by other .
Application for Grant by David Mitchell Lubmann dated Oct. 25, 1992 and Oct. 29, 1992. cited by other .
Application for Continuation Grant by David Mitchell Lubmann dated Jun. 10, 1994 and Jun. 24, 1994. cited by other .
Application for Grant by David Mitchell Lubmann dated Sep. 1, 1994 and Sep. 27, 1994. cited by other .
Application for Continuation Grant by David Mitchell Lubmann dated Jun. 4, 1996 and Jun. 14, 1996. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed May 28, 2003. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed May 19, 2003 interview summary report. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed May 23, 2003. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Jul. 22, 2008. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed May 23, 2005. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Jun. 2, 2006. cited by other .
U.S. Appl. No. 10/323,438 Office Communication Mailed Nov. 20, 2003. cited by other .
U.S. Appl. No. 10/323,438 Office Communication Mailed Jul. 26, 2004. cited by other .
U.S. Appl. No. 10/325,527 Office Communication Mailed Dec. 3, 2003. cited by other .
U.S. Appl. No. 10/325,527 Office Communication Mailed Aug. 16, 2004. cited by other .
U.S. Appl. No. 10/325,527 Office Communication Mailed Mar. 11, 2005. cited by other .
U.S. Appl. No. 10/326,642 Office Communication Mailed Nov. 21, 2003. cited by other .
U.S. Appl. No. 10/326,642 Office Communication Mailed Jul.14, 2004. cited by other .
U.S. Appl. No. 10/660,998 Office Communication Mailed Apr. 7, 2009. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed Oct. 17, 2007. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed Jan. 23, 2008. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed Nov. 3, 2008. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Jun. 4, 2009. cited by other .
U.S. Appl. No. 10/829,826 Office Communication Mailed Jul. 6, 2007. cited by other .
U.S. Appl. No. 10/829,826 Office Communication Mailed Apr. 4, 2008. cited by other .
U.S. Appl. No. 10/829,826 Office Communication Mailed Dec. 10, 2008. cited by other .
U.S. Appl. No. 10/844,938 Office Communication Mailed Feb. 2, 2007. cited by other .
U.S. Appl. No. 10/844,938 Office Communication Mailed Aug. 7, 2007. cited by other .
U.S. Appl. No. 10/844,938 Office Communication Mailed May 20, 2008. cited by other .
U.S. Appl. No. 10/844,938 Office Communication Mailed Jan. 30, 2009. cited by other .
U.S. Appl. No. 10/891,337 Office Communication Mailed Apr. 20, 2009. cited by other .
U.S. Appl. No. 10/933,928 Office Communication Mailed Jun. 2, 2006. cited by other .
U.S. Appl. No. 10/943,344 Office Communication Mailed Feb. 27, 2007. cited by other .
U.S. Appl. No. 10/943,344 Office Communication Mailed May 21, 2008. cited by other .
U.S. Appl. No. 10/943,344 Office Communication Mailed Feb. 23, 2009. cited by other .
U.S. Appl. No. 11/059,776 Office Communication Mailed Jan. 23, 2008. cited by other .
U.S. Appl. No. 11/060,135 Office Communication Mailed Mar. 25, 2008. cited by other .
U.S. Appl. No. 11/060,135 Office Communication Mailed Jan. 2, 2009. cited by other .
U.S. Appl. No. 11/136,134 Office Communication Mailed Jun. 20, 2007 +A887. cited by other .
U.S. Appl. No. 11/136,134 Office Communication Mailed Mar. 26, 2008. cited by other .
U.S. Appl. No. 11/136,134 Office Communication Mailed Oct. 31, 2008. cited by other .
U.S. Appl. No. 11/136,134 Office Communication Mailed Feb. 12, 2009. cited by other .
U.S. Appl. No. 11/136,134 Office Communication Mailed May 21, 2009. cited by other .
U.S. Appl. No. 11/331,978 Office Communication Mailed Aug. 15, 2008. cited by other .
U.S. Appl. No. 11/331,978 Office Communication Mailed Oct. 17, 2008. cited by other .
U.S. Appl. No. 11/331,978 Office Communication Mailed Jun. 2, 2008 (interview summary). cited by other .
U.S. Appl. No. 11/404,561 Office Communication Mailed May 16, 2008. cited by other .
U.S. Appl. No. 11/404,561 Office Communication Mailed Feb. 4, 2009. cited by other .
U.S. Appl. No. 11/409,535 Office Communication Mailed Apr. 16, 2008. cited by other .
U.S. Appl. No. 11/491,376 Office Communication Mailed Oct. 31, 2008. cited by other .
U.S. Appl. No. 11/491,376 Office Communication Mailed Apr. 22, 2009. cited by other .
U.S. Appl. No. 11/582,859 Office Communication Mailed Oct. 21, 2008. cited by other .
U.S. Appl. No. 11/582,863 Office Communication Mailed Aug. 20, 2007. cited by other .
U.S. Appl. No. 11/582,863 Office Communication Mailed Jun. 17, 2008. cited by other .
U.S. Appl. No. 11/582,863 Office Communication Mailed Feb. 26, 2009. cited by other .
U.S. Appl. No. 11/582,930 Office Communication Mailed Sep. 14, 2007. cited by other .
U.S. Appl. No. 11/582,930 Office Communication Mailed May 2, 2008. cited by other .
U.S. Appl. No. 11/582,930 Office Communication Mailed Oct. 24, 2008. cited by other .
U.S. Appl. No. 11/582,930 Office Communication Mailed Jan. 16, 2009. cited by other .
U.S. Appl. No. 12/211,641 Office Communication Mailed Apr. 17, 2009. cited by other .
Arbique et al., "Comparison of the Velogene Rapid MRSA Identification Assay, Denka MRSA-Screen Assay, and BBL Crystal MRSA ID System for rapid identification of methicillin-resistant Staphylococcus aureus" Diagn. Microbiol. Infect. Dis. (2001) 40(1-2):5-10. cited by other .
Archer, G. L. et al., "Detection of Methicillin Resistance in Staphylococci by Using a DNA Probe," Antimicrob. Agents Chemother. (1990) 34(9): 1720-1724. cited by other .
Armstrong, P. et al., "Sensitive and Specific Colorimetric Dot Assay to Detect Eastern Equine Encephalomyelitis Viral RNA in Mosquitoes After PCR Amplification" J. Med, Entomol. (1995) 32(1): 42-52. cited by other .
Arnal et al., "Quantification of Hepatitis A virus in shellfish by competitive reverse transcription PCR with coextraction of standard RNA" Applied and Environmental Microbiology, American Society for Microbiology (1999) 65(1):322-326. cited by other .
Aronsson et al., Persistence of the influenza A/WSN/33 virus RNA at midbrain levels of immunodefective mice, Online Publication Date: Apr. 1, 2001, Journal of the NeuroVirology 7:117-124, 2001. cited by other .
Avellon et al. "Rapid and sensitive diagnosis of human adenovirus infections by a generic polymerase chain reaction" J. Virol. Methods (2001) 92:113-120. cited by other .
Azevedo et al. "Detection of influenza, parainfluenza, adenovirus and respiratory syncytial virus during asthma attacks in children older than two years old." Allergol. Immunopathol. (2003) 31:311-317. cited by other .
Baba et al., "Genome and virulence determinants of high virulence community-acquired MRSA" Lancet (2002) 359:1819-1827. cited by other .
Bai, J, T.H. Liu and D.M.. Lubman, "Matrix-Assisted Laser Desorption/lonization Mass Spectrometry of Restriction Enzyme-Digested Plasmid DNA Using an Active Nafion Substrate," 8 Rapid Commun. Mass Spectrom. 687-691 (1994) ('787 reexamination). cited by other .
Banik et al. "Multiplex PCR assay for rapid identification of oculopathogenic adenoviruses by amplification of the fiber and hexon genes" J. Clin. Microbiol (2005) 43:1064-1068. cited by other .
Baron, E. J., "Genetic Aspects of Methicillin Resistance in Staphylococcus aureus and Methods Used for its Detection in Clinical Laboratories in the United States," J. Chemother. (1995) 7(Supp1.3): 87-92. cited by other .
Barr et al., "An Influenza A(H3) Reassortant Was Epidemic in Australia and New Zealand in 2003" J. Med. Virol. (2005) 76:391-397. cited by other .
Barski, P. et al., "Rapid assay for detection of methicillin-resistant Staphylococcus aureus using multiplex PCR," Mol. Cell Probes (1996) 10:471-475. cited by other .
Beall, B., et al. "Survey of emm Gene Sequences and T-Antigen Types from Systemic Streptococcus pyogenes Infection Isolates Collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995" (1997), J. Clin. Micro. 35, 1231-1235. cited by other .
Beall et al., "Sequencing emm-Specific PCR Products for Routine and Accurate Typing of Group A Streptococci" (1996) J. Clin. Micro. 34, 953-958. cited by other .
Benko, M. et al., "Family Adenoviridae", Virus taxonomy, VIIIth report of the International Committee on Taxonomy of Viruses (2004) Fauquet, C.M. et al. (Eds.) Academic Press, New York, pp. 213-228. cited by other .
Berencsi, G. et al., "Molecular Biological Characterization of Adenovirus DNA", Acta Microbiol. Immunol. Hung, 1998, vol. 45, Nos. 3-4; pp. 297-304. cited by other .
Bisno, A.L. (1995) in Principles and Practice of Infectious Diseases, eds., Mandell, G.L., Bennett, J.E. & Dolin, R. (Churchill Livingston, New York), vol. 2, pp. 1786-1799. cited by other .
Blaiotta, G. et al., "PCR detection of staphylococcal enterotoxin genes in Staphyiococcus spp. strains isolated from meat and dairy products. Evidence for new variants of seG and sel in S. aureus AB-8802," J. Appl. Microbiol. (2004) 97:719-730. cited by other .
Bolton and Mccarthy, Proc. Natl. Acad. Sci. U.S.A., 48, (1962), pp. 1390-1397. cited by other .
Bont, Thomas et al., "Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based detection of microsatellite instabilities in coding DNA sequences: a novel approach to identify DNA-mismatch repair-deficient cancer cells," Clinical Chemistry, 49(4):552-561 Apr. 2003. cited by other .
Boubaker, K. et al., "Panton-Valentine Leukocidin and Staphyloccoccal Skin Infections in Schoolchildren," Emerg.Infct. Dis. (2004) 10(1):121-124. cited by other .
Bowers, K. M. et al., "Screening for methicillin resistance in Staphylococars aureus and coagulase-negative staphylococci: evaluation of three selective and Mastalex-MRSA latex agglutination," Br. J. Biomed. Sci. (2003) 60(2):71-74. cited by other .
Brakstad, O. G, et al., "Multiplex polylnerase chain reaction for detection of genes for Staphylococcus aureus themonuclease and methicillin resistance and correlation with oxacillin resistance," APMIS (1993) 101:681-688. cited by other .
Brakstad, O. G. et al., "Direct identification of Staphylococcus aureus in blood cultures by detection of the gene, encoding the thermostable nuclease or the gene product," APMIS (1995) 103:209-218. cited by other .
Brandt, C.D., et al., "Infections in 18,000 Infants and Children in a Controlled Study of Respiration Tract Disease. I. Adenovirus Pathogenicity in Relation to Serologic Type and Illness Syndrome," Am. J. Epidemio.; 1969, vol. 90, No. 6, pp. 484-500. cited by other .
Brayshaw, D. P., "Methicillin-resistant Staphylococcus aureus: evaluation of detection techniques on laboratory-passaged organisms," Br. J Biomed. Sci. (1999) 56:170-176. cited by other .
Brightvvell et al., "Development of internal controls for PCR detection of Bacillus anthracis" Molecular and Cellular Probes (1998) 12(6):367-377. cited by other .
Brightvvell , G. et a., "Genetic targets for the detection and identifiaction of Venezuelan equine encephalitis viruses," Arch. Virol (1998) 143(4): 731-742. cited by other .
Bronzoni, R. V. M. et al., "Multiplex nested PCR for Brazilian Alphavirus diagnosis," Trans. R. Soc. Trop. Med. Hyg. (2004) 98(8): 456-461. cited by other .
Bronzoni, R. V. M. et al., "Duplex Reverse Transcription-PCR Followed by Nested PCR Assats for Detection and Identification of Brazilan Alphaviruses and Flaviviruses." J. Clin. Microbiol. (2005) 43(2): 696-702. cited by other .
Brown, "Advances in Molecular Diagnostics for Avian Influenza" Dev. Biol. (2006) 124:93-97. cited by other .
Brownstein et al., "Modulation of Non-Templated Nucleotide Addition by Taq DNA Polymerase: Primer Modifications that Facilitate Genotyping" BioTechniques (1996) 20:1004-1010. cited by other .
Brunaud et al., "T-DNA integration into the Arabidopsis genome depends on sequences of pre-insertion sites" EMBO Rep. (2002) 3(12):1152-1157. cited by other .
Buck et al., "Design Strategies and Performance of Custom DNA Sequencing Primers" Biotechniques (1999) 27:528-536. cited by other .
Butler "DNA profiling and quantitation of human DNA" CCQM BAWG 04122005, Apr. 12, 2005. cited by other .
Carroll, K. C. et al., "Rapid Detection of the Staphylococcal mec A Gene from BACTEC Blood Culture Bottles by the Polymerase Chain Reaction," Am. J. Clin. Pathol. (1996) 106:600-5. cited by other .
Cattoli et al., "Comparison of three rapid detection systems for type A influenza virus on tracheal swabs of experimentally and naturally infected birds" Avian Pathology (2004) 33(4):432-437. cited by other .
Cavassini, M. et al., "Evaluation of MRSA-Screen, a Simple Anti-PBP 2a Slide Latex Agglutination Kit, for Rapid Detection of Methicillin Resistance in Staphylococcus aureus ," J. Clin. Microbial. (1999) 37(5): 1591-1594. cited by other .
Chamberlin et al., "New RNA polymerase from Escerichia coli infected with bacteriophage T7" Nature 228:pp. 227-231 (1970). cited by other .
Chandra, S. et al., "Virus reduction in the preparation and intravenous globulin: in vitro experiments," Transfusion (1999) 39(3): 249-257. cited by other .
Chaves, F. et al., "Molecular Characterization of Resistance to Mupirocin in Methidlin-Susceptible and -Resistant Isolates of Staphylococcus aureu s from Nasal Samples," J. Clin. Microbiol. (2004) 42(2):822-824. cited by other .
Chelly et al., "Transcription of the dystrophin gene in human muscle and non-muscle tissue" Nature (1988) 333(6176):858-860. cited by other .
Chen et al., "Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist)" Virology (2006) 345:416-423. cited by other .
Chen, CH, K. Tang, N. Taranenko and S. Allman, "Laser Desorption Mass Spectrometry for Fast DNA Sequencing," (Nov. 1994), http://www.ornl.gove/sci/techresources/Human.sub.--Genome/publicat/94SANT- A/sequencing/seqtoc.shtml ('787 reexamination). cited by other .
Chmielewicz, B. et al., "Development of a PCR-Based Assay for Detection, Quantification, and Genotyping of Human Adenoviruses," Clin. Chem., 2005, vol. 51, No. 8, pp. 1365-1373. cited by other .
Choi et al., "Detection and subtying of swine influenza H1N1, H1N2 and H3N2 viruses in clinical samples using two multiplex RT-PCR assays" J. Virol. Methods (2002) 102:53-59. cited by other .
Choi, S. et al., "Real-Time PCR Quantification of Human Adenoviruses in Urban Rivers Indicates Genome Prevalence but Low Infectivity," Appl. Environ. Microbiol., 2005, vol. 71, No. 11, pp. 7426-7433. cited by other .
Christel, LA et al., "Rapid, Automated Nucleic Acid Probe Assays Using Silicon Microstructures for Nucleic Acid Concentration" J. Biomech. Eng., 1999, 121, 22-27. cited by other .
Claas, E.C.J. et al., "Internally Controlled Real-Time PCT Monitoring of Adenovirus DNA Load in.Serum or Plasma of Transplant Recipients," J. Clin. Microbiol., 2005, vol. 43, No. 4, pp. 1738-1744. cited by other .
Cloney, L. et al., "Rapid detection of mecA in methicillin resistant Stuphylococcus aureus using cycling probe technology," Mol. Cell Probes (1999) 13:191-197. cited by other .
Couto, I. et al., "Devetopment of Methicillin Resistance in Clinical Isolates of Staphylococcus sciuri by Transcriptional Activation of the mecA Homologue Native to the Species," J. Bacteriol. (2003) 185(2):645-653. cited by other .
Crawford-Miksza, L.K. et al., "Analysis of 15 Adenovirus Hexon Proteins Reveals the Location and Structure of Seven Hypervariable Regions Containing Serotype-Specific Residues," J. Virol., 1996, vol. 70, No. 3, pp. 1836-1844. cited by other .
Crawford-Miksza, L.K. et al., "Adenovirus Serotype Evolution is Driven by Illegitimate Recombination in the Hypervariable Regions of the Hexon Protein," Virol., 1996, vol. 224, pp. 357-367. cited by other .
Crawfor-Miksza et al., "Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease." (1999) 37:1107-1112. cited by other .
Cui, L. et al., "Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomnycin Resistance Expressed by Staphylococcus aureus Mu50," Antimicrob. Agents Chemother. (2000) 44(9):2276-2285. cited by other .
De Sousa, M. A. et al., "Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones," FEMS Immunol. Med. Microbiol. (2004) 40:101-111. cited by other .
De Jong, J.C. et al., "Adenoviruses from Human Immunodeficiency Virus-Infected Individuals, Including Two Strains That Represent New Candidate Serotypes Ad50 and Ad51 of Species B1 and D, Respectively," J. Clin. Microbiol., 1999, vol. 37, No. 12, pp. 3940-3945. cited by other .
Del Vecchio, V. G. et al., "Molecular Genotyping of Methicillin- Resistant Staphylococcus aureus via Fluorophore-Enhanced Repetitive-Sequence PCR," J. Clin. Microbiol. (1995) 33(8):2141-2144. cited by other .
Denis et al., "Development of a semiquantitative PCR assay using internal standard and colorimetric detection on microwell plate for pseudorabies virus" Mol. Cell. Probes (1997) 11(6):439-448. cited by other .
Deurenberg et al., "Rapid detection of Panton-Valentine leukocidin from clinical isolates of Staphylococcus aureus strains by real-time PCR" FEMS Microbiol. Lett. (2004) 240(2):225-228. cited by other .
Di Guilmi, A.M. et al., "Human adenovirus serotype 3 (Ad3) and the Ad3 fiber p[protein bind to a 130-kDa membrane protein on HeLa cells," Virus Res., 1995, vol. 38, pp. 71-81. cited by other .
Diep, B. A. et al., "Complete genome sequence of USA300, an epidemic clone of community acquired meticillin-resistant Staphylococcus aureus," Lancet (2006) 367:731-739. cited by other .
Ding et al., "A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS" PNAS (2003) 100(6):3059-3064. cited by other .
Donehower, et al., "The use of primers from highly conserved pol regions to identify uncharacterized retroviruses by the polymerase chain reaction," J. Vir. Methods (1990) 28:33-46. cited by other .
Donofrio et al., "Detection of influenza A and B in respiratory secretions with the polymerase chain reaction" PCR methods and applications, Cold Spring Harbor Lab. Press vol. 1, No. 4, (1992) pp. 263-268. cited by other .
Doty et al., Proc. Natl. Acad. Sci. USA 46:pp. 461-476 (1960). cited by other .
Drosten et al., New England Journal of Medicine, 2003, 348, pp. 1967-1976. cited by other .
EBI Accession No. AEM14131 (Jan. 11, 2007)--Bacterial DNA PCR Primer Seq ID No. 874. cited by other .
Ebner, K. et al., "Molecular Detection and Quantitative Analysis of the Entire Spectrum of Human Adenoviruses by a Two-Reaction Real-Time PCR Assay," J. Clin. Microbiol., 2005, vol. 43, No. 7, pp. 3049-3053. cited by other .
Ebner et al., "Typing of human adenoviruses in specimens of immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR" Journal of Clinical Microbiology (2006) 44:2808-2815. cited by other .
Echavarria, M. et al., "PCR Method for Detection of Adenovirus in Urine of Healthy and Human Immunodeficiency Virus-Infected Individuals," J. Clin. Microbiol., 1998, vol. 36, No. 11, pp. 3323-3326. cited by other .
Echavarria, M. et al., "Detection of Adenoviruses (AdV) in Culture-Negative Environmental Samples by PCR During an AdV-Associated Respiratory Disease Outbreak," J. Clin. Microbiol., 2000, vol. 38, No. 8, pp. 2982-2984. cited by other .
Echavarria, M. et al., "Prediction of severe disseminated adenovirus infection by serum PCR," Lancet, 2001, vol. 358, pp. 384-385. cited by other .
Echavarria, M. et al., "Rapid Detection of Adenovirus in Throat Swab Specimens by PCR During Respiratory Disease Outbreaks among Military Recruits", J. Clin. Microbiol., 2003, vol. 41, No. 2, pp. 810-812. cited by other .
Echavarria, M. et al., "Use of PCR to demonstrate of Adenovirus Species B, C, of F as Well as Coinfection with Two Adenovirus Species in Children with Flu-Like Symptoms", J. Clin. Microbiol, 2006, vol. 44, No. 2, pp. 625-627. cited by other .
Ecker et al., "Rapid identification and strain-typing of respiratory pathogens for epidemic surveillance" PNAS (2005) 102(22):8012-8017. cited by other .
Ecker et al., "The Ibis T5000 Universal Biosensor: An Automated Platform for Pathogen Identification and Strain Typing" JALA (2006) 11:341-351. cited by other .
Edwards, K.M. et al., "Adenovirus Infections in Young Children", Pediatrics, 1985, vol. 76, No. 3, pp. 420-424. cited by other .
Ellis et al., "Molecular diagnosis of influenza" Rev. Med. Virol. (2002) 12(6):375-389. cited by other .
Elsayed, S. et al., "Development and Validation of a Molecular Beacon Probe-Based Real-Time Polymerase Chain Reaction Assay for Rapid Detection of Methicillin Resistance in Staphylococcus aureus," Arch. Pathol. Lab. Med. (2003) 127945-849. cited by other .
EMBL Accession AJ552897 (Mar. 29, 2003). cited by other .
EMBL Accession AR321656 (Aug. 12, 2003). cited by other .
EMBL Accession L15697 (Mar. 4, 2000). cited by other .
EMBL Accession AB068711 (May 21, 2003). cited by other .
EMBL Accession Z48571 (Jun. 9 1995). cited by other .
Enright, M. C, et al., "Multilocus Sequence Typing for Characterization of Methicillin-Resistant and Methicillin-Susceptible Clones of Staphylococcus aureus," J. Clin. Microbial. (2000) 38(3): 1008-1015. cited by other .
Enright, M. C. et al., "The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)," PNAS(2002) 99(11): 7687-7692. cited by other .
Enright, M. C. et al., "The evolution of a resistant pathogen--the case of MRSA," Curr. Opin. Pharmacol. (2003) 3:474-479. cited by other .
Enright, M.C., et al., "Multilocus Sequence Typing of Streptococcus pyogenes and the Relationships between emm Type and Clone" Infection and Immunity, 2001, 69, 2416-2427. cited by other .
Eremeeva et al., "Evaluation of a PCR Assay for Quantitation of Rickettsia rickettsii and Closely Related Spotted Fever Group Rickettsiae" J. Clin. Microbiol. (2003) 41(12):5466-5472. cited by other .
Erlich (ed.). PCR Technology, Stockton Press (1989). cited by other .
European Patent Office Communication for 06849755.1 dated Mar. 12, 2008. cited by other .
European Supplemental Search Report for 03810055.8 dated Jun. 9, 2007. cited by other .
European Supplemental Search Report for 04752257.8 dated Feb. 15, 2006. cited by other .
European Supplemental Search Report for 05751872.2 dated Jan. 28, 2008. cited by other .
European Supplemental Search Report for 05856582.1 dated Nov. 10, 2008. cited by other .
European Supplemental Search Report for 04775904.8 dated Jul. 25, 2008. cited by other .
Facklam, R., et al., "emm Typing and Validation of Provisional M Types for Group A Streptococci" (1999) Emerging Infectious Diseases, 5, 247-253. cited by other .
Fang, H. et al., "Rapid Screening and Identification of Methicillin-Resistant Staphylococcus aureus from Clinical Samples by Selective-Broth and Real-Time PCR Assay," J. Clin. Microbial. (2003) 41 (7):2894-2899. cited by other .
Farrell, D. J., "'The Reliability of Microscan Conventional and Rapid Panels to Identify Staphylococcus aureus and Detect Methicillin Resistance: an Evaluation Using the Tube Coagulase Test and mecA PCR," Pathology ( 1 997) 29:406-410. cited by other .
Fedele C G et al., "Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK, and SV40 DNA in clinical samples", Journal of Virological Methods, 82(2), Oct. 1999, pp. 137-144. cited by other .
Fedele C G et al., "Quantitation of polyomavirus DNA by a competitive nested polymerase chain reaction," Journal of Virological Methods, 88(1):51-61 (Jul. 2000). cited by other .
Feng, P., "Impact of molecular biology on the detection of food pathogens" Mol. Biotechnol., 1997, 7, 267-278. cited by other .
Fong, W. K., et al., "Rapid Solid-Phase Immunoassay for Detection of Methicillin-Resistant Staphylococcus aureus Using Cycling Probe Technology." J. Clin. Microbiol. (2000) 38(7): 2525-2529. cited by other .
Fox, J.P. et al., "The Virus Watch Program: A Continuing Surveillance of Viral Infections in Metropolitan New York Families", Am. J. Epidemiol., 1969, vol. 89, No. 1, pp. 25-50. cited by other .
Francois, P. et al., "Rapid Detection of Methicillin-Resistant Staphylococcus aureus Directly from Sterile or Nonsterile Clinical Samples by a New Molecular Assay," J. Clin. Microbiol. (2003) 41(1):254-260. cited by other .
Fred, et al., "Comparison of algorithms and databases for matching unknown mass spectra" J. Am. Soc. Mass Spectrom., 9:92-95 (1998). cited by other .
Freiberg et al. Genome-wide mRNA profiling: impact on compound evaluation and target identification in anti-bacterial research. Targets 1(1):20-29 (2002). cited by other .
Freymuth et al., "Comparison of Multiplex PCR Assays and Conventional Techniques for the Diagnostic of Respiratory Virus Infections in Children Admitted to Hospital with an Acute Respiratory Illness" J. Med. Virol. (2006) 78(11):1498-1504. cited by other .
Freymuth, F. et al., "Detection of respiratory syncytial virus, parainfluenzavirus 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridization", Clin. Dian. Virol, 1997, vol. 8, pp. 31-40. cited by other .
Fujimoto, T. et al., "Single-Tube Multiplex PCR for Rapid and Sensitive Diagnosis of Subgenus B and Other Subgenera Adenoviruses in Clinical Samples", Microbiol. Immunol., 2000, vol. 44, No. 10, pp. 821-826 (abstract only). cited by other .
Fujimura, S, et al., "Characterization of the mupA Gene in Strains of Methicillin-Resistant Staphylococcus aureus with a Low Level of Resistance to Mupirocin," Antimicrob. Agents Chemother. (2001) 45(2):641-642. cited by other .
Fujimura, S. et al., "Isoleucyl-tRNA Synthetase Mutations in Staphylococcus aureus Clinical Isolates and in Vitro Selection of Low-Level Mupirocin-Resistant Strains," Antimicrob. Agents Chemother. (2003) 47(10): 3373-3374. cited by other .
Gall, J.G.D. et al., "Construction and Characterization of Hexon-Chimeric Adenoviruses: Specification of Adenovirus Serotype", J. Virol, 1998, vol. 72, No. 12, pp. 10260-10264. cited by other .
Gammelin et al., "Two Subtypes of Nucleoproteins (NP) of Influenza A Viruses" Virology (1989) 170:71-80. cited by other .
Garcia et al., "Quantitative Real-Time PCR Detection of Rift Valley Fever Virus and Its Application to Evaluation of Antiviral Compounds" J. Clin. Microbiol. (2001) 39(12):4456-61. cited by other .
Gaydos, C.A. et al., "Adenovirus Vaccines in the U.S. Military", Military Med., 1995, vol. 160, No. 6, pp. 300-304. cited by other .
Geha et al., J. Clin. Microbiol. (1994) 32:1768-1772. cited by other .
Genbank Accession AF304460 (Jul. 11, 2001). cited by other .
Genbank Accession No. M21150 Apr. 29, 1993. cited by other .
Genbank Accession No. AF375051.1 (Jun. 26, 2001). cited by other .
Genbank Accession No. Z48571 (Jun. 9, 1995). cited by other .
Genbank Accession No. X84646 (Jul. 2, 1995). cited by other .
Genbank GI:15922990 [online] Oct. 4, 2001 [retrieved on Jun. 22, 2008] retrieved from: http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?I5922990:OLD08:50885 (pp. 1, 12, 15, 148, 216, 476, 722, 723, 725, 881, 1251). cited by other .
Genbank GI:18542231 [online] Sep. 16, 2003 [retrieved on Jun. 23, 20081 retrieved from http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nuccore&id=I8542231 (2 pages). cited by other .
Genbank GI:21281729 [online], publicly available at least as of May 31, 2002 [retrieved on Apr. 11, 20081, retrieved from: http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?21281729:OLD11:599579 (pp. 1, 723 and 1137). cited by other .
Gibb et al., "Development and evaluation of a 5' fluorogenic nuclease assay to detect and differentiate between Ebola Virus subtypes Zaire and Sudan", Journal of Clinical Microbiology, 39(11):4125-4130 (Nov. 2001). cited by other .
Giles+A137, R.E., et al., Proc. Natl. Acad. Sci., 1980, 77, 6715-6719. cited by other .
Gilbert et al., "Comparison of commercial assays for the quantitation of HBV DNA load in health care workers: calibration differences" J. Virol. Methods (2002) 100(1-2):37-47. cited by other .
Gill, S. R. et al., "Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing Methicillin-Resistant Staphylococcus epidemidis Strain," J. Bacteriol. (2005) 187(7): 2426-2438. cited by other .
Gilliland et al., "Analysis of cytokine mRNA and DNA: detectionf and quantitation by competitive polymerase chain reaction" PNAS (1990) 87(7):2725-2729. cited by other .
Ginther, C., et al., Nature Genetics, 1992, 2, 135-138. cited by other .
Gjoen et al., "Specific detection of coxsackie viruses A by the polymerase chain reaction" Clinical and Diagnostic Virology (1997) 8:183-188. cited by other .
Golden et al., Pilot Study of COBAS PCR and Ligase Chain Reaction for Detection of Rectal Infections Due to Chlamydia trachomatis, J. Clin. Microbiol., 41(5):2174-2175 (May 2003). cited by other .
Gravet et al., "Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family" FEBS Lett. (1998) 436(2):202-208. cited by other .
Gray, G.C. et al., "Adult Adenovirus Infections: Loss of Orphaned Vaccines Precipitates Military Respiratory Disease Epidemics", Clin. Infect. Diseases, 2000, vol. 31, pp. 663-670. cited by other .
Grondahl, B. et al., "Rapid Identification of Nine Microorganisms Causing Acute Respiratory Tract Infections by Single-Tube Multiplex Reverse Transcription-PCR: Feasibility Study", J. Clin. Microbiol., 1999, vol. 37, No. 1, pp. 1-7. cited by other .
Grundmann, H. et al., "Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat," Lancet (2006) 368: 874-885. cited by other .
Gu, Z et al., "Multiplexed, Real-Time PCR for Quantitative Detection of Human Adenovirus", J. Clin. Microbiol., 2003, vol. 41, No. 10, pp. 4636-4641. cited by other .
Guatelli et al., "Nucleic Acid Amplification In Vitro: Detection of Sequences with Low Copy Numbers and Application to Diagnosis of Human Immunodeficiency Virus Type 1 Infection" Clin. Microbiol. Rev. (1989) 2(2):217-226. cited by other .
Haff et al., "Multiplex Genotyping of PCR Products with Mass Tag-Labeled Primers" Nucleic Acids Research (1997) 25(18):3749-3750. cited by other .
Heim, A. et al., "Rapid and Quantitative Detection of Human Adenovirus DNA by Real-Time PCR", J. Med. Virol., 2003, vol. 70, pp. 228-239. cited by other .
Haines, J.D., et al., "Medical response to bioterrorism: Are we prepared?" J. Okla. State Med. Assoc. 2000, 93, 187-196. cited by other .
Hall et al., "Base composition analysis of human mitochondrial DNA using electrospray ionization mass spectrometry: a novel tool for the identification and differentiation of humans" Analytical Biochemistry (2005) 344:53-69. cited by other .
Hamdad, F. et al., "Detection of Methicillin/Oxacillin Resistance and Typing in Aminoglycoside-Susceptible Methicillin-Resistant and Kanamycin-Tobramycin-Resistant Methicillin-Susceptible" Microbial Drug Resistance (2006) 12(3): 177-185. cited by other .
Hamels et al., "Consensus PCR and Microarray for Diagnosis of the Genus Staphylococcus, Species, and Methicillin Resistance" BioTechniques (2001) 31(6):1364-1366. cited by other .
Hammerle et al., "A sensitive PCR assay system for the quantitation of viral genome equivalents: hepatitis C virus (HCV)" Arch. Virol. (1996) 141:2103-2114. cited by other .
Hanssen, A.M. et al., "SCCmec in staphylococci: genes on the move," FEMS Immuol. Med. Microbiol. (2006) 46:8-20. cited by other .
Hasebe, F. et al. "Combined Detection and Genotyping of Chikungunya Virus by a Specific Reverse Transcription-Polymerase Chain Reaction," J. Med. Virol. (2002) 67(3): 370-374. cited by other .
Hassan et al., "Inter- and Intraspecies Variations of the 16S-23S rDNA lntergenic Spacer Region of Various Streptococcal Species" Systematic and Applied Microbiology (2003) 26(1):97-103. cited by other .
Higgins, J.A., et al., Ann. NY Acad. Sci., 1999, 894, 130-148. cited by other .
Hill, F., et al., "Polymerase recognition of synthetic oligodeoxyribonucleotides incorporating degenerate pyrimidine and purine bases," Proc. Natl. Acad. Sci. USA 95:4258-4263 (1998). cited by other .
Hiramatsu, K. et al., "The emergence and evolution of methicillin-resistant Staphylococcus aureus," Trends Microbiol. (2001) 9(10):486-493. cited by other .
Hoffmann et al., "Rescue of influenza B virus from eight plasmids" PNAS (2002) 99:11411-11416. cited by other .
Hofstadler et al., "TIGER: the universal biosensor" Inter. J. Mass Spectrom. (2005) 242:23-41. cited by other .
Hodgson et al. Molecular Characterization of the Gene Encoding High-Level Mupirocin Resistance in Staphylococcus aureus J2870. Antimicrobial Agents and Chemotherapy 38(5):1205-1208, May 1994. cited by other .
Holden, M. T. G. et al., "Complete genomes of two clinical Staphylocuccus aureus strain: Evidence for the rapid evolution of virulence and drug resistance," PNAS (2004) 101(26):9786-9791. cited by other .
Holland, M.M. and T.J. Parsons "Mitochondrial DNA analsysis.sub.--Validation and use for forensic casework" (1999) Forensic Science Review, vol. 11, pp. 25-51. cited by other .
Holmes et al., "Whole-Genome Analysis of Human Influenza A Virus Reveals Multiple Persistent Lineages and Reassortment among Recent H3N2 Viruses" PLoS Biol. (2005) 3(9):1579-1589. cited by other .
Hongoh et al., "Evaluation of primers and PCR conditions for the analysis of 16s rRNA genes from a natural environment" FEMS Microbiol. Lett. (2003) 221:299-304. cited by other .
Hood, E., "Chemical and biological weapons: New questions, new answers" Environ. Health Perspect., 1999, 107:931-932. cited by other .
Houng, H.-S. H. et al., "Rapid type-specific diagnosis of adenovirus type 4 infection using a hexon-based quantitative fluorogenic PCR", Diagn. Microbiol. Infect. Dis., 2002, vol. 42, pp. 227-236. cited by other .
Hunag, C. et al., "Detection of arboviral RNA directly from mosquito homogenates by reverse transcription-polymerase chain reaction," J. Virol. Methods (2001) 94(1-2): 121-128. cited by other .
Huber et al., On-line cation exchange for suppression of adduct formation in negative-ion electrospray mass spectrometry of nucleic acids. Anal. Chem. (1998) 70:5288-5295. cited by other .
Huletsky, A. et al., New real-time PCR assay for rapid detection of methicillin-resistant Staphylococcus aureus directly from specimens containing a mixture of staphylococci. J. Clin. Microbial. (2004) 42(5): 1875-84. cited by other .
Hung, "Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome" Clin. Chem. (2003) vol. 49, pp. 2108-2109. cited by other .
Hurdle, J. G. et al., "Analysis of Mupirocin Resistance and Fitness in Staphylococcus aureus by Molecular Genetic and Structural Modeling Techniques," Antimicrob. Agents Chemother. (2004) 48(11):4366-4376. cited by other .
Ieven, M. et al., "Rapid Detection of Methicillin Resistance in Coagulase-Negative Staphylococci by Commercially Available Fluorescence Test," J. Clin. Microbiol. (1995) 33(8):2183-2185. cited by other .
Ihle et al., "Efficient purification of DNA fragments using a protein binding membrane" Nucleic Acids Research (2000) 28:e76. cited by other .
Inglis, T. J. et al., "Rapid Genotypic Confirmation of Methicillin Resistance," Pathology (1 996) 28(3):259-261. cited by other .
Australian Search Report for AU 2003297687 dated Sep. 4, 2008. cited by other .
Australian Search Report for AU 2003302236 dated Sep. 10, 2008. cited by other .
Australian Search Report for AU 2004248107 dated Jul. 30, 2008. cited by other .
Canadian patent office communication for Application No. 2,525,498 dated Apr. 7, 2009. cited by other .
International Prelim. Exam. Report for PCT/US2005/033707 dated Mar. 20, 2007. cited by other .
International Search Report for PCT/US02/06763 dated Oct. 23, 2002. cited by other .
International Search Report for PCT/US03/009802 dated Aug. 20, 2004. cited by other .
International Search Report for PCT/US03/22835 dated Dec. 12, 2003. cited by other .
International Search Report for PCT/US03/38830 dated Aug. 25, 2004. cited by other .
International Search Report for PCT/US04/007236 dated Feb. 24, 2006. cited by other .
International Search Report for PCT/US04/012671 dated Sep. 28, 2007. cited by other .
International Search Report for PCT/US04/015123 dated Oct. 3, 2005. cited by other .
International Search Report for PCT/US04/015196 dated Jul. 1, 2005. cited by other .
International Search Report for PCT/US2004/028869 dated Jul. 17, 2006. cited by other .
International Search Report for PCT/US04/033742 dated May 15, 2006. cited by other .
International Search Report for PCT/US05/005356 dated Aug. 7, 2007. cited by other .
International Search Report for PCT/US05/007022 dated Oct. 20, 2006. cited by other .
International Search Report for PCT/US05/018337 dated Oct. 10, 2006. cited by other .
International Search Report for PCT/US05/024799 dated Dec. 28, 2006. cited by other .
International Search Report for PCT/US05/030058 dated Aug. 20, 2007. cited by other .
International Search Report for PCT/US05/033707 dated Feb. 6, 2006. cited by other .
International Search Report for PCT/US05/06133 dated Jul. 26, 2007. cited by other .
International Search Report for PCT/US05/09557 dated Sep. 19, 2005. cited by other .
International Search Report for PCT/US06/007747 dated Sep. 5, 2006. cited by other .
International Search Report for PCT/US2006/040747 dated Mar. 17, 2009. cited by other .
International Search Report for PCT/US06/015160 dated Oct. 10, 2006. cited by other .
International Search Report for PCT/US2006/061307 dated Jan. 9, 2008. cited by other .
International Search Report for PCT/US2007/020045 dated Mar. 26, 2009. cited by other .
International Search Report for PCT/US2007/066194 dated Jan. 15, 2008. cited by other .
International Search Report for PCT/US2008/054926 dated Jan. 26, 2009. cited by other .
International Search Report for PCT/US2008/057717 dated Jan. 13, 2009. cited by other .
International Search Report for PCT/US2008/057901 dated Aug. 28, 2008. cited by other .
International Search Report for PCT/US2008/065332 dated Nov. 28, 2008. cited by other .
Inyaku, K. et al., "Rapid Detection and Identification of Mycobacteria in Sputum Samples by Nested Polymerase Chain Reaction and Restriction Fragment Length Polymorphisms of dnaJ Heat Shock Protein Gene," 42 J. Med. Sci. 21-31 (1993) ('787 reexamination). cited by other .
Iqbal et al., "A review of molecular recognition technologies for detection of biological threat agents" Biosensors & Bioelectronics, 15:549-578 (2000). cited by other .
Ito, T. et al., "Structural Comparison of Three Types of Staphylococcal Cassette Chromosome mec Integrated in the Chromosome in Methicillin-Resistant Staphylococcus aureus," Antimicrob. Agents Chemother. (2001) 45(5): 1323-1336. cited by other .
Ito, T. et al., "Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic istand SCC," Drug Resist. Updat. (2003) 6(1):41-52. cited by other .
Jambrina et al., GenBank: AF005737.1 influenza B virus B/Panama/45/90 polymerase (PB2) mRNA, complete cds, (1997), pp. 1-3. cited by other .
Jaulhac, B. et al., "Synthetic DNA probes for detection of genes for enterotoxins A, B, C, D, E and for TSST-1 in staphylococcal strains," J. Appl. Bacterial. (1992) 72(5):386-392. cited by other .
Jeong, J, et al., "Early Screening of Oxacillin-Resistant Staphylococcus aureus and Staphylcoccus epidermidis from Blood Culture," J. Korean Med. Sci. (2002) 17: 168-172. cited by other .
Jonas, D. et al., "Rapid PCR-Based Identification of Methicillin-Resistant Staphylococcus aureus from Screening Swabs," J. Clin. Microbiol. (2002) 40(5): 1821-1823. cited by other .
Jurinke C et al., "Application of nested PCR and mass specctrometry for DNA based virus detection: HBV-DNA detected in the majority of isolated anti-Hbc positive sera", Genetic Analysis: Biomolecular Engineering, Elsevier Science Publishing, US, 14(3):97-102 (Jan. 3, 1998)+A627+A661. cited by other .
Jurinke et al., "MALDI-TOF Mass Spectrometry. A Versatile Tool for High-Performance DNA Analysis" Molecular Biotechnology (2004) 26(2):147-163. cited by other .
Kacian et al., "A Replicating RNA Molecule Suitable for a Detailed Analysis of Extracellular Evolution and Replication" Proc. Natl. Acad. Sci. Usa 69:pp. 3037-3042 (1972). cited by other .
Kajon, A.E. et al., "Genome Type Analysis of Brazilian Adenovirus Strains of Serotypes 1, 2, 3, 5, and 7 Collected Between 1976 and 1995", J. Med. Virol., 1999, vol. 58, pp. 408-412. cited by other .
Katano, H., et al., "Identification of Adeno-associated virus contamination in cell and virus stocks by PCR", Biotechniques, Informa Life Sciences Publishing, Westborough, MA, US, 36(4):676-680 (Apr. 2004). cited by other .
Katayama, Y. et al., "Genetic Organization of the Chromosome Region Surrounding mecA in Clinical Staphylococcal Strains: Role of IS431-Mediated mecl Deletion in Expression of Resistance in med-Canying, Low-Level Methicillin-Resistant Staphylococcus haemolyticus," Antimicrob. Agents Chemother. (2001) 45(7): 1955-1963. cited by other .
Kearns, A. M. et al., "Rapid detection of methicillin-resistant staphylococci by multiplex PCR," J. Hosp. Infect. (1999) 43:33-37. cited by other .
Khan, A.S., et al., "An outbreak of Crimean-Congo haemorrhagic fever in the United Arab Emirates, 1994-1995" Am. J. Trop. Med. Hyg., 1997, 57, 519-525. cited by other .
Khan, S. A. et al., "Simultaneous detection of erythromycin-resistant methylase genes ermA and ermC from Staphylococcus spp. By multiplex-PCR," Mol. Cell Probes (1999) 13:381-387. cited by other .
Kidd, A.H. et al., "Rapid Subgenus Identification of Human Adenovirus Isolates by a General PPCR", J. Clin. Microbiol., 1996, vol. 34, No. 3, pp. 622-627. cited by other .
Kilbourne, "Influenza Pandemics: Can We Prepare for the Unpredictable?" Viral Immunol. (2004) 17(3):350-357. cited by other .
Kilbourne, "Influenza Pandemics of the 20th Century" Emerg. Infect. Dis. (2006) 12(1):9-14. cited by other .
Kinney et al., American J. Trop. Med. Hyg., (1998), vol. 59, No. 6, p. 952-954. cited by other .
Kolbert et al., J. Clin. Microbiol. (1998) 36:2640-2644. cited by other .
Krafft, A.E. et al., "Evaluation of PCR Testing of Ethanol-Fixed Nasal Swab Specimens as an Augmented Surveillance Strategy for Influenza Virus and Adenovirus Identification", J. Clin. Microbiol., 2005, vol. 43, No. 4, pp. 1768-1775. cited by other .
Kramer, L. D. et al., "Dection of St. Louis Encephalitis and Western Equine Encephalomyelitis RNA in Mosquitoes Tested Without Maintainance of a Cold Chain," J. Am. Mosq. Control Assoc. (2001) 17(4): 213-215. cited by other .
Kramer, L. D. et al., "Dection of Encephalitis Viruses in Mosquitoes (Diptera: Culicidea) and Avian Tissues," J. Med. Entomol. (2002) 39(2): 312-323. cited by other .
Kroes et al., "Bacterial diversity within the human subgingival crevice," Proc. Natl. Acad. Sci. USA (1999) 96:14547-14552. cited by other .
Kresken, M. et al., "Prevalence of mupirocin resistance in clinical isolates of Staphylococccus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001," Int. J. Antimicrob. Agents (2004) 23:577-581. cited by other .
Krishnan, P.U. et al., "Detection of methicillin and mupirocin resistance in Staphylococcus aureus isolates using conventional and molecular methods: a descriptive study from a burns unit with high prevalence of MRSA," J. Clin. Pathol. (2002) 55:745-748. cited by other .
Krossoy et al., "The putative polymerase sequence of infectious anemia virus suggests a new geneus within the Orthomyxoviridae" Journal of Virology (1999) 73:2136-2142. cited by other .
Ksiaxek, Thomas G., et al., "A novel coronavirus associated with severe acute respiratory syndrome," New England Journal of Medicine, 348(20):1953-1966 (Apr. 10, 2003). cited by other .
Kuroda, M., et al., "Whole genome Sequencing of meticillin-resistant Staphylococcus aureus", The Lancet, 357(9264):1225-1240 (Apr. 21, 2001). cited by other .
Kwok, S. and R. Hguchi, "Avoiding false positives with PCR" Nature, 1989, 339,237-238. cited by other .
Labandeira-Rey, M. et al., "Staphylococcus aureus Panton Valentine Leukocidin Causes Necrotizing Pneumonia" Sciencexpress (2007) Jan. 18. cited by other .
Lamb et al., "Sequence of Interrupted and Uninterrupted mRNAs and Cloned DNA Coding for the Two Overlapping Nonstructural Proteins of Influenza Virus" Cell (1980) 21:475-485. cited by other .
Lambert, A.J. et al., "Detection of North American Eastern and Western Equine Encephalitis Viruses by Nucleic Acid Amplification Assays," J. Clin. Microbiol. (2003) 41(1): 379-385. cited by other .
Lau et al., "Nucleic acid sequence-based amplification methods to detect avian influenza virus" Biochem. Biophys. Res. Commun. (2004) 313:336-342. cited by other .
Lau et al., "A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification" Biochem. Biophys. Res. Comm. (2003) 312:1290-1296. cited by other .
Lee, J.H. et al., "Simultaneous Detection of Three Mosquito-Borne Encephalitis Viruses ( . . . ) with a Single-Tube Multiplex Reverse Transcriptase Polymerase Chaine Reaction Assay," J. Am. Mosq. Control Assoc. (2002) 18(1): 26-31. cited by other .
Lengyel, A. et al., "Characterization of the Main Protein Components of Adenovirus Virion and its Possible Use in Laboratory Diagnostics", Acta Microbiol. Immunol. Hung., 1998, vol. 43, Nos. 3-4; pp. 281-283. cited by other .
Letter count for Jambrina et al., GenBank: AF005737.1 influenza B virus B/Panama/45/90 polymerase (PB2) mRNA, complete cds, (1997), pp. 1-2. Same as entry titled "Jambrina et al., GenBank: AF005737.1". cited by other .
Levi, K. et al., "Evaluation of an Isothermal Signal Amplification Method for Rapid Detection of Methicillin-Resistant Staphylococcus aureus from Patient-Screening Swabs," J. Clin. Microbiol. (2003) 41(7):3 187-3191. cited by other .
Levine et al., "PCR-based detection of Bacillus anthracis in formalin-fixed tissue from a patient receiving ciprofloxacin" Journal of Clinical Microbiology (2002) 40(11):4360-4362. cited by other .
Levison et al., "Recent developments of magnetic beads for use in nucleic acid purification" Journal of Chromatography (1998) A 816:107-111. cited by other .
Le Cann et al., "Quantification of human astroviruses in sewage using real-time RT-PCR" Res. Microbiol. (2004) 155(1):11-15. cited by other .
Li, Q.-G. et al., "Analysis of 15 Different Genome Types of Adenovirus Type 7 Isolated on Five Continents", J. Virol., 1986, vol. 60, No. 1, pp. 331-335. cited by other .
Li, Q.-G. et al., "Genetic variability of hexon loops 1 and 2 between seven genome types of adenovirus serotype 7", Arch. Virol., 1999, vol. 144, No. 9, pp. 1739-1749. cited by other .
Li et al., "Screening of the high yield influenza B virus on MDCK cell and cloning of its whole genome" International Congress Series 1263 (2004) 610-614. cited by other .
Li et al., "Evolution of H9N2 influenza viruses from domestic poultry in Mainland China" Virology (2005) 340:70-83. cited by other .
Liebermann, H. et al., "Mapping of linear epitopes on fibre knob of human adenovirus serotype 5", Virus Res., 2001, vol. 73, No. 2, pp. 145-151. cited by other .
Liebermann, H. et al., "Mapping of Epitopes on the Fiber Knobs of Human Adenovirus Serotypes 8 and 15", Intervirology, 2002, vol. 45, pp. 59-66. cited by other .
Lim et al., Genes and Development 17:991-1008 (2003). cited by other .
Limbach, P.A., et al., "Enzymatic Sequencing of Oligonucleotides with Electrospray Mass Spectrometry" 42nd ASMS Conference on Mass Spectrometry (Jun. 1994) ('787 reexamination). cited by other .
Limoncu, M. H. et al., "Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains," Int. J. Antimicrob. Agents (2003) 21:420-424. cited by other .
Lin et al., "Oxidative Damage to Mitochondrial DNA in Atrial Muscle of Patients with Atrial Fibrillation," Free Radical Biology and Medicine, 35(10):1310-1318 (2003). cited by other .
Lin, B. et al., "Use of Oligonucleotide Microarrays for Rapid Detection and Serotyping of Acute Respiratory Disease-Associated Adenoviruses", J. Clin. Microbiol., 2004, vol. 42, No. 7, pp. 3232-3239. cited by other .
Lina, G. et al., "Involvement of Panton-Valentine Leukocidin-Producing Staphylococcus aurues in Primary Skin Infections and Pneumonia," Clin. Infect. Dis. (1999) 29(5):1128-1132. cited by other .
Lina, G. et al., "Bacterial Competition for Human Nasal Cavity Colonization: Role of Staphylococcal agr Alleles," Appl. Environ. Microbiol. (2003) 69(1):18-23. cited by other .
Linssen, B. et al., "Development of Reverse Transcription-PCR Assays Specific for Detection of Equine Encephalitis Viruses," J. Clin. Microbiol. (2000) 38(4): 1527-1535. cited by other .
Livermore, D. M., "The threat from the pink corner," Ann. Med. (2003) 35(4):226-234. cited by other .
Liu et al., "Interregional Transmission of the Internal Protein Genes of H2 Influenza Virus in Migratory Ducks from North America to Eurasia" Virus Genes (2004) 29(1):81-86. cited by other .
Loo, J. A et al., "Applying Charge Discrimination with Electrospray Ionization-Mass Spectrometry to Protein Analysis," J. Am. Soc. Mass. Spectrom. (1995) 6:1098-1104. cited by other .
Lott, "Nucleotide Sequence Analysis of the 5-8s rDNA and Adjacent ITS2 Region of Candida albicans and Related Species" Yeast, 9:1199-1206 (1999). cited by other .
Louie, L. et al., "Evaluation of Three Rapid Methods for Detection of Methicillin Resistance in Staphylococcus aureus," J. Clin. Microbiol. (2000) 38(6):2170-2173. cited by other .
Lovseth, A. et al., "Modified Multiplex PCR Method for Detection of Pyrogenic Exotoxin Genes in Staphylococcal Isolates," J. Clin. Microbiol. (2004) 42(8):3869-3872. cited by other .
Lu, X. et al., "Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene", Arch. Virol,., 2006, vol. 15, No. 8, pp. 1587-1602. cited by other .
Ludwig, S.L. et al., "Prevalence of Antibodies to Adenovirus Serotypes 4 and 7 among Unimmunized US Army Trainees: Results of Retrospective Nationwide Seroprevalence Survey", J. Infect. Dis., (1998) 178, pp. 1776-1778. cited by other .
Ma, X. X. et al., "Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains," Antimicrob. Agents Chemother. (2002) 46(4):1147-1152. cited by other .
Mack and Sninsky, "A sensitive method for the identification of uncharacterized viruses related to known virus groups: Hepadnavirus model system," Proc. Natl. Acad. Sci. USA (1988) 85:6977-6981. cited by other .
Magnuson, VL, "Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: Implications for PCR-based genotyping and cloning" Biotechniques, 21:700-709 (Oct. 1996). cited by other .
Malasig, M.D. et al., "Simplified Microneutralization Test for Serotyping Adenovirus Isolates", J. Clin. Microbiol., 2001, vol. 39, No. 8, pp. 2984-2986. cited by other .
Manian, F. A,, "Asymptomatic Nasal Carriage of Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus (MRSA) in a Pet Dog Associated with MRSA Infection in Household Contacts," Clin. Infect. Dis. (2003) 36:e26-e28. cited by other .
Marmur et al., "Strand Separation and Specific Recombination in Deoxyribonucleic Acids: Biological Studies" Proc. Natl. Acad. Sci. USA 46:pp. 453-461 (1960). cited by other .
Martineau, F. et al., "Species-Specific and Ubiquitous-DNA-Based Assays for Rapid Identification of Staphylococcus aureus," J. Clin. Microbial. (1998) 36(3):618-623. cited by other .
Martineau, F. et al., "Development of a PCR Assay for Identification of Staphylococci at Genus and Species Levels," J. Clin. Microbial. (2001) 39(7):2541-2547. cited by other .
Martin-Lopez, J. V. et al., "Simultaneous PCR detection of ica cluster and methicillin and mupirocin resistance genes in catheter-isolated Staphylococcus," Int. Microbial. (2004) 7:63-66. cited by other .
Mason et al., "Diversity and linkage of replication and mobilisation genes in Bacillus rolling circle-replicating plasmids from diverse geographical origins" FEMS Microbiol. Ecol. 2002, 42:235-241. cited by other .
Matsuoka, M. et al., "Characteristic expression of three genes, msr(A), mph(C) and erm(Y), that confer resistance to macrolide antibiotics on Staphylococcus aureus," FEMS Microbiol. Lett. (2003) 220:287-293. cited by other .
May, "Percent sequence identity: The need to be explicit" Structure (2004) 12(5):737-738. cited by other .
McLuckey, S.A., et al., "Ion Trap Tandem Mass Spectrometry Applied to Small Multiply Charged Oligonucleotides with a Modified Base," 5 J. Am. Soc. Mass. Spectrom. 740-747 (1994) ('787 reexamination). cited by other .
Mehrotra et al., "Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance", Journal of Clinical Microbiology, Washington, DC US 38(3):1032-1035 (Mar. 1, 2000)+.A256. cited by other .
Mellor et al., "Genotype Dependence of Hepatitis C Virus Load Measurement in Commercially Available Quantitative Assays" J. Clin. Microbiol. (1999) 37(8):2525-2532. cited by other .
Merlino, J. et at., "New Chromogenic Identification and Detection of Staphylococcus aureus and Methicillin-Resistant S. aureus." J. Clin. Microbiol (2000) 38(6): 2378-2380. cited by other .
Merlino, J. et al., "Rapid Detection of Non-Multidrug-Resistant and Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus Using Cycling Probe Technology for the mecA Gene," Eur. J. Clin. Microbiol. Infect. Dis. (2003) 22: 322.323. cited by other .
Metzgar, D. et al., "PCR Analysis of Egyptian Respiratory Adenovirus Isolates, Including Identification of Species, Serotypes and Coinfections", J. Clin. Microbiol., 2005, vol. 43, No. 11, p. 5743-5752. cited by other .
Miragaia, M. et al., "Genetic Diversity among Methicillin-Resistant Staphylococcus epidemidis (MRSE)," Microbial Drug Resistance (2005) 11(2):83-93. cited by other .
Miura-Ochiai, R. et al., "Quantitative detection and rapid identification of human adenoviruses", J. Clin. Microbiol., 2007, vol. 45, No. 3, pp. 958-967. cited by other .
Monroy, A.M. et al., "Exvaluation of Reverse Transcriptase Polymerase Chain Reaction for the Detection of Eastern Equine Encephalumyelitis Virus during Vector Surveillance," J. Med. Entomol. (1996) 33(3): 449-457. cited by other .
Moore et al., "Development and Evaluation of a Real-Time Nucleic Acid Sequence Based Amplification Assay for Rapid Detection of Influenza A" J. Med. Virol. (2004) 74(4):619-628. cited by other .
Morinaga, N. er al., "Purification, Cloning and Charactarizarion of Variant LukE-LukD with Strong Leukocidal Activity of Staphylococcal Bi-Component Leukotoxin Family," Microbiol. Immunol. (2003) 47(1):81-90. cited by other .
Murakami, K. et al., "Identification of Methicillin-Resistant Strains of Staphylococci by Polymerase Chain Reaction," J. Clin. Microbiol. (1991) 29(10):2240-2244. cited by other .
Na et al., "Detection and typing of respiratory adenoviruses in a single-tube multiplex polymerase chain reaction" Journal of Medical Virology (2002) 66:512-517. cited by other .
Nagy, M. et al., "Sequence Analysis of Porcine Adenovirus Serotype 5 Fibre Gene: Evidence for Recombination", Virus Genes, 2002, vol. 24, No. 2, pp. 181-185. cited by other .
Nakagawa et al., "Gene sequences and specific detection for Panton-Valentine leukocidin" Biochem. Biophys. Res. Commun. (2005) 328(4):995-1002. cited by other .
Narita et al., "Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT" Gene (2001) 268(1-2):195-206. cited by other .
Neumann et al., "Host Range Restriction and Pathogenicity in the Context of Influenza Pandemic" Emerg. Infect. Dis. (2006) 12(6):881-886. cited by other .
New England Biolabs Catalog (1998-1999) pp. 1, 79, 121, 284. cited by other .
Newcombe et al. "PCR of peripheral blood for diagnosis of meningococcal disease" (1996) 34:1637-1640. cited by other .
Ng et al., "Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome" Clin. Chem. (2003) 49:2085. cited by other .
Ng et al., "Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome" Clin. Chem. (2003) 49:1976-1980. cited by other .
Nordhoff, E., et al., "Matrix Assisted Laser Desorption/Ionization Mass Spectrometry of Nucleic Acids with Wavelengths in the Ultraviolet and Infrared" 6 Rapid Commun. Mass Spectrom. 771-776 (1992) ('787 reexamination). cited by other .
Nubel et al., "PCR primers to amplify 16S rRNA genes from Cyanobacteria," Applied and Environmental Microbiology, 63(8):3327-3332 (Aug. 1997). cited by other .
Nunes, E. L. et al., "Detection of ileS-2 Gene Encoding Mupirocin Resistance in Methicillin-Resistant Staphylococcus aureus bv Multiplex PCR" Diagn. Microbiol. Infect. Dis. (1999) 34(2): 77-81. cited by other .
Nygren et al., "Quantification of HIV-1 Using Multiple Quantitative Polymerase Chain Reaction Standards and Bioluminometric Detection" Anal. Biochem. (2001) 288(1):28-38. cited by other .
Oberacher H et al., "Increased foresnic efficiency of DNA fingerprints through simultaneous resolution of length and nucleotide variability by high-performance mass spectrometry," Human Mutation 29(3):427-432 (Mar. 2008)+A613+A714. cited by other .
Oberacher et al., "Analysis of polymerase chain reaction products by on-line liquid chromatography-mass spectrometry for genotyping of polymeric short tandem repeat loci" (2001) 73:5109-5115. cited by other .
Oberste, et al., "Molecular phylogeny and proposed classification of the Simian picornaviruses," J. Virol. (2002) 76:1244-1251. cited by other .
Oberste, et al., "Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing," J. Clin. Virol. (2003) 26:375-377. cited by other .
Oberste, et al., "Molecular epidemiology and type-specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, southern Asia and the Middle East," Virus Res. (2003) 91:241-248. cited by other .
O'Guinn, M.L. et al., "Field Detection of Eastern Equine Encephalitis Virus in the Amazon Basin Region of Peru Using Reverse Transcription-Polymerase Chain Reaction Adapted for Field Identification of Arthropod-Borne Pathogens," Am. J. Trop. Med. Hyg. (2004) 70(2): 164-171. cited by other .
Oizumi, N, et al., "Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus," Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy, 7(3):191-194 (Sep. 2001). cited by other .
Okada, M. et al., "Detection and sequence-based typing of human adenoviruses using sensitive universal primer sets for the hexon gene", Arch. Virol., 2007, vol. 152, No. 1, pp. 1-9. cited by other .
Okuma, K. et al., "Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community," J. Clin. Mcrobiol. (2002) 40(11):4289-4294. cited by other .
Oliveira, D. C. et al., "Genetic Organization of the Downstream Region of the mecA Element in Methicillin-Resistant Staphylococcus aureus Isolates Carrying Different Polymorphisms of This Region," Antimicrob. dients Chemother. (2000) 44(7): 1906-1910. cited by other .
Oliveira, D. C. et al., "Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the mec Element in Methicillin- Resistant Staphylococcus aureus," Antimicrob. Agents Chemother. (2002) 46(7):2155-2161. cited by other .
Osiowy, C. et al., "Direct Detection of Respiratory Syncytial Virus, Parainfluenze Virus, and Adenovirus in Clinical Respiratory Specimens by a Multiplex Reverse Transcription-PCR Assay", J. Clin. Microbiol., 1998, vol. 36, No. 11, pp. 3149-3154. cited by other .
Ounissi, H. et al., "Gene Homogeneity for Aminoglycoside-Modifying Enzymes in Gram-Positive Cocci," Antimicrob. Agents Chemother. (1990) 34(11):2164-2168. cited by other .
Pastorino, B. et al., "Development of a TaqMan PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses," J. Virol. Methods (2005) 124(1-2): 65-71. cited by other .
Pawa, A. et al., "Co-transfer of plasmids in association with conjugative transfer of mupirocin or mupirocin and penicillin resistance in methicillin-resistant Staphylococcus aureus;" J. Med. Microbiol. (2000) 49: 1103-1107. cited by other .
Payne et al. Antimicrobials: The challenge of antibiotic resistant bacterial pathogens: the medical need, the market and prospects for new antimicrobial agents. Current Opinion in Microbiology 7:435-438 (2004). cited by other .
Perez-Roth, E. et al., "Multiplex PCR for Simultaneous Identification of Staphylococcus aureus and Detection of Methicillin and Mupirocin Resistance," J. Clin. Microbial. (2001) 39(11):4037-4041. cited by other .
Peters et al., "Quantification of the detection of Pneumocystis carinii by DNA amplification" Mol. Cell. Probes (1992) 6:115-117. cited by other .
Pfeffer, M. et al., "Genus-Specific Detection of Alphaviruses by a Semi-Nested Reverse Transcription-Polymerase Chain Reaction," Am. J. Trop. Med Hyg. (I 997) 57(6): 709-718. cited by other .
Pfeffer, M. et al., "Specific Detection of Chikungunya Virus Using a RT-PCR/Nested PCR Combination," J. Vet. Med. B (2002) 49(1): 49-54. cited by other .
Pieles, U, et al., Matrix-Assisted Laser Desorption Ionization Time-of-Flight Spectrometry: A Powerful Tool for the Mass and Sequence Analysis of Natural and Modified Oligonucleotides 21 Nucleic Acids Res. 3191-3196 (1993) ('787 reexamination). cited by other .
Pillai, S.D., :Rapid molecular detection of microbial pathogens: breakthroughs and challenges Arch Virol., 1997, 13 Suppl., 67-82. cited by other .
Piper, J. et al., "Commercially Available Technique for Rapid Laboratory Detection of Methicillin Resistance Among Staphylococcus aureus," Diagn. Microbial. Infect. Dis. (1988) 11(3): 177-180. cited by other .
Poddar, S.K., "Detection of adenovirus using PCR and molecular beacon", J. Virol. Methods., 1999, vol. 82, No. 1, pp. 19-26. cited by other .
Pring-Akerblom, P., et al., "PCR-based detection and typing of human adenoviruses in clinical samples", Res. Virol., 1997, vol. 148, No. 3, pp. 225-231. cited by other .
Pring-Akerblom, P., et al., "Multiplex Polymerase Chain Reaction for Subgenus-Specific Detection of Human Adenoviruses in Clinical Samples", J. Med. Virol., 1999, vol. 58, No. 1, pp. 87-92. cited by other .
Promega T4 Polynucleotide Kinase, Promega Technical Bulletin No. 519, Jul. 2002. cited by other .
Puthavathana et al., "Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand" J. Gen. Virol. (2005) 86:423-433. cited by other .
Qadri, S. M. et al., "Rapid Detection of Methicillin-Resistant Staphylococcus aureus by Crystal MRSA ID System,"J. Clin. Microbiol. (1994) 32(7):1830-1832. cited by other .
Ramisse et al., "Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pX01 and pX02 and chromosomal DNA" FEMS Microbiology Letters (1996) 145(1):9-16. cited by other .
Rangarajan, Sampath, et al., "Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry" Ann. N.Y. Acad. Of Sci (2007) 1102:109-120. cited by other .
Reischl, Frontiers Biosci., 1996, 1, Application of Molecular Biology-Based Methods to the Diagnosis of Infectious Diseases 1, e72-e77. cited by other .
Reischl, U. et al., "Rapid Identification of Methicillin-Resistant Staphylococcuss aureus and Simultaneous Species Confirmation Using Real-Time Fluorescence PCR," J. Clin. Microbiol. (2000) 38(6):2429-2433. cited by other .
Roberts, M.M. et al., "Three-Dimensional Structure of the Adenovirus Major Coat Protein Hexon", Science, 1986, vol. 232, No. 4754, pp. 1148-1151. cited by other .
Robinson, D. A. et al., "Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus," Clin. Microbiol. Infect. (2004) 10:92-97. cited by other .
Rong et al., "Design and Application of 60mer oligonucleotide microarray in SARS coronavirus detection", Chinese Sci. Bull., 2003, 48, 1165-1169. cited by other .
Ruan et al., Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with the putative origins of infection, Lancet (2003) 361:1832. cited by other .
Rota et al., "Sequencing of a cDNA clone of the nucleoprotein gene of influenza B/Ann Arbor/1/86" Nucleic Acids Research (1989) 17:3595. cited by other .
Ruest et al., "Comparison of the Directigen Flu A+B test, the QuickVue Influenza Test, and Clinical Case Definition to Viral Culture and Reverse Transcription-PCR for Rapid Diagnosis of Influenza Virus Infection" J. Clin. Microbiol. (2003) 41(8):3487-3493. cited by other .
Rupf et al., "Quantitative determination of Streptococcus mutans by using competitive polymerase chain reaction" Eur. J. Oral. Sci. (1999) 107(2):75-81. cited by other .
Russell, K.L. et al., "Transmission Dynamics and Prospective Environmental Sampling of Adenovirus in a Military Recruit Setting", J. Infect. Dis., 2006, vol. 194, No. 7, pp. 877-885. cited by other .
Sabat, A. et al., "Comparison of PCR-Based Methods for Typing Staphylococcus aureus Isolates," J. Clin. Microbiol. (2006) 44(10):3804-3807. cited by other .
Sackesen, C. et al., "Use of polymerase chain reaction for detection of adenovirus in children with or without wheezing", Turk. J. Pediatr., 2005, vol. 47, No. 3, pp. 227-231. cited by other .
Sakai, H. et al., "Simultaneous Detection of Staphylococcus aureus and Coagulase-Negative Staphylococci in Positive Blood Cultures by Real-Time PCR with Two Fluorescence Resonance Energy Transfer Probe Sets," J. Clin. Microbiol. (2004) 42(12):5739-5744. cited by other .
Sampath et al., "Rapid Identification of Emerging Pathogens: Coronavirus" Emerg. Infect. Dis. (2005) 11(3):373-379. cited by other .
Sanchez et al., "Detection and Molecular Characterizatio of Ebola viruses causing disease in human and nonhuman primates" The Journal of Infectious Diseases, 179(1):S164-S169 (1991). cited by other .
Sanchez, J.L. et al., "Epidemic of Adenovirus-Induced Respiratory Illness Among US Military Recruits: Epidemiologic and Immunologic Risk Factors in Healthy, Young adults", J. Med. Virol., 2001, vol. 65, No. 4, pp. 710-718. cited by other .
Sanchez-Seco, M. P. et al., "A generic nested-RT-PCR followed by sequencing for detection and identification of members of the alphavirus genus," J. Virol. Methods (2001) 95(1-2): 153-161. cited by other .
Sarantis, H. et al., "Comprehensive Detection and Serotyping of Human Adenoviruses by PCR and Sequencing", J. Clin. Microbial., 2004, vol. 42, No. 9, pp. 3963-3969. cited by other .
Schmidt et al., "Analysis of a marine pikoplankton community by 16s rRNA gene cloning and sequencing," J. Bacteriol. (1991) 173:4371-4378. cited by other .
Schmitz, F. J. et al., "Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR." J. Med. Microbiol. (1997) 46:773-778. cited by other .
Schmitz, F. J. et al., "Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates," J. Med. Microbiol. (1998) 47(4):335-340. cited by other .
Schmitz, F. J. et al., "Development of Resistance to Ciprofloxacin, Rifampin, and Mupirocin in Methicillin-Susceptible and -Resistant Staphylococcus aureus Isolates," Antimicrob. Agents Chemother. (2000) 44(11): 3229-3231. cited by other .
Schwartz, M, et al., "Prenatal diagnosis of alpha-1-antitrypsin deficiency using polymerase chain reaction (PCR). Comparison of conventional RFLP methods with PCR used in combination with allele specific oligonucleotides or RFLP analysis," 36 Clin. Genet. 419-426 (1989) ('787 reexamination). cited by other .
Schweiger et al., "Application of a Fluorogenic PCR Assay for Typing and Subtyping of Influenza Viruses in Respiratory Samples" J. Clin. Microbiol. (2000) 38(4):1552-1558. cited by other .
Sciacchitano et al., "Analysis of polymerase chain reaction-amplified DNA fragments of clostridium botulinum type E neurotoxin gene by high performance capillary electrophoresis." J. Liq. Chromatogr. Relat. Technol. (1996) 19:2165-2178. cited by other .
Scott-Taylor, T.H. et al., "Conserved Sequences of the Adenovirus Genome for Detection of all Human Adenovirus Types by Hybridization", J. Clin. Microbiol., 1992, vol. 30, No. 7, pp. 1703-1710. cited by other .
Seifarth, et al., "Rapid identification of all known retroviral reverse transcriptase sequences with a novel versatile detection assay," AIDS Res. Human Retrovir. (2000) 16:721-729. cited by other .
Sellner, L. N. et al., "Sensitive detection of Ross River virus--a one-tube nested RT-PCR," J. Virol. Methods (1994) 49(1): 47-58. cited by other .
Sellner, L., "A Single-Tube Nested RT-PCR for the Detection of Ross River Virus," Methods Mol. Biol. (1998) 92: 145-152. cited by other .
Shi et al., "Design and application of 60mer oligonucleotide microarray in SARS coronavirus detection" Chinese Sci. Bull. (2003) 48:1165-1169. cited by other .
Shimaoka, M. et al., "Development of Enzyme-Labeled Oligonucleotide Probe for Detection of mecA gene in Methicillin- Resistant Staphylococcus aureus," J. Clin. Microbiol (1994) 32(8): 1866-1869. cited by other .
Shimaoka, M. et al., "Detection of the gene for toxic shock syndrome toxin 1 in Siaphylococcus aureus by enzyme-labelled oligonucleotideprobes," J. Med. Microbiol. (1996) 44:215-218. cited by other .
Shrestha, N. K. et al., "Rapid Identification of Staphylococcus aureus and the mecA Gene from BacT/ALERT Blood Culture Bottles by Using the Lightcycler System," J. Clin. Microbiol. (2002) 40(1):2659-2661. cited by other .
Simonsen et al., "The Impact of Influenza Epidemics on Hospitalizations" J. Infect. Dis. (2000) 181:831-837. cited by other .
Skov, R L. et al., "Evaluation of a new 3-h hybridization method for detecting the mecA gene in Staphylococcus aureus and comparison with existing genotypic and phenotypic susceptibility testing methods," J. Antimicrob. Chemother. (1999) 43: 467-475. cited by other .
Smirnov et al. "Application of DNA-binding polymers for preparation of DNA for analysis by matrix-assisted laser desorption/ionization mass spectrometry." Rapid Comm in Mass Spectrometry (2001) 15:1427-1432. cited by other .
Smith and Waterman, Adv. Appl. Math., 1981, 2, 482-489. cited by other .
Song et al., "Identification of cry11-type genes from Bacilus thuringiensis strains and characterization of a novel cry11-type gene" App. Environ. Microbiol. (2003) 69:5207-5211. cited by other .
Spackman et al., "Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes" Journal of Clinical Microbiology (2002) 40:3256-3260. cited by other .
Spiess, et al., Trehalose is a potent PCR enhancer: Lowering of DNA melting temperature and thermal stabilization of Taq polymerase by the disaccharide trehalose, In: Clinical Chemistry, 2004, 50(7):1256-1259. cited by other .
Stephensen CB et al., "Phylogenetic analysis of a highly conserved region of the polymerase gene from 11 coronaviruses and development ofa consensus polymerase chain reaction assay" Virus Research Amsterdam NL, 60(2):181-189 (Apr. 1, 1999). cited by other .
Stone et al., "Rapid detection and simultaneous subtype differentiation of influenza A viruses by real time PCR" (2004) Journal of Virological Methods (2004) 117:103-112. cited by other .
Stratagene, 1988 Catalog, p. 39. cited by other .
Strommenger, B. et al., "Multiplex PCR Assay for Simultaneous Detection of Nine Clinically Relevant Antibiotic Resistance Genes in Staphylococcus aureus," J. Clin. Microbial. (2003) 41(9):4089-4094. cited by other .
Studdert, M. J. et al., "Polymerase chain reaction tests for the identification of Ross River, Kunjin and Murray Valley encephalitis virus infections in horses," Aust. Vet. J. (2003) 81(1-2): 76-80. cited by other .
Stuhlmeier, R et al., "Fast, simultaneous, and sensitive detection of staphylococci," J. Clin. Pathol (2003) 56:782-785. cited by other .
Sundsfjord, A. et al., "Genetic methods for detection of antimicrobial resistance," APMIS (2004) 112:815-837. cited by other .
Swanborg, R.H., "Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis--a critical review"Microbes and Infection, 4:1327-1333 (2002). cited by other .
Swaminathan, B., et al., Emerging Infectious Diseases, 2001, 7, 382-389. cited by other .
Swenson, J. M. et al., "Perfomance of Eight Methods, Including Two New Rapid Methods, for Detection of Oxacillin Resistance in a Challenge Set of Staphylococcus aureus Organisms," J. Clin. Microbial. (2001) 39(10):3785-3788. cited by other .
Takahata M, et al., "Mutations in the gyrA and gr1A genes of quinolone-resistant clinical isolates of methicillin-resistant Staphylococcus aureus," The Journal of Antimicrobial Chemotherapy, 38(3):543-546 (Sep. 1996). cited by other .
Takayama, R. et al., "Quantification of Adenovirus Species B and C Viremia by Real-Time PCR in Adults and Children Undergoing Stem Cell Transplantation", J. Med. Virol., 2007, vol. 79, No. 3, pp. 278-284. cited by other .
Talaat et al., "Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis" Nature Biotechnology 17:676-682. cited by other .
Tan, T. Y., "Use of molecular techniques for the detection of antibiotic resistance in bacteria," Expert. Rev. Mol. Diagn. (2003) 3(1):93-103. cited by other .
Tanabe, F. et al., "The Properties and mec A Gene of the Methicillin-Resistant Staphylccoccus aureus Isolated in Fukushima Medical College Hospital," Fukushima J. Med. Sci (1993) 39(1):35-42. cited by other .
Tang, K., "Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry of Oligonucleotides,"Dissertation submitted to the Faculty of Vanderbilt University (Aug. 1994) ('787 reexamination). cited by other .
Tang, K, N.I. Taranenko, S.L. Allman, L.Y. Chang and C.H. Chen, "Double-Stranded DNA Analysis by Matrix Assisted Laser Desorption/Ionization," 42nd ASMS Conference on Mass Spectrometry (Jun. 1994) ('787 reexamination). cited by other .
Tang, K, N.I. Taranenko, S.L. Allman, L.Y. Chang and C.H. Chen, "Detection of 500-Nucleotide DNA by Laser Desorption Mass Spectrometry," Rapid Commun. Mass Spectrom. 727-730 (Sep. 1994) ('787 reexamination). cited by other .
Tarassishin, L. et al., "Adenovirus core protein VII displays a linear epitope conserved in a range of human adenoviruses", J. Gen. Virol., 1999, vol. 80, pp. 47-50. cited by other .
Tarassishin, L. et al., "An epitope on the adenovirus fibre tail is common to all human subgroups", Ach. Virol., 2000, vol. 145, pp. 805-811. cited by other .
Taubenberger et al., "Characterization of the 1918 influenza virus polymerase genes" Nature (2005) 437:889-893. cited by other .
Taylor, L.H., et al., Philos. Trans. R. Soc. Lond B. Biol. Sci. 2001, 356, 983-989. cited by other .
Tenover, F. C. et al., "Characterization of a Strain of Community-Associated Methicillin-Resistant Slaphylococcus aureus Widely Disseminated in the United States," J. Clin.Microbiol. (2006) 44(1):108-118. cited by other .
Teramura, T. et al., "Quantitative detection of serum adenovirus in a transplant recipient", Lancet, 2002, vol. 359, pp. 1945. cited by other .
Thiel, et al., "Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus" J. Gen. Virology 2001 82:1273-1281. cited by other .
Thompson et al., "Influenza-Associated Hospitalizations in the United States" JAMA (2004) 292:1333-1340. cited by other .
Thompson et al., Nucleic Acid Res., 22, 4673-80. cited by other .
Tokue, Y. et al., "Comparison of a Polymerase Chain Reaction Assay and a Conventional Microbiologic Method for Detection of Methicillin-Resistant Slaphylococcus aureus," Antimicrob. Agents Chemother. (1992) 36(1):6-9. cited by other .
Top, F., Jr., "Control of Adenovirus Acute Respiratory Disease in U.S. Army Trainees", Yale J. Biol. Med., 1975, vol. 48, pp. 185-195. cited by other .
Towner, K. J. et al., "Development and evaluation of a PCR-based immunoassay for the rapid detection of methicillin-resistant Staphylococcus aureus," J. Med. Microbial. (1998) 47:607-613. cited by other .
Tsuneyoshi et al., "Mass spectrometric gene diagnosis of one-base substitution from polymerase chain reaction amplified human DNA" (1997) 11:719-722. cited by other .
Tsunoda et al., Time and Memory Efficient Algorithm for Extracting Palindromic and Repetitive Subsequences in Nucleic Acid Sequences Pacific Symposium on Biocomputing (1999) 4:202-213. cited by other .
Udo, E. E. et al., "Rapid detection of methicillin resistance in staphylococci using a slide latex agglutination kit," Int. J Antimicrob. Agents. (2000) 15(1):19-24. cited by other .
Udo, E. E. et al., "Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high-and low-level mupirocin resistance."J. Med. Microbiol. (2001) 50:909-515. cited by other .
Udo, E. E. et al., "A chromosomal location of the mupA gene in Staphylococcus aureus expressing high-level mupirocin resistance," J. Antimicrob. Chemother. (2003) 51:1283-1286. cited by other .
Unal et al., J. Clin. Microbiol. (1992) 30:1685-1691. cited by other .
Upton, A. et al., "Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance," J. Antimicrob. Chemother. (2003) 51: 613-617. cited by other .
Vabret, A., et al., "Development of a PCR-and hybridization-based assay (PCR Adenovirus Consensusa) for the detection and the species identification of adenoviruses in respiratory specimens", J. Clin. Virol., 2004, vol. 31, No. 2, pp. 116-122. cited by other .
Van Der Zee, et al., "Rapid and alternative screening methods for microbiological analysis" J. AOAC Int., 1997, 80, 934-940. cited by other .
Van Dinten et al., "Proteolytic Processing of the Open Reading Frame 1b-Encoded Part of Arterivirus Replicase Is Mediated by nsp4 Serine Protease and Is Essential for Virus Replication" J. Virology, 1999, vol. 73, pp. 2027-2037. cited by other .
Van Elden et al., "Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR" J. Clin. Microbiol. (2001) 39(1):196-200. cited by other .
Van Elden et al., "Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice" Br. J. Gen. Pract. (2001) 51:630-634. cited by other .
Van Leeuwen, W. B. et al., "Rapid Detection of Methicillin-Resistance in Staphylococus aureus Isolates by the MRSA-Screen Latex Agglutination Test,"J. Clin. Microbiol. (1999) 37(9):3029-3030. cited by other .
Van Leeuwen, W. B. et al., "Multilocus Sequence Typing of Staphylococcus aureus with DNA Array Technology," J. Clin. Microbiol. (2003) 41(7):3323-3326. cited by other .
Vannuffel, P. et al.. "Specific Detection of Methicillin-Resistant Staphylococcus Species by Multiplex PCR," J. Clin Microbiol. (1995) 33(11):2864-2867. cited by other .
Vannuffel, P. et al., "Rapid and Specific Molecular Identification of Methicillin-Resistant Staphylococcus aureus in Endotracheal Aspirates from Mechanically Ventilated Patients," J Clin. Microbiol. (1998) 36(8):2366-2368. cited by other .
Videla, C. et al., "Genomic analysis of adenovirus isolated from Argentinean children with acute lower respiratory infections", J. Clin. Virol., 1999, vol. 14, pp. 67-71. cited by other .
Vilchez, Regis A et al., "Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS related systemic non-Hodgkin lymphoma," J. AIDS Journal of Acquired Immune Deficiency Syndromes, 29(2):109-116 (Feb. 1, 2002). cited by other .
Voelter C et al., "Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses", Virology, Academic Press, Orlando, US 237(2):389-396 (Oct. 1997). cited by other .
Volokhov et al. Microarray analysis of erythromycin resistance determinants. Journal of Applied Microbiology 95:787-798 (2003). cited by other .
Von Eiff, C. et al., "Pathogenesis of infections due to coagulase-negative staphylococci," Lancet Infect. Dis. (2002) 2:677-685. cited by other .
Walker, E. S. et al., "A Decline in Mupimcin Resistance in Methicillin-Resistant Staphylococcus aureus Accompanied Administrative Control of Prescriptions," J. Clin. Microbiol. (2004) 42(6):2792-2795. cited by other .
Wallace, et al., "The Enigma of Endonuclease VII. DNA Repair," 2:441-453 (2003). cited by other .
Wallet, F. et al., "Choice of a routine method for detecting methicillin-resistance in staphylococci,"I Antimicrob. Chemother. (1996) 37:901-909. cited by other .
Ward et al ., "Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement" Journal of Clinical Virology (2004) 29:179-188. cited by other .
Weissenbacher, M. et al., "Etiologic and Clinical Evaluation of Acute Lower Respiratory Tract Infections in Young Argentinean Children: An Overview", Rev. Infect. Dis., 1990, vol. 12, Suppl. 8; pp. S889-S898. cited by other .
Wertheim, H. F. et al., "Effect of Mupirocin Treatment on Nasal, Pharyngeal, and Perineal Carriage of Staphylococcus aureus in Healthy Adults," Antimicrob. Agents Chemother. (2005) 49(4):1465-1467. cited by other .
Whiley, David M et al., "Simultaneous detection and differentiation of human polyomaviruses JC and BK by a rapid and sensitive PCR-ELAHA assay and a survey of the JCV subtypes within an Australian population," Journal of Medical Virology, 72(3):467-472 (Mar. 2004). cited by other .
Wichelhaus, T. A. et al., "Rapid Detection of Epidemic Strains of Methicillin-Resistant Staphylococcus aureus," J. Clin. Microbiol. (1999) 37(3):690-693. cited by other .
Wickham, T.J., "Targeting adenovirus", Gene Therapy, 2000, vol. 7, pp. 110-114. cited by other .
Winger et al., "High resolution accurate mass measurements of biomolecules using a new electrospray ionization ion cyclotron resonance mass spectrometer" J. Am. Soc. Mass Spectrom. 4, pp. 566-577, 1993. cited by other .
Wood, S.R. et al., "Rapid Detection and Serotyping of Adenovirus by Direct Immunofluorescence", J. Med. Virol., 1997, vol. 51, No. 3, pp. 198-201. cited by other .
Wright et al., "Typing and Subtyping of Influenza Viruses in Clinical Samples by PCR" J. Clin. Microbiol. (1995) 33(5):1180-1184. cited by other .
Wu et al., "Genetic Organization of the mecA Region in Methicillin-Susceptible and Methicillin-Resistant Strains of Staphylococcus sciuri" J. Bacteriol. (1998) 180(2):236-242. cited by other .
Wu et al., "Establishment of a fluorescent polymerase chain reaction method for the detection of SARS-associated coronavirus and its clinical application" Chin. Med. J. (2003) 116:988-990. cited by other .
Xu et al., "Intercontinental Circulation of Human Influenza A(H1N2) Reassortant Viruses During the 2001-2002 Influenza Season" J. Infect. Dis. (2002):186:1490-1493. cited by other .
Xu, W. et al., "Species-Specific Identification of Human Adenoviruses by a Multiplex PCR Assay", J. Clin. Microbiol., 2000, vol. 38, No. 11, pp. 4114-4120. cited by other .
Xu, W. et al., "Type-Specific Identification of Human Adenovirus, 3, 7, and 21 by a Multiplex PCR Assay", J. Med. Virol., 2001, vol. 64, No. 4, pp. 537-542. cited by other .
Yun, H J et al., "Increased antibacterial activity of OW286, a novel fluoronaphthyridone antibiotic, against Staphylococcus aureus strains with defined mutations in DNA gyrase and toposiomerase IV", International Journal of Antimicrobial Agents, Amsterdam, NL, 25(4):334-337 (Apr. 1, 2005). cited by other .
Zhang et al., "Detectiona and identification of human influenza viruses by the polymerase chain reaction" J. Virol. Methods (1991) 33(1-2):165-189. cited by other .
Zhang, K. et al., "New Quadriplex PCR Assay for Detection of Methicillin and Mupirocin Resistance and Simultaneous Discrimination of Staphylococcus aureus from Coagulase-Negative Staphylococci," J. Clin. Microbiol. (2004) 42(11):4947-4955. cited by other .
Zhang, Y.-Q. et al., "Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidimis strain (ATCC 12228):" Mol. Microbiol. (2003) 49(6):1577-1593. cited by other .
Agostini et al. "Complete genome of a JC virus genotype Type 6 from the brain of an African American with progressive multifocal leukoencephalopathy" (1998) 1:267-272, journal of human virology. cited by other .
U.S. Appl. No. 10/943,344 Office Communication Mailed Oct. 14, 2009. cited by other .
U.S. Appl. No. 11/060,135 Office Communication Mailed Jul. 15, 2009. cited by other .
U.S. Appl. No. 11/070,634 Office Communication Mailed Jul. 23, 2009. cited by other .
U.S. Appl. No. 11/582,930 Office Communication Mailed Jul. 2, 2009. cited by other .
U.S. Appl. No. 11/685,598 Office Communication Mailed Aug. 18, 2009. cited by other .
U.S. Appl. No. 11/754,163 Office Communication Mailed Jul. 28, 2009. cited by other .
U.S. Appl. No. 11/754,169 Office Communication Mailed Aug. 25, 2009. cited by other .
U.S. Appl. No. 11/754,174 Office Communication Mailed Aug. 3, 2009. cited by other .
U.S. Appl. No. 11/754,182 Office Communication Mailed Jul. 2, 2009. cited by other .
U.S. Appl. No. 90/010,447 Office Communication Mailed Apr. 24, 2009. cited by other .
U.S. Appl. No. 90/010,447 Office Communication Mailed Mar. 12, 2009. cited by other .
U.S. Appl. No. 90/010,448 Office Communication Mailed Apr. 24, 2009. cited by other .
U.S. Appl. No. 90/010,448 Office Communication Mailed Mar. 12, 2009. cited by other .
Barbour et al. "Identification of an uncultivatable Borrelia species in the hard tick Amblyomma americanum: Possible agent of a Lyme disease-like illness" The Journal of Infectious Diseases (1996) 173:403-409. cited by other .
Barns et al., "Detection of diverse new Francisella-like bacteria in environmental samples." Applied and Environmental Microbiology (2005) 71:5494-5500. cited by other .
Butel et al. "Cell and molecular biology of simian virus 40: implications for human infections and diseases" J. Natl. Cancer Institute (1999) 91(2):119-134. cited by other .
Chen, Y. Z. et al., "A BAC-Based STS-Content Map Spanning a 35-Mb Region of Human Chromosome 1p35-36," Genomics (2001) 74(1):55-70. cited by other .
Contreras-Salazar et al. "up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-Butyrate and after EBV superinfection" J. Virol. (1990) 64(11):5441-5447. cited by other .
De La Puente-Redondo et al., "Comparison of different PCR approaches for typing of Francisella tularensis strains." (2000) 38:1016-1022, Journal of Clinical Microbiology. cited by other .
Del Blanco et al., "Genotyping of Francisella tularensis strains by pulsed-field gel electrophoresis, amplified fragment length polymorphism fingerprinting, and 16S rRNA gene sequencing." (2002) 40:2964-2972, journal of clinical microbiology. cited by other .
Deurenberg et al., "The prevalence of the Staphylococcus aureus tst gene among community-and hospital-acquired strains and isolates from Wegener's Granulomatosis patients" FEMS Microbiol. Lett. (2005) 245:185-189. cited by other .
European Patent Office Communication for 07760292.8 dated Apr. 7, 2009. cited by other .
European Supplemental Search Report for 05753037 dated Aug. 28, 2009. cited by other .
Farlow et al., "Francisella tularensis Strain Typing Using Multiple-Locus, Variable-Number Tandem Repeat Analysis" Journal of Critical Microbiology, (2001) 39(9):3186-3192. cited by other .
Francois et al. "Sequence-specific recognition and cleavage of duplex DNA via triple-helix formation by oligonucleotides covalently linked to a phenanthroline-copper chelate" Proc. Natl. Acad. Sci. USA (1989) 86:9702-9706. cited by other .
GenBank accession No. AE009948.1 (gi:22535226; Aug. 8, 2002). cited by other .
GenBank accession No. AE009949.1 (gi:19913450; Apr. 3, 2002). cited by other .
GenBank accession No. AE015927.1 (gi:28204652; Feb. 4, 2003). cited by other .
GenBank accession No. AE015929.1 (gi:27316888; Jan. 2, 2003). cited by other .
GenBank accession No. AF274728 (gi:11612419; Dec. 11, 2000). cited by other .
GenBank accession No. AF276257.1 (gi:1457889; Jul. 1, 2001). cited by other .
GenBank Accession No. BX571857.1 (gi:49243355; Jun. 25, 2004). cited by other .
GenBank GI:147581 [online] Sep. 14, 1992 [retrieved on Jul. 20, 20091 from http://www.ncbi.nlm.nih.gov/sviewer/viewer.fqi?I47581:OLDID:114614. cited by other .
GenBank GI:174375 [online] Aug. 11, 1995 [retrieved on Jul. 20, 20091 retrieved from http://www.ncbi.nlm.nih.gov/nuccore/I74375. cited by other .
GenBank GI:42813 [online] Feb. 28, 1992 [retrieved on Jul. 20, 2009] retrieved from the Internet at http://www.ncbi.nlm.nih.gov/sviewer/viewer.fqi?42813:OLDID:25896. cited by other .
GenBank GI:49243355 [online] Jun. 24, 2004 [retrieved on Jul. 27, 2009] retrieved from http://www.ncbi.nlm.nih.govlsviewer/viewer.fi?49243355:OLDO4:1481434. cited by other .
GenBank GI:73916349 [online] Sep. 30, 2005 [retrieved on Jul. 25, 2009] retrieved from http://www.ncbi.nlm.nih.gov/nuccore/73916349. cited by other .
GenBank GI:78099429 [online] Mar. 11, 2006 [retrieved on Jul. 22, 20091 retrieved from http://www.ncbi.nlm.nih.gov/sviewer/viewer.fi?78099429:NCBI:I2971731. cited by other .
Hyde-Deruyscher, R. et al., "Polyomavirus early-late switch is not regulated at the level of transcription initiation and is associated with changes in RNA processing" Proc. Natl. Acad. Sci. USA (1988) 85:8993-8997. cited by other .
Chinese Office Communication for CN2004800161.9 dated Jun. 12, 2009. cited by other .
International Search Report for PCT/US2008/057901 dated Jun. 29, 2009. cited by other .
International Search Report for PCT/US2009/045635 dated Oct. 7, 2009. cited by other .
James et al., "Borelia lonestari infection after a bite by an Amblyomma americanum tick" The Journal of Infectious Diseases (2001) 183:1810-1814. cited by other .
Jaulhac, B. et al., "Specific detection of the toxic shock syndrome toxin-1 gene using the polymerase chain reaction" Mol. Cel. Probes (1991) 5:281-284. cited by other .
Johansson et al., "Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis." Journal of Clinical Microbiology (2000) 38:4180-4185. cited by other .
Johnson et al. "Detection of genes for enterotoxins, exfoliative toxins, and toxic shock Syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction" J. Clin. Microbiol. (1991) 29:426-430. cited by other .
Kim et al. "Identification of Mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB)" Journal of Clinical Microbiology 37(6):1714-1720, Jun. 1999. cited by other .
Kitagawa et al. "Rapid diagnosis of methicillin-resistant Staphylococcus aureus bacteremia by nested polymerase chain reaction" Ann. Surgery (1996) 224:665-671. cited by other .
Lacroix, L. et al., "Triplex Formation by Oligonucleotides Containing 5-(1-Propynyl)-2'-deoxyuridine: Decreased Magnesium Dependence and Improved Intracellular Gene Targeting" Biochem. (1999) 38(6):1893-1 901. cited by other .
Lednicky, J. A. et al., "Polyomaviruses and Human Tumors: A Brief Review of Current Concenpts and Interpretations," Front. Biosci. (1999) 4:d153-164. cited by other .
Lee, J.A. et al., "Rapid Identification of Human Adenovirus Types 3 and 7 from Respiratory Specimens via Multiplex Type-Specific PCR", J. Clin. Microbiol., 2005, vol. 43, No. 11, pp. 5509-5514. cited by other .
Leroy et al., "Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting", Journal of Medical Virology, 60:463-467 (2000). cited by other .
Li, Q.-G. et al., "Comparison of 17 Genome Types of Adenovirus Type 3 Identified among Strains Recovered from Six Continents", J. Clin. Microbiol, 1988. vol. 26, No. 5, pp. 1009-1015. cited by other .
Lowe et al., "A computer program for selection of oligonucleotide primers for polymerase chain reactions" Nucleic Acids Research, (1990) vol. 18(7):1757-1761. cited by other .
Ludwig W. "Bacterial phylogeny based on 16s and 23s rRNA sequence analysis" FEMS Microbiol Rev 15(2-3):155-73, Oct. 1994. cited by other .
Lukashov, V. V. et al., "Evolutionary Relationships among Parvoviruses: Virus-Host Coevolution among Autonomous Primate Parvoviruses and Links between Adeno-Associated and Avian Parvoviruses," J. Virol. (2001) 75(6):2729-2740. cited by other .
Mollet et al. "rpoB sequence analysis as a novel basis for bacterial identification" Molecular Microbiology 26(5):1005-1011 (1997). cited by other .
Pan, Z.-Q et al., "Oligonucleotide-targeted degradation of U1 and U2 snRNAs reveals differential interactions of simian virus 40 pre-mRNAs with snRNPs," Nucleic Acids Res. (1989) 17(16):6553-6568. cited by other .
Sampath et al "Global surveillance of emerging influenza virus genotypes by mass spectrometry" Plos ONE (2007) 5:e489. cited by other .
Sampath et al "Rapid Identification of Emerging Infectious Agents Using PCR and Electrospray Ionization Mass Spectrometry" Ann. N.y. Acad. Sci. (2007) 1102:109-120. cited by other .
Santos et al. "Identification and phylogenetic sorting of bacterial lineages with universally conserved genes and proteins" Environmental Microbiology 6(7):754-759, Jul. 2004. cited by other .
Schabereiter-Gurtner et al "Application of broad-range 16s rRNA PCR amplification and DGGE fingerprinting for detection of tick-infecting bacteria" The Journal of Microbiological Methods (2003 52:251-260. cited by other .
Scheffner, M. et al., "The E6 Oncoprotein Encoded by Human Papillomavirus Types 16 and 18 Promotes the Degradation of p53," Cell (1990) 63:1129-1136. cited by other .
Scheuermann et al. "Polymerase chain-reaction-based mRNA quantification Using an internal standard: analysis of oncogene expression" (1993) 218:446-473, Methods in Enzymology. cited by other .
Schlecht, N. F. et al., "Viral Load as a Predictor of the Risk of Cervical Intraepithelial Neoplasia," Int. J. Cancer (2003) 103:519-524. cited by other .
Shadan, F. F. et al., "n-Butyrate, a Cell Cycle Blocker, Inhibits the Replication of Polyomaviruses and Papillomaviruses but Not That of Adenoviruses and Herpesviruses," J. Virol. (1994) 68(8):4785-4796. cited by other .
Sumner et al. "PCR Amplification and Comparison of Nucleotide Sequences from the groESL Heat Shock Operon of Ehrlichia Species" Journal of Critical Microbiology (1997) 35:2087-2092. cited by other .
Takagaki, Y. et at., "Four factors are required for 3'-end cleavage of pre-mRNAs," Genes Dev. (1989) 3:1711-1724. cited by other .
Unpublished U.S. Appl. No. 10/318,463, filed Dec. 13, 2002. cited by other .
Unpublished U.S. Appl. No. 10/323,186, filed Dec. 18, 2002. cited by other .
Unpublished U.S. Appl. No. 10/323,187, filed Dec. 18, 2002. cited by other .
Unpublished U.S. Appl. No. 10/324,721, filed Dec. 18, 2002. cited by other .
Unpublished U.S. Appl. No. 10/728,486, filed Dec. 5, 2003. cited by other .
Unpublished U.S. Appl. No. 11/209,439, filed Aug. 23, 2005. cited by other .
Unpublished U.S. Appl. No. 11/233,630, filed Sep. 2, 2005. cited by other .
Unpublished U.S. Appl. No. 11/682,259, filed Mar. 5, 2007. cited by other .
Unpublished U.S. Appl. No. 60/604,329, filed Aug. 24, 2004. cited by other .
Unpublished U.S. Appl. No. 60/632,862, filed Dec. 3, 2004. cited by other .
Unpublished U.S. Appl. No. 60/639,068 filed Dec. 22, 2004. cited by other .
Unpublished U.S. Appl. No. 60/648,188 filed Jan. 28, 2005. cited by other .
Unpublished U.S. Appl. No. 60/658,248 filed Mar. 3, 2005. cited by other .
Vanchiere et al. "Detection of BK virus and Simian virus 40 in the urine of healthy children" Journal of Medical Virology (2005) 75:447-454. cited by other .
Wang, G. et al., "Targeted Mutagenesis in Mammalian Cells Mediated by Intracellular Triple Helix Formation," Mol. Cell. Biol. (1995) 15(3):1759-1768. cited by other .
Westermann, P. et al., "Inhibition of expression of SV40 virus large T-antigen by antisense oligodeoxyribonucleotides," Biomed. Biochim. Acta (1989) 1:85-93. cited by other .
Widjojoatmodjo et al. "The magnetic Immuno polymerase chain reaction assay for direct detection of Salmonellae in fecal samples" J. Clin. Microbiol. (1992) 30(12):3195-3199. cited by other .
Wintzingerode et al. "Base-specific fragmentation of amplified 16s rRNA genes analyzed by mass spectrometry: A tool for rapid bacterial identification" PNAS 99(10):7039-7044, 2002. cited by other .
Xu et al. "Electrospray mass tag dideoxy DNA sequencing" Anal. Chem. (1997) 69:3595-3602. cited by other .
Ye, K. et al., "Three Distinct Promoters Direct Transcription of Different 5' Untranslated Regions of the Human Interleukin 1 Type I Receptor: A Possible Mechanism for Control of Translation," Cytokine (1996) 8(6):421-429. cited by other .
Batey, R.T. et al., Nucleic Acids Research 20:4515-4523 Preparation of Isotopically Labeled Ribonucleotides For Multidemsional NMR Spectroscopy of RNA, (1992). cited by other .
Baumer et al., Am. J. Hum. Genet. 1994 54:618-630 Age-related Human mtDNA Deletions: A Heterogeneous Set of Deletions Arising at a Single Pair of Directly Repeated Sequences. cited by other .
Fraser, C.M. et al., Science 1995 270:397-403 The Minimal Gene Complement of Mycoplasma Genitalium. cited by other .
Goto et al., J. Gen. Appl. Microbiol. 2000 46:1-8 Application of the Partial 16S rDNA Sequence as an Index Fro Rapid Identification of Species in the Genus Bacillus. cited by other .
Holm, L., et al., Bioinformatics 1998 14:423-429 Removing Near -neighbour Redundancy From Large Portein Sequence Collections. cited by other .
Howell et al., Am. J. Hum. Genet. 2000 66:1589-1598 "Persistent Heteroplasmy of a Mutation in the Human mtDNA Control Region: Hypermutation as an Apparent Consequence of Simp". cited by other .
Jansen et al., Theor. Appl. Genet. 1995 91:33-37 "Genotype-by-environment interaction in genetic mapping of multiple quantitative trait loci". cited by other .
Jensen et al., Appl. Environ. Microbiol. 1993 59:945-952 Rapid Identification of Bacteria on the Basis of Polymerase Chain Reaction-Amplified Ribosomal DNA Spacer Polymorphism. cited by other .
Keller et al., Anal. Chem. 2002 74:5383-5392 Empirical Statistical Model to Estimate the Accuracy of Peptide Identifications Made By MS/MS and Database Search. cited by other .
McLafferty, F. et al., J. Am. Soc. Mass Spectrom., 1998 9:92-95 Comparison of Algorithms and Databases for Matching Unknown Mass Spectra. cited by other .
Parson et al., "Polulation data for 101 Austrian Caucasian mitochondrial DNA d-loop sequences: Application of mtDNA sequence analysis to" Int. J. Legal Med. 1998 111:124-132. cited by other .
Torroni et al., Genetics 1996 144:1835-1850 Classification of European mtDNAs From an Analysis of Three European Populations. cited by other .
Haugland et al:, Mol. Cell. Probes 1998 12:387-396 Identification of Putative Sequence Specific PCR Primers for Detection of the Toxigenic Fungal Species Stachybotrys Chartaru. cited by other .
Van Der Vossen et al., Int. J. Food Microbial. 1996; 33:35-49 "DNA based typing, identification and detection systems for food spoilage microorganisms: development and implem". cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Feb. 10, 2005. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Feb. 27, 2003. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Apr. 16, 2002. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Jun. 20, 2002. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Jun. 30, 2004. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Jul. 11, 2003. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Nov. 6, 2002. cited by other .
U.S. Appl. No. 09/798,007 Office Communication Mailed Nov. 19, 2003. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Mar. 8, 2005. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Mar. 9, 2004. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Mar. 16, 2006. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Jun. 14, 2004. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Aug. 26, 2003. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Sep. 13, 2006. cited by other .
U.S. Appl. No. 09/891,793 Office Communication Mailed Oct. 20, 2004. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Apr. 1, 2004. cited by other .
Hurst, et al. "MALDI-ROF Analysis of Polymerase Chain Reaction Products from Methaneotrophic Bacteria", Analytical Chemistry vol. 70, pp. 2693-8 (1998). cited by other .
Takeuchi, et al. Jrnl of Clinical Micro., Jun. 1999, p. 1839-1845, Serotyping of Adenoviruses on Conjunctional Scrapings by PCR and Sequence Analysis. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed May 26, 2005. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Oct. 14, 2004. cited by other .
U.S. Appl. No. 10/156,608 Office Communication Mailed Nov. 19, 2004. cited by other .
U.S. Appl. No. 10/418,514 Office Communication Mailed Feb. 27, 2006. cited by other .
U.S. Appl. No. 10/418,514 Office Communication Mailed Mar. 27, 2007. cited by other .
U.S. Appl. No. 10/418,514 Office Communication Mailed Sep. 29, 2005. cited by other .
U.S. Appl. No. 10/418,514 Office Communication Mailed Dec. 6, 2007. cited by other .
U.S. Appl. No. 10/660,122 Office Communication Mailed Mar. 17, 2006. cited by other .
U.S. Appl. No. 10/660,122 Office Communication Mailed Apr. 20, 2007. cited by other .
U.S. Appl. No. 10/660,122 Office Communication Mailed Jul. 6, 2006. cited by other .
U.S. Appl. No. 10/660,122 Office Communication Mailed Sep. 19, 2006. cited by other .
U.S. Appl. No. 10/660,996 Office Communication Mailed Feb. 28, 2006. cited by other .
U.S. Appl. No. 10/660,996 Office Communication Mailed May 30, 2006. cited by other .
U.S. Appl. No. 10/660,996 Office Communication Mailed Sep. 5, 2006. cited by other .
U.S. Appl. No. 10/660,997 Office Communication Mailed Mar. 13, 2006. cited by other .
U.S. Appl. No. 10/660,997 Office Communication Mailed May 26, 2006. cited by other .
U.S. Appl. No. 10/660,997 Office Communication Mailed Sep. 18, 2006. cited by other .
U.S. Appl. No. 10/660,998 Office Communication Mailed Jan. 24, 2007. cited by other .
U.S. Appl. No. 10/660,998 Office Communication Mailed May 1, 2006. cited by other .
U.S. Appl. No. 10/660,998 Office Communication Mailed Aug. 3, 2006. cited by other .
U.S. Appl. No. 10/660,998 Office Communication Mailed Aug. 7, 2007. cited by other .
U.S. Appl. No. 10/660,998 Office Communication Mailed Dec. 11, 2007. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed Apr. 10, 2006. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed May 11, 2007. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed Jul. 27, 2006. cited by other .
U.S. Appl. No. 10/728,486 Office Communication Mailed Dec. 20, 2006. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Feb. 27, 2007. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Mar. 13, 2006. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Aug. 28, 2006. cited by other .
U.S. Appl. No. 10/754,415 Office Communication Mailed Aug. 30, 2007. cited by other .
U.S. Appl. No. 11/059,776 Office Communication Mailed Jan. 19, 2007. cited by other .
U.S. Appl. No. 11/059,776 Office Communication Mailed May 29, 2007. cited by other .
U.S. Appl. No. 11/060,135 Office Communication Mailed Mar. 8, 2007. cited by other .
U.S. Appl. No. 11/060,135 Office Communication Mailed Jul. 24, 2007. cited by other .
U.S. Appl. No. 11/060,135 Office Communication Mailed Dec. 21, 2006. cited by other .
U.S. Appl. No. 11/210,516 Office Communication Mailed Jun. 8, 2007. cited by other .
U.S. Appl. No. 11/210,516 Office Communication Mailed Oct. 19, 2007. cited by other .
U.S. Appl. No. 11/233,630 Office Communication Mailed Jun. 8, 2007. cited by other .
U.S. Appl. No. 11/233,630 Office Communication Mailed Jul. 13, 2007. cited by other .
U.S. Appl. No. 11/331,978 Office Communication Mailed Nov. 15, 2007. cited by other .
U.S. Appl. No. 11/331,987 Office Communication Mailed Jul. 16, 2007. cited by other .
U.S. Appl. No. 11/331,987 Office Communication Mailed Oct. 22, 2007. cited by other .
U.S. Appl. No. 11/409,535 Office Communication Mailed Oct. 31, 2007. cited by other .
Elnifro, et al., Jrnl. Clinical Micro., Jun. 2000, p. 2055-2061 PCR and Restriction Endonuclease Analysis for Rapid Identificatoin of Human Adenovirus Subgenera. cited by other.

Primary Examiner: Benzion; Gary
Assistant Examiner: Bertagna; Angela
Attorney, Agent or Firm: Casimir Jones S.C. Sappenfield; Christopher C.

Government Interests

STATEMENT OF GOVERNMENT SUPPORT

This invention was made with United States Government support under DARPA contract numbers MDA972-00-C-0053 and MDA972-99-3-0022. The United States Government has certain rights in the invention.

Parent Case Text

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application: 1) is a continuation-in-part of U.S. application Ser. No. 10/323,233 filed Dec. 18, 2002 now abandoned; 2) is a continuation-in-part of U.S. application Ser. No. 10/326,051 filed Dec. 18, 2002 now abandoned; 3) is a continuation-in-part of U.S. application Ser. No. 10/325,526 filed Dec. 18, 2002 now abandoned; 4) is a continuation-in-part of U.S. application Ser. No. 10/325,527 filed Dec. 18, 2002 now abandoned; 5) is a continuation-in-part of U.S. application Ser. No. 09/798,007 filed Mar. 2, 2001 now abandoned; 6) claims the benefit of U.S. provisional application Ser. No. 60/431,319 filed Dec. 6, 2002 now abandoned; 7) claims the benefit of U.S. provisional application Ser. No. 60/443,443 filed Jan. 29, 2003; 8) claims the benefit of U.S. provisional application Ser. No. 60/443,788 filed Jan. 30, 2003; and 9) claim the benefit of U.S. provisional application Ser. No. 60/447,529 filed Feb. 14, 2003; each of which is incorporated herein by reference in its entirety.

Claims

What is claimed is:

1. A method of identifying a virus comprising: contacting nucleic acid from said virus with at least one pair of primers which hybridize to flanking sequences of said nucleic acid, wherein said flanking sequences flank a variable nucleic acid sequence of said virus; amplifying said variable nucleic acid sequence to produce an amplification product; determining the base composition of said amplification product by mass spectrometry, wherein said base composition identifies the number of A residues, C residues, T residues, G residues, U residues, analogues thereof and mass tag residues thereof in said amplification product; and comparing said base composition of said amplification product to calculated or measured base compositions of analogous amplification products of one or more known viruses present in a database comprising 5 or more base compositions with the proviso that sequencing of said amplification product is not used to identify the virus.

2. The method of claim 1, further comprising repeating said contacting, amplifying, determining and comparing steps using one or more additional pairs of primers.

3. The method of claim 1, wherein said virus is a biological warfare threat agent.

4. The method of claim 1, wherein said virus is identified at the sub-species level.

5. The method of claim 1, wherein said virus is a respiratory pathogen.

6. The method of claim 1, wherein said virus is a hepatitis C virus.

7. The method of claim 1, wherein said virus is an immunodeficiency virus.

8. The method of claim 1, wherein said virus is a member of a viral family selected from the group consisting of Filoviridae, Flaviviridae, Arenaviridae, Bunyaviridae, Adenoviridae, Picornaviridae, Togaviridae, and Cononaviridae.

9. The method of claim 1, wherein said nucleic acid is a housekeeping gene.

10. The method of claim 9, wherein said housekeeping gene is a polymerase, a virion component, a helicase, a protease, a methyltransferase, or an accessory protein.

11. The method of claim 10, wherein said polymerase is RNA-dependent RNA polymerase, DNA-dependent DNA polymerase or DNA-dependent RNA polymerase.

12. The method of claim 1, wherein said amplifying step comprises the polymerase chain reaction.

13. The method of claim 1, wherein the sequences to which the primers hybridize are separated by between about 60-100 nucleotides.

14. The method of claim 1, wherein said virus is identified at the species level.

15. The method of claim 1, wherein said pair of primers comprises at least one nucleotide analog.

16. The method of claim 15, wherein said nucleotide analog is inosine, uridine, 2,6-diaminopurine, propyne C, or propyne T.

17. The method of claim 1, wherein a molecular mass-modifying tag is incorporated into said amplification product to limit the number of possible base compositions consistent with the mass of said amplification product.

Description

FIELD OF THE INVENTION

The present invention relates generally to clinical applications of directed to the identification of pathogens in biological samples from humans and animals. The present invention is also directed to the resolution of a plurality of etiologic agents present in samples obtained from humans and animals. The invention is further directed to the determination of detailed genetic information about such pathogens or etiologic agents.

The identification of the bioagent is important for determining a proper course of treatment and/or eradication of the bioagent in such cases as biological warfare and natural infections. Furthermore, the determination of the geographic origin of a selected bioagent will facilitate the identification of potential criminal identity. The present invention also relates to methods for rapid detection and identification of bioagents from environmental, clinical or other samples. The methods provide for detection and characterization of a unique base composition signature (BCS) from any bioagent, including bacteria and viruses. The unique BCS is used to rapidly identify the bioagent.

BACKGROUND OF THE INVENTION

In the United States, hospitals report well over 5 million cases of recognized infectious disease-related illnesses annually. Significantly greater numbers remain undetected, both in the inpatient and community setting, resulting in substantial morbidity and mortality. Critical intervention for infectious disease relies on rapid, sensitive and specific detection of the offending pathogen, and is central to the mission of microbiology laboratories at medical centers. Unfortunately, despite the recognition that outcomes from infectious illnesses are directly associated with time to pathogen recognition, as well as accurate identification of the class and species of microbe, and ability to identify the presence of drug resistance isolates, conventional hospital laboratories often remain encumbered by traditional slow multi-step culture based assays. Other limitations of the conventional laboratory which have become increasingly apparent include: extremely prolonged wait-times for pathogens with long generation time (up to several weeks); requirements for additional testing and wait times for speciation and identification of antimicrobial resistance; diminished test sensitivity for patients who have received antibiotics; and absolute inability to culture certain pathogens in disease states associated with microbial infection.

For more than a decade, molecular testing has been heralded as the diagnostic tool for the new millennium, whose ultimate potential could include forced obsolescence of traditional hospital laboratories. However, despite the fact that significant advances in clinical application of PCR techniques have occurred, the practicing physician still relies principally on standard techniques. A brief discussion of several existing applications of PCR in the hospital-based setting follows.

Generally speaking molecular diagnostics have been championed for identifying organisms that cannot be grown in vitro, or in instances where existing culture techniques are insensitive and/or require prolonged incubation times. PCR-based diagnostics have been successfully developed for a wide variety of microbes. Application to the clinical arena has met with variable success, with only a few assays achieving acceptance and utility.

One of the earliest, and perhaps most widely recognized applications of PCR for clinical practice is in detection of Mycobacterium tuberculosis. Clinical characteristics favoring development of a nonculture-based test for tuberculosis include week to month long delays associated with standard testing, occurrence of drug-resistant isolates and public health imperatives associated with recognition, isolation and treatment. Although frequently used as a diagnostic adjunctive, practical and routine clinical application of PCR remains problematic due to significant inter-laboratory variation in sensitivity, and inadequate specificity for use in low prevalence populations, requiring further development at the technical level. Recent advances in the laboratory suggest that identification of drug resistant isolates by amplification of mutations associated with specific antibiotic resistance (e.g., rpoB gene in rifampin resistant strains) may be forthcoming for clinical use, although widespread application will require extensive clinical validation.

One diagnostic assay, which has gained widespread acceptance, is for C. trachomatis. Conventional detection systems are limiting due to inadequate sensitivity and specificity (direct immunofluorescence or enzyme immunoassay) or the requirement for specialized culture facilities, due to the fastidious characteristics of this microbe. Laboratory development, followed by widespread clinical validation testing in a variety of acute and nonacute care settings have demonstrated excellent sensitivity (90-100%) and specificity (97%) of the PCR assay leading to its commercial development. Proven efficacy of the PCR assay from both genital and urine sampling, have resulted in its application to a variety of clinical setting, most recently including routine screening of patients considered at risk.

While the full potential for PCR diagnostics to provide rapid and critical information to physicians faced with difficult clinical-decisions has yet to be realized, one recently developed assay provides an example of the promise of this evolving technology. Distinguishing life-threatening causes of fever from more benign causes in children is a fundamental clinical dilemma faced by clinicians, particularly when infections of the central nervous system are being considered. Bacterial causes of meningitis can be highly aggressive, but generally cannot be differentiated on a clinical basis from aseptic meningitis, which is a relatively benign condition that can be managed on an outpatient basis. Existing blood culture methods often take several days to turn positive, and are often confounded by poor sensitivity or false-negative findings in patients receiving empiric antimicrobials. Testing and application of a PCR assay for enteroviral meningitis has been found to be highly sensitive. With reporting of results within 1 day, preliminary clinical trials have shown significant reductions in hospital costs, due to decreased duration of hospital stays and reduction in antibiotic therapy. Other viral PCR assays, now routinely available include those for herpes simplex virus, cytomegalovirus, hepatitis and HIV. Each has a demonstrated cost savings role in clinical practice, including detection of otherwise difficult to diagnose infections and newly realized capacity to monitor progression of disease and response to therapy, vital in the management of chronic infectious diseases.

The concept of a universal detection system has been forwarded for identification of bacterial pathogens, and speaks most directly to the possible clinical implications of a broad-based screening tool for clinical use. Exploiting the existence of highly conserved regions of DNA common to all bacterial species in a PCR assay would empower physicians to rapidly identify the presence of bacteremia, which would profoundly impact patient care. Previous empiric decision making could be abandoned in favor of educated practice, allowing appropriate and expeditious decision-making regarding need for antibiotic therapy and hospitalization.

Experimental work using the conserved features of the 16S rRNA common to almost all bacterial species, is an area of active investigation. Hospital test sites have focused on "high yield" clinical settings where expeditious identification of the presence of systemic bacterial infection has immediate high morbidity and mortality consequences. Notable clinical infections have included evaluation of febrile infants at risk for sepsis, detection of bacteremia in febrile neutropenic cancer patients, and examination of critically ill patients in the intensive care unit. While several of these studies have reported promising results (with sensitivity and specificity well over 90%), significant technical difficulties (described below) remain, and have prevented general acceptance of this assay in clinics and hospitals (which remain dependent on standard blood culture methodologies). Even the revolutionary advances of real-time PCR technique, which offers a quantitative more reproducible and technically simpler system, remains encumbered by inherent technical limitations of the PCR assay.

The principle shortcomings of applying PCR assays to the clinical setting include: inability to eliminate background DNA contamination; interference with the PCR amplification by substrates present in the reaction; and limited capacity to provide rapid reliable speciation, antibiotic resistance and subtype identification. Some laboratories have recently made progress in identifying and removing inhibitors; however background contamination remains problematic, and methods directed towards eliminating exogenous sources of DNA report significant diminution in assay sensitivity. Finally, while product identification and detailed characterization has been achieved using sequencing techniques, these approaches are laborious and time-intensive thus detracting from its clinical applicability.

Rapid and definitive microbial identification is desirable for a variety of industrial, medical, environmental, quality, and research reasons. Traditionally, the microbiology laboratory has functioned to identify the etiologic agents of infectious diseases through direct examination and culture of specimens. Since the mid-1980s, researchers have repeatedly demonstrated the practical utility of molecular biology techniques, many of which form the basis of clinical diagnostic assays. Some of these techniques include nucleic acid hybridization analysis, restriction enzyme analysis, genetic sequence analysis, and separation and purification of nucleic acids (See, e.g., J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y., 1989). These procedures, in general, are time-consuming and tedious. Another option is the polymerase chain reaction (PCR) or other amplification procedure that amplifies a specific target DNA sequence based on the flanking primers used. Finally, detection and data analysis convert the hybridization event into an analytical result.

Other not yet fully realized applications of PCR for clinical medicine is the identification of infectious causes of disease previously described as idiopathic (e.g. Bartonella henselae in bacillary angiomatosis, and Tropheryma whippellii as the uncultured bacillus associated with Whipple's disease). Further, recent epidemiological studies which suggest a strong association between Chlamydia pneumonia and coronary artery disease, serve as example of the possible widespread, yet undiscovered links between pathogen and host which may ultimately allow for new insights into pathogenesis and novel life sustaining or saving therapeutics.

For the practicing clinician, PCR technology offers a yet unrealized potential for diagnostic omnipotence in the arena of infectious disease. A universal reliable infectious disease detection system would certainly become a fundamental tool in the evolving diagnostic armamentarium of the 21.sup.st century clinician. For front line emergency physicians, or physicians working in disaster settings, a quick universal detection system, would allow for molecular triage and early aggressive targeted therapy. Preliminary clinical studies using species specific probes suggest that implementing rapid testing in acute care setting is feasible. Resources could thus be appropriately applied, and patients with suspected infections could rapidly be risk stratified to the different treatment settings, depending on the pathogen and virulence. Furthermore, links with data management systems, locally regionally and nationally, would allow for effective epidemiological surveillance, with obvious benefits for antibiotic selection and control of disease outbreaks.

For the hospitalists, the ability to speciate and subtype would allow for more precise decision-making regarding antimicrobial agents. Patients who are colonized with highly contagious pathogens could be appropriately isolated on entry into the medical setting without delay. Targeted therapy will diminish development of antibiotic resistance. Furthermore, identification of the genetic basis of antibiotic resistant strains would permit precise pharmacologic intervention. Both physician and patient would benefit with less need for repetitive testing and elimination of wait times for test results.

It is certain that the individual patient will benefit directly from this approach. Patients with unrecognized or difficult to diagnose infections would be identified and treated promptly. There will be reduced need for prolonged inpatient stays, with resultant decreases in iatrogenic events.

Mass spectrometry provides detailed information about the molecules being analyzed, including high mass accuracy. It is also a process that can be easily automated. Low-resolution MS may be unreliable when used to detect some known agents, if their spectral lines are sufficiently weak or sufficiently close to those from other living organisms in the sample. DNA chips with specific probes can only determine the presence or absence of specifically anticipated organisms. Because there are hundreds of thousands of species of benign bacteria, some very similar in sequence to threat organisms, even arrays with 10,000 probes lack the breadth needed to detect a particular organism.

Antibodies face more severe diversity limitations than arrays. If antibodies are designed against highly conserved targets to increase diversity, the false alarm problem will dominate, again because threat organisms are very similar to benign ones. Antibodies are only capable of detecting known agents in relatively uncluttered environments.

Several groups have described detection of PCR products using high resolution electrospray ionization-Fourier transform-ion cyclotron resonance mass spectrometry (ESI-FT-ICR MS). Accurate measurement of exact mass combined with knowledge of the number of at least one nucleotide allowed calculation of the total base composition for PCR duplex products of approximately 100 base pairs. (Aaserud et al., J. Am. Soc. Mass Spec., 1996, 7, 1266-1269; Muddiman et al., Anal. Chem., 1997, 69, 1543-1549; Wunschel et al., Anal. Chem., 1998, 70, 1203-1207; Muddimanetal., Rev. Anal. Chem., 1998, 17, 1-68). Electrospray ionization-Fourier transform-ion cyclotron resistance (ESI-FT-ICR) MS may be used to determine the mass of double-stranded, 500 base-pair PCR products via the average molecular mass (Hurst et al., Rapid Commun. Mass Spec. 1996, 10, 377-382). The use of matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry for characterization of PCR products has been described. (Muddiman et al., Rapid Commun. Mass Spec., 1999, 13, 1201-1204). However, the degradation of DNAs over about 75 nucleotides observed with MALDI limited the utility of this method.

U.S. Pat. No. 5,849,492 describes a method for retrieval of phylogenetically informative DNA sequences which comprise searching for a highly divergent segment of genomic DNA surrounded by two highly conserved segments, designing the universal primers for PCR amplification of the highly divergent region, amplifying the genomic DNA by PCR technique using universal primers, and then sequencing the gene to determine the identity of the organism.

U.S. Pat. No. 5,965,363 discloses methods for screening nucleic acids for polymorphisms by analyzing amplified target nucleic acids using mass spectrometric techniques and to procedures for improving mass resolution and mass accuracy of these methods.

WO 99/14375 describes methods, PCR primers and kits for use in analyzing preselected DNA tandem nucleotide repeat alleles by mass spectrometry.

WO 98/12355 discloses methods of determining the mass of a target nucleic acid by mass spectrometric analysis, by cleaving the target nucleic acid to reduce its length, making the target single-stranded and using MS to determine the mass of the single-stranded shortened target. Also disclosed are methods of preparing a double-stranded target nucleic acid for MS analysis comprising amplification of the target nucleic acid, binding one of the strands to a solid support, releasing the second strand and then releasing the first strand which is then analyzed by MS. Kits for target nucleic acid preparation are also provided.

PCT WO97/33000 discloses methods for detecting mutations in a target nucleic acid by nonrandomly fragmenting the target into a set of single-stranded nonrandom length fragments and determining their masses by MS.

U.S. Pat. No. 5,605,798 describes a fast and highly accurate mass spectrometer-based process for detecting the presence of a particular nucleic acid in a biological sample for diagnostic purposes.

WO 98/21066 describes processes for determining the sequence of a particular target nucleic acid by mass spectrometry. Processes for detecting a target nucleic acid present in a biological sample by PCR amplification and mass spectrometry detection are disclosed, as are methods for detecting a target nucleic acid in a sample by amplifying the target with primers that contain restriction sites and tags, extending and cleaving the amplified nucleic acid, and detecting the presence of extended product, wherein the presence of a DNA fragment of a mass different from wild-type is indicative of a mutation. Methods of sequencing a nucleic acid via mass spectrometry methods are also described.

WO 97/37041, WO 99/31278 and U.S. Pat. No. 5,547,835 describe methods of sequencing nucleic acids using mass spectrometry. U.S. Pat. Nos. 5,622,824, 5,872,003 and 5,691,141 describe methods, systems and kits for exonuclease-mediated mass spectrometric sequencing.

Thus, there is a need for a method for bioagent detection and identification which is both specific and rapid, and in which no nucleic acid sequencing is required. The present invention addresses this need.

SUMMARY OF THE INVENTION

The present invention is directed towards methods of identifying a pathogen in a biological sample by obtaining nucleic acid from a biological sample, selecting at least one pair of intelligent primers with the capability of amplification of nucleic acid of the pathogen, amplifying the nucleic acid with the primers to obtain at least one amplification product, determining the molecular mass of at least one amplification product from which the pathogen is identified. Further, this invention is directed to methods of epidemic surveillance. By identifying a pathogen from samples acquired from a plurality of geographic locations, the spread of the pathogen to a given geographic location can be determined.

The present invention is also directed to methods of diagnosis of a plurality of etiologic agents of disease in an individual by obtaining a biological sample from an individual, isolating nucleic acid from the biological sample, selecting a plurality of amplification primers with the capability of amplification of nucleic acid of a plurality of etiologic agents of disease, amplifying the nucleic acid with a plurality of primers to obtain a plurality of amplification products corresponding to a plurality of etiologic agents, determining the molecular masses of the plurality of unique amplification products which identify the members of the plurality of etiologic agents.

The present invention is also directed to methods of in silico screening of primer sets to be used in identification of a plurality of bioagents by preparing a base composition probability cloud plot from a plurality of base composition signatures of the plurality of bioagents generated in silico, inspecting the base composition probability cloud plot for overlap of clouds from different bioagents, and choosing primer sets based on minimal overlap of the clouds.

The present invention is also directed to methods of predicting the identity of a bioagent with a heretofore unknown base composition signature by preparing a base composition probability cloud plot from a plurality of base composition signatures of the plurality of bioagents which includes the heretofore unknown base composition, inspecting the base composition probability cloud for overlap of the heretofore unknown base composition with the cloud of a known bioagent such that overlap predicts that the identity of the bioagent with a heretofore unknown base composition signature equals the identity of the known bioagent.

The present invention is also directed to methods for determining a subspecies characteristic for a given pathogen in a biological sample by identifying the pathogen in a biological sample using broad range survey primers or division-wide primers, selecting at least one pair of drill-down primers to amplify nucleic acid segments which provide a subspecies characteristic about the pathogen, amplifying the nucleic acid segments to produce at least one drill-down amplification product and determining the base composition signature of the drill-down amplification product wherein the base composition signature provides a subspecies characteristic about the pathogen.

The present invention is also directed to methods of pharmacogenetic analysis by obtaining a sample of genomic DNA from an individual, selecting a segment of the genomic DNA which provides pharmacogenetic information, using at least one pair of intelligent primers to produce an amplification product which comprises the segment of genomic DNA and determining the base composition signature of the amplification product, wherein the base composition signature provides pharmacogenetic information about said individual.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1A-1H and FIG. 2 are consensus diagrams that show examples of conserved regions from 16S rRNA (FIG. 1A-1, 1A-2, 1A-3, 1A-4, and 1A-5), 23S rRNA (3'-half, FIG. 1B, 1C, and 1D; 5'-half, FIGS. 1E-F), 23S rRNA Domain I (FIG. 1G), 23S rRNA Domain IV (FIG. 1H) and 16S rRNA Domain III (FIG. 2) which are suitable for use in the present invention. Lines with arrows are examples of regions to which intelligent primer pairs for PCR are designed. The label for each primer pair represents the starting and ending base number of the amplified region on the consensus diagram. Bases in capital letters are greater than 95% conserved; bases in lower case letters are 90-95% conserved, filled circles are 80-90% conserved; and open circles are less than 80% conserved. The label for each primer pair represents the starting and ending base number of the amplified region on the consensus diagram. The nucleotide sequence of the 16S rRNA consensus sequence is SEQ ID NO:3 and the nucleotide sequence of the 23S rRNA consensus sequence is SEQ ID NO:4.

FIG. 2 shows a typical primer amplified region from the 16S rRNA Domain III shown in FIG. 1A-1.

FIG. 3 is a schematic diagram showing conserved regions in RNase P. Bases in capital letters are greater than 90% conserved; bases in lower case letters are 80-90% conserved; filled circles designate bases which are 70-80% conserved; and open circles designate bases that are less than 70% conserved. The nucleotide sequence of RNase P is SEQ ID NO: 378.

FIG. 4 is a schematic diagram of base composition signature determination using nucleotide analog "tags" to determine base composition signatures. The "Watson" strand is SEQ ID NO: 349 and the "Crick" strand is SEQ ID NO: 380.

FIG. 5 shows the deconvoluted mass spectra of a Bacillus anthracisregion with and without the mass tag phosphorothioate A (A*). The two spectra differ in that the measured molecular weight of the mass tag-containing sequence is greater than the unmodified sequence.

FIG. 6 shows base composition signature (BCS) spectra from PCR products from Staphylococcus aureus (S. aureus 16S.sub.--1337F) and Bacillus anthracis (B. anthr. 16S.sub.--1337F), amplified using the same primers. The two strands differ by only two (AT.fwdarw.CG) substitutions and are clearly distinguished on the basis of their BCS.

FIG. 7 shows that a single difference between two sequences (A14 in B. anthracisvs. A15 in B. cereus) can be easily detected using ESI-TOF mass spectrometry.

FIG. 8 is an ESI-TOF of Bacillus anthracisspore coat protein sspE 56mer plus calibrant. The signals unambiguously identify B. anthracis versus other Bacillus species.

FIG. 9 is an ESI-TOF of a B. anthracis synthetic 16S.sub.--1228 duplex (reverse and forward strands). The technique easily distinguishes between the forward and reverse strands.

FIG. 10 is an ESI-FTICR-MS of a synthetic B. anthracis16S.sub.--1337 46 base pair duplex.

FIG. 11 is an ESI-TOF-MS of a 56 mer oligonucleotide (3 scans) from the B. anthracis saspB gene with an internal mass standard. The internal mass standards are designated by asterisks.

FIG. 12 is an ESI-TOF-MS of an internal standard with 5 mM TBA-TFA buffer showing that charge stripping with tributylammonium trifluoroacetate reduces the most abundant charge state from [M-8H+]8- to [M-3H+]3-.

FIG. 13 is a portion of a secondary structure defining database according to one embodiment of the present invention, where two examples of selected sequences are displayed graphically thereunder, SEQ ID NO: 381 and SEQ ID NO. 382.

FIG. 14 is a three dimensional graph demonstrating the grouping of sample molecular weight according to species.

FIG. 15 is a three dimensional graph demonstrating the grouping of sample molecular weights according to species of virus and mammal infected.

FIG. 16 is a three dimensional graph demonstrating the grouping of sample molecular weights according to species of virus, and animal-origin of infectious agent.

FIG. 17 is a figure depicting how the triangulation method of the present invention provides for the identification of an unknown bioagent without prior knowledge of the unknown agent. The use of different primer sets to distinguish and identify the unknown is also depicted as primer sets I, II and III within this figure. A three dimensional graph depicts all of bioagent space (170), including the unknown bioagent, which after use of primer set I (171) according to a method according to the present invention further differentiates and classifies bioagents according to major classifications (176) which, upon further analysis using primer set II (172) differentiates the unknown agent (177) from other, known agents (173) and finally, the use of a third primer set (175) further specifies subgroups within the family of the unknown (174).

FIG. 18 shows a representative base composition probability cloud for a region of the RNA polymerase B gene from a cluster of enterobacteria. The dark spheres represent the actual base composition of the organisms. The lighter spheres represent the transitions among base compositions observed in different isolates of the same species of organism.

FIG. 19 shows resolution of enterobacteriae members with primers targeting RNA polymerase B (rpoB). A single pair of primers targeting a hyper-variable region within rpoB was sufficient to resolve most members of this group at the genus level (Salmonella from Escherichia from Yersinia) as well as the species/strain level (E. coli K12 from O157). All organisms with the exception of Y. pestis were tested in the lab and the measured base counts (shown with arrow) matched the predictions in every case.

FIG. 20 shows detection of S. aureus in blood. Spectra on the right indicate signals corresponding to S. aureus detection in spiked wells A1 and A4 with no detection in control wells A2 and A3.

FIG. 21 shows a representative base composition distribution of human adenovirus strain types for a single primer pair region on the hexon gene. The circles represent different adenovirus sequences in our database that were used for primer design. Measurement of masses and base counts for each of the unknown samples A, B, C and D matched one or more of the known groups of adenoviruses.

FIG. 22 shows a representative broad range survey/drill-down process as applied to emm-typing of streptococcus pyogenes (Group A Streptococcus: GAS). Genetic material is extracted (201) and amplified using broad range survey primers (202). The amplification products are analyzed (203) to determine the presence and identity of bioagents at the species level. If Streptococcus pyogenes is detected (204), the emm-typing "drill-down" primers are used to reexamine the extract to identify the emm-type of the sample (205). Different sets of drill down primers can be employed to determine a subspecies characteristic for various strains of various bioagents (206).

FIG. 23 shows a representative base composition distribution of bioagents detected in throat swabs from military personnel using a broad range primer pair directed to 16S rRNA.

FIG. 24 shows a representative deconvoluted ESI-FTICR spectra of the PCR products produced by the gtr primer for samples 12 (top) and 10 (bottom) corresponding to emm types 3 and 6, respectively. Accurate mass measurements were obtained by using an internal mass standard and post-calibrating each spectrum; the experimental mass measurement uncertainty on each strand is +0.035 Daltons (1 ppm). Unambiguous base compositions of the amplicons were determined by calculating all putative base compositions of each stand within the measured mass (and measured mass uncertainty) and selecting complementary pairs within the mass measurement uncertainty. In all cases there was only one base composition within 25 ppm. The measured mass difference of 15.985 Da between the strands shown on the left is in excellent agreement with the theoretical mass difference of 15.994 Da expected for an A to G substitution.

FIG. 25 shows representative results of the base composition analysis on throat swab samples using the six primer pairs, 5'-emm gene sequencing and the MLST gene sequencing method of the present invention for an outbreak of Streptococcus pyogenes (group A streptococcus; GAS) at a military training camp.

FIG. 26 shows: a) a representative ESI-FTICR mass spectrum of a restriction digest of a 986 bp region of the 16S ribosomal gene from E. coli K12 digested with a mixture of BstNI, BsmFI, BfaI, and NcoI, b) a deconvoluted representation (neutral mass) of the above spectrum showing the base compositions derived from accurate mass measurements of each fragment; and c) a representative reconstructed restriction map showing complete base composition coverage for nucleotides 1-856. The Nco1 did not cut.

FIG. 27 shows a representative base composition distribution of poxviruses for a single primer pair region on the DNA-dependent polymerase B gene (DdDpB). The spheres represent different poxvirus sequences that were used for primer design.

DESCRIPTION OF EMBODIMENTS

A. Introduction

The present invention provides, inter alia, methods for detection and identification of bioagents in an unbiased manner using "bioagent identifying amplicons." "Intelligent primers" are selected to hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions to yield a bioagent identifying amplicon which can be amplified and which is amenable to molecular mass determination. The molecular mass then provides a means to uniquely identify the bioagent without a requirement for prior knowledge of the possible identity of the bioagent. The molecular mass or corresponding "base composition signature" (BCS) of the amplification product is then matched against a database of molecular masses or base composition signatures. Furthermore, the method can be applied to rapid parallel "multiplex" analyses, the results of which can be employed in a triangulation identification strategy. The present method provides rapid throughput and does not require nucleic acid sequencing of the amplified target sequence for bioagent detection and identification.

B. Bioagents

In the context of this invention, a "bioagent" is any organism, cell, or virus, living or dead, or a nucleic acid derived from such an organism, cell or virus. Examples of bioagents include, but are not limited, to cells, including but not limited to, cells, including but not limited to human clinical samples, bacterial cells and other pathogens) viruses, fungi, and protists, parasites, and pathogenicity markers (including but not limited to: pathogenicity islands, antibiotic resistance genes, virulence factors, toxin genes and other bioregulating compounds). Samples may be alive or dead or in a vegetative state (for example, vegetative bacteria or spores) and may be encapsulated or bioengineered. In the context of this invention, a "pathogen" is a bioagent which causes a disease or disorder.

Despite enormous biological diversity, all forms of life on earth share sets of essential, common features in their genomes. Bacteria, for example have highly conserved sequences in a variety of locations on their genomes. Most notable is the universally conserved region of the ribosome. but there are also conserved elements in other non-coding RNAs, including RNAse P and the signal recognition particle (SRP) among others. Bacteria have a common set of absolutely required genes. About 250 genes are present in all bacterial species (Proc. Natl. Acad. Sci. U.S.A., 1996, 93, 10268; Science, 1995, 270, 397), including tiny genomes like Mycoplasma, Ureaplasma and Rickettsia. These genes encode proteins involved in translation, replication, recombination and repair, transcription, nucleotide metabolism, amino acid metabolism, lipid metabolism, energy generation, uptake, secretion and the like. Examples of these proteins are DNA polymerase III beta, elongation factor TU, heat shock protein groEL, RNA polymerase beta, phosphoglycerate kinase, NADH dehydrogenase, DNA ligase, DNA topoisomerase and elongation factor G. Operons can also be targeted using the present method. One example of an operon is the bfp operon from enteropathogenic E. coli. Multiple core chromosomal genes can be used to classify bacteria at a genus or genus species level to determine if an organism has threat potential. The methods can also be used to detect pathogenicity markers (plasmid or chromosomal) and antibiotic resistance genes to confirm the threat potential of an organism and to direct countermeasures.

C. Selection of "Bioagent Identifying Amplicons"

Since genetic data provide the underlying basis for identification of bioagents by the methods of the present invention, it is necessary to select segments of nucleic acids which ideally provide enough variability to distinguish each individual bioagent and whose molecular mass is amenable to molecular mass determination. In one embodiment of the present invention, at least one polynucleotide segment is amplified to facilitate detection and analysis in the process of identifying the bioagent. Thus, the nucleic acid segments which provide enough variability to distinguish each individual bioagent and whose molecular masses are amenable to molecular mass determination are herein described as "bioagent identifying amplicons." The term "amplicon" as used herein, refers to a segment of a polynucleotide which is amplified in an amplification reaction.

As used herein, "intelligent primers" are primers that are designed to bind to highly conserved sequence regions that flank an intervening variable region and yield amplification products which ideally provide enough variability to distinguish each individual bioagent, and which are amenable to molecular mass analysis. By the term "highly conserved," it is meant that the sequence regions exhibit between about 80-100%, or between about 90-100%, or between about 95-100% identity. The molecular mass of a given amplification product provides a means of identifying the bioagent from which it was obtained, due to the variability of the variable region. Thus design of intelligent primers requires selection of a variable region with appropriate variability to resolve the identity of a given bioagent.

In one embodiment, the bioagent identifying amplicon is a portion of a ribosomal RNA (rRNA) gene sequence. With the complete sequences of many of the smallest microbial genomes now available, it is possible to identify a set of genes that defines "minimal life" and identify composition signatures that uniquely identify each gene and organism. Genes that encode core life functions such as DNA replication, transcription, ribosome structure, translation, and transport are distributed broadly in the bacterial genome and are suitable regions for selection of bioagent identifying amplicons. Ribosomal RNA (rRNA) genes comprise regions that provide useful base composition signatures. Like many genes involved in core life functions, rRNA genes contain sequences that are extraordinarily conserved across bacterial domains interspersed with regions of high variability that are more specific to each species. The variable regions can be utilized to build a database of base composition signatures. The strategy involves creating a structure-based alignment of sequences of the small (16S) and the large (23S) subunits of the rRNA genes. For example, there are currently over 13,000 sequences in the ribosomal RNA database that has been created and maintained by Robin Gutell, University of Texas at Austin, and is publicly available on the Institute for Cellular and Molecular Biology web page on the world wide web of the Internet at, for example, "rna.icmb.utexas.edu/." There is also a publicly available rRNA database created and maintained by the University of Antwerp, Belgium on the world wide web of the Internet at, for example, "rrna.uia.ac.be."

These databases have been analyzed to determine regions that are useful as bioagent identifying amplicons. The characteristics of such regions include: a) between about 80 and 100%, or greater than about 95% identity among species of the particular bioagent of interest, of upstream and downstream nucleotide sequences which serve as sequence amplification primer sites; b) an intervening variable region which exhibits no greater than about 5% identity among species; and c) a separation of between about 30 and 1000 nucleotides, or no more than about 50-250 nucleotides, or no more than about 60-100 nucleotides, between the conserved regions.

As a non-limiting example, for identification of Bacillus species, the conserved sequence regions of the chosen bioagent identifying amplicon must be highly conserved among all Bacillus species while the variable region of the bioagent identifying amplicon is sufficiently variable such that the molecular masses of the amplification products of all species of Bacillus are distinguishable.

Bioagent identifying amplicons amenable to molecular mass determination are either of a length, size or mass compatible with the particular mode of molecular mass determination or compatible with a means of providing a predictable fragmentation pattern in order to obtain predictable fragments of a length compatible with the particular mode of molecular mass determination. Such means of providing a predictable fragmentation pattern of an amplification product include, but are not limited to, cleavage with restriction enzymes or cleavage primers, for example.

Identification of bioagents can be accomplished at different levels using intelligent primers suited to resolution of each individual level of identification. "Broad range survey" intelligent primers are designed with the objective of identifying a bioagent as a member of a particular division of bioagents. A "bioagent division" is defined as group of bioagents above the species level and includes but is not limited to: orders, families, classes, clades, genera or other such groupings of bioagents above the species level. As a non-limiting example, members of the Bacillus/Clostridia group or gamma-proteobacteria group may be identified as such by employing broad range survey intelligent primers such as primers which target 16S or 23S ribosomal RNA.

In some embodiments, broad range survey intelligent primers are capable of identification of bioagents at the species level. One main advantage of the detection methods of the present invention is that the broad range survey intelligent primers need not be specific for a particular bacterial species, or even genus, such as Bacillus or Streptomyces. Instead, the primers recognize highly conserved regions across hundreds of bacterial species including, but not limited to, the species described herein. Thus, the same broad range survey intelligent primer pair can be used to identify any desired bacterium because it will bind to the conserved regions that flank a variable region specific to a single species, or common to several bacterial species, allowing unbiased nucleic acid amplification of the intervening sequence and determination of its molecular weight and base composition. For example, the 16S.sub.--971-1062, 16S.sup.-1228-1310 and 16S.sup.-1100-1188 regions are 98-99% conserved in about 900 species of bacteria (16S=16S rRNA, numbers indicate nucleotide position). In one embodiment of the present invention, primers used in the present method bind to one or more of these regions or portions thereof.

Due to their overall conservation, the flanking rRNA primer sequences serve as good intelligent primer binding sites to amplify the nucleic acid region of interest for most, if not all, bacterial species. The intervening region between the sets of primers varies in length and/or composition, and thus provides a unique base composition signature. Examples of intelligent primers that amplify regions of the 16S and 23S rRNA are shown in FIGS. 1A-1H. A typical primer amplified region in 16S rRNA is shown in FIG. 2. The arrows represent primers that bind to highly conserved regions which flank a variable region in 16S rRNA domain III. The amplified region is the stem-loop structure under "1100-1188." It is advantageous to design the broad range survey intelligent primers to minimize the number of primers required for the analysis, and to allow detection of multiple members of a bioagent division using a single pair of primers. The advantage of using broad range survey intelligent primers is that once a bioagent is broadly identified, the process of further identification at species and sub-species levels is facilitated by directing the choice of additional intelligent primers.

"Division-wide" intelligent primers are designed with an objective of identifying a bioagent at the species level. As a non-limiting example, a Bacillus anthracis, Bacillus cereus and Bacillus thuringiensis can be distinguished from each other using division-wide intelligent primers. Division-wide intelligent primers are not always required for identification at the species level because broad range survey intelligent primers may provide sufficient identification resolution to accomplishing this identification objective.

"Drill-down" intelligent primers are designed with an objective of identifying a sub-species characteristic of a bioagent. A "sub-species characteristic" is defined as a property imparted to a bioagent at the sub-species level of identification as a result of the presence or absence of a particular segment of nucleic acid. Such sub-species characteristics include, but are not limited to, strains, sub-types, pathogenicity markers such as antibiotic resistance genes, pathogenicity islands, toxin genes and virulence factors. Identification of such sub-species characteristics is often critical for determining proper clinical treatment of pathogen infections.

Chemical Modifications of Intelligent Primers

Ideally, intelligent primer hybridization sites are highly conserved in order to facilitate the hybridization of the primer. In cases where primer hybridization is less efficient due to lower levels of conservation of sequence, intelligent primers can be chemically modified to improve the efficiency of hybridization.

For example, because any variation (due to codon wobble in the 3.sup.rd position) in these conserved regions among species is likely to occur in the third position of a DNA triplet, oligonucleotide primers can be designed such that the nucleotide corresponding to this position is a base which can bind to more than one nucleotide, referred to herein as a "universal base." For example, under this "wobble" pairing, inosine (I) binds to U, C or A; guanine (G) binds to U or C, and uridine (U) binds to U or C. Other examples of universal bases include nitroindoles such as 5-nitroindole or 3-nitropyrrole (Loakes et al., Nucleosides and Nucleotides, 1995, 14, 1001-1003), the degenerate nucleotides dP or dK (Hill et al.), an acyclic nucleoside analog containing 5-nitroindazole (Van Aerschot et al., Nucleosides and Nucleotides, 1995, 14, 1053-1056) or the purine analog 1-(2-deoxy-.beta.-D-ribofuranosyl)-imidazole-4-carboxamide (Sala et al., Nucl. Acids Res., 1996, 24, 3302-3306).

In another embodiment of the invention, to compensate for the somewhat weaker binding by the "wobble" base, the oligonucleotide primers are designed such that the first and second positions of each triplet are occupied by nucleotide analogs which bind with greater affinity than the unmodified nucleotide. Examples of these analogs include, but are not limited to, 2,6-diaminopurine which binds to thymine, propyne T which binds to adenine and propyne C and phenoxazines, including G-clamp, which binds to G. Propynylated pyrimidines are described in U.S. Pat. Nos. 5,645,985, 5,830,653 and 5,484,908, each of which is commonly owned and incorporated herein by reference in its entirety. Propynylated primers are claimed in U.S. Ser. No. 10/294,203 which is also commonly owned and incorporated herein by reference in entirety. Phenoxazines are described in U.S. Pat. Nos. 5,502,177, 5,763,588, and 6,005,096, each of which is incorporated herein by reference in its entirety. G-clamps are described in U.S. Pat. Nos. 6,007,992 and 6,028,183, each of which is incorporated herein by reference in its entirety.

D. Characterization of Bioagent Identifying Amplicons

A theoretically ideal bioagent detector would identify, quantify, and report the complete nucleic acid sequence of every bioagent that reached the sensor. The complete sequence of the nucleic acid component of a pathogen would provide all relevant information about the threat, including its identity and the presence of drug-resistance or pathogenicity markers. This ideal has not yet been achieved. However, the present invention provides a straightforward strategy for obtaining information with the same practical value based on analysis of bioagent identifying amplicons by molecular mass determination.

In some cases, a molecular mass of a given bioagent identifying amplicon alone does not provide enough resolution to unambiguously identify a given bioagent. For example, the molecular mass of the bioagent identifying amplicon obtained using the intelligent primer pair "16S.sub.--971" would be 55622 Da for both E. coli and Salmonella typhimurium. However, if additional intelligent primers are employed to analyze additional bioagent identifying amplicons, a "triangulation identification" process is enabled. For example, the "16S.sub.--1100" intelligent primer pair yields molecular masses of 55009 and 55005 Da for E. coli and Salmonella typhimurium, respectively. Furthermore, the "23S.sub.--855" intelligent primer pair yields molecular masses of 42656 and 42698 Da for E. coli and Salmonella typhimurium, respectively. In this basic example, the second and third intelligent primer pairs provided the additional "fingerprinting" capability or resolution to distinguish between the two bioagents.

In another embodiment, the triangulation identification process is pursued by measuring signals from a plurality of bioagent identifying amplicons selected within multiple core genes. This process is used to reduce false negative and false positive signals, and enable reconstruction of the origin of hybrid or otherwise engineered bioagents. In this process, after identification of multiple core genes, alignments are created from nucleic acid sequence databases. The alignments are then analyzed for regions of conservation and variation, and bioagent identifying amplicons are selected to distinguish bioagents based on specific genomic differences. For example, identification of the three part toxin genes typical of B. anthracis (Bowen et al., J. Appl. Microbiol., 1999, 87, 270-278) in the absence of the expected signatures from the B. anthracis genome would suggest a genetic engineering event.

The triangulation identification process can be pursued by characterization of bioagent identifying amplicons in a massively parallel fashion using the polymerase chain reaction (PCR), such as multiplex PCR, and mass spectrometric (MS) methods. Sufficient quantities of nucleic acids should be present for detection of bioagents by MS. A wide variety of techniques for preparing large amounts of purified nucleic acids or fragments thereof are well known to those of skill in the art. PCR requires one or more pairs of oligonucleotide primers that bind to regions which flank the target sequence(s) to be amplified. These primers prime synthesis of a different strand of DNA, with synthesis occurring in the direction of one primer towards the other primer. The primers, DNA to be amplified, a thermostable DNA polymerase (e.g. Taq polymerase), the four deoxynucleotide triphosphates, and a buffer are combined to initiate DNA synthesis. The solution is denatured by heating, then cooled to allow annealing of newly added primer, followed by another round of DNA synthesis. This process is typically repeated for about 30 cycles, resulting in amplification of the target sequence.

Although the use of PCR is suitable, other nucleic acid amplification techniques may also be used, including ligase chain reaction (LCR) and strand displacement amplification (SDA). The high-resolution MS technique allows separation of bioagent spectral lines from background spectral lines in highly cluttered environments.

In another embodiment, the detection scheme for the PCR products generated from the bioagent(s) incorporates at least three features. First, the technique simultaneously detects and differentiates multiple (generally about 6-10) PCR products. Second, the technique provides a molecular mass that uniquely identifies the bioagent from the possible primer sites. Finally, the detection technique is rapid, allowing multiple PCR reactions to be run in parallel.

E. Mass Spectrometric Characterization of Bioagent Identifying Amplicons

Mass spectrometry (MS)-based detection of PCR products provides a means for determination of BCS which has several advantages. MS is intrinsically a parallel detection scheme without the need for radioactive or fluorescent labels, since every amplification product is identified by its molecular mass. The current state of the art in mass spectrometry is such that less than femtomole quantities of material can be readily analyzed to afford information about the molecular contents of the sample. An accurate assessment of the molecular mass of the material can be quickly obtained, irrespective of whether the molecular weight of the sample is several hundred, or in excess of one hundred thousand atomic mass units (amu) or Daltons. Intact molecular ions can be generated from amplification products using one of a variety of ionization techniques to convert the sample to gas phase. These ionization methods include, but are not limited to, electrospray ionization (ES), matrix-assisted laser desorption ionization (MALDI) and fast atom bombardment (FAB). For example, MALDI of nucleic acids, along with examples of matrices for use in MALDI of nucleic acids, are described in WO 98/54751 (Genetrace, Inc.).

In some embodiments, large DNAs and RNAs, or large amplification products therefrom, can be digested with restriction endonucleases prior to ionization. Thus, for example, an amplification product that was 10 kDa could be digested with a series of restriction endonucleases to produce a panel of, for example, 100 Da fragments. Restriction endonucleases and their sites of action are well known to the skilled artisan. In this manner, mass spectrometry can be performed for the purposes of restriction mapping.

Upon ionization, several peaks are observed from one sample due to the formation of ions with different charges. Averaging the multiple readings of molecular mass obtained from a single mass spectrum affords an estimate of molecular mass of the bioagent. Electrospray ionization mass spectrometry (ESI-MS) is particularly useful for very high molecular weight polymers such as proteins and nucleic acids having molecular weights greater than 10 kDa, since it yields a distribution of multiply-charged molecules of the sample without causing a significant amount of fragmentation.

The mass detectors used in the methods of the present invention include, but are not limited to, Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-MS), ion trap, quadrupole, magnetic sector, time of flight (TOF), Q-TOF, and triple quadrupole.

In general, the mass spectrometric techniques which can be used in the present invention include, but are not limited to, tandem mass spectrometry, infrared multiphoton dissociation and pyrolytic gas chromatography mass spectrometry (PGC-MS). In one embodiment of the invention, the bioagent detection system operates continually in bioagent detection mode using pyrolytic GC-MS without PCR for rapid detection of increases in biomass (for example, increases in fecal contamination of drinking water or of germ warfare agents). To achieve minimal latency, a continuous sample stream flows directly into the PGC-MS combustion chamber. When an increase in biomass is detected, a PCR process is automatically initiated. Bioagent presence produces elevated levels of large molecular fragments from, for example, about 100-7,000 Da which are observed in the PGC-MS spectrum. The observed mass spectrum is compared to a threshold level and when levels of biomass are determined to exceed a predetermined threshold, the bioagent classification process described hereinabove (combining PCR and MS, such as FT-ICR MS) is initiated. Optionally, alarms or other processes (halting ventilation flow, physical isolation) are also initiated by this detected biomass level.

The accurate measurement of molecular mass for large DNAs is limited by the adduction of cations from the PCR reaction to each strand, resolution of the isotopic peaks from natural abundance .sup.13C and .sup.15N isotopes, and assignment of the charge state for any ion. The cations are removed by in-line dialysis using a flow-through chip that brings the solution containing the PCR products into contact with a solution containing ammonium acetate in the presence of an electric field gradient orthogonal to the flow. The latter two problems are addressed by operating with a resolving power of >100,000 and by incorporating isotopically depleted nucleotide triphosphates into the DNA. The resolving power of the instrument is also a consideration. At a resolving power of 10,000, the modeled signal from the [M-14H+].sup.14- charge state of an 84 mer PCR product is poorly characterized and assignment of the charge state or exact mass is impossible. At a resolving power of 33,000, the peaks from the individual isotopic components are visible. At a resolving power of 100,000, the isotopic peaks are resolved to the baseline and assignment of the charge state for the ion is straightforward. The [.sup.13C,.sup.15N]-depleted triphosphates are obtained, for example, by growing microorganisms on depleted media and harvesting the nucleotides (Batey et al., Nucl. Acids Res., 1992, 20, 4515-4523).

While mass measurements of intact nucleic acid regions are believed to be adequate to determine most bioagents, tandem mass spectrometry (MS.sup.n) techniques may provide more definitive information pertaining to molecular identity or sequence. Tandem MS involves the coupled use of two or more stages of mass analysis where both the separation and detection steps are based on mass spectrometry. The first stage is used to select an ion or component of a sample from which further structural information is to be obtained. The selected ion is then fragmented using, e.g., blackbody irradiation, infrared multiphoton dissociation, or collisional activation. For example, ions generated by electrospray ionization (ESI) can be fragmented using IR multiphoton dissociation. This activation leads to dissociation of glycosidic bonds and the phosphate backbone, producing two series of fragment ions, called the w-series (having an intact 3' terminus and a 5' phosphate following internal cleavage) and the .alpha.-Base series(having an intact 5' terminus and a 3' furan).

The second stage of mass analysis is then used to detect and measure the mass of these resulting fragments of product ions. Such ion selection followed by fragmentation routines can be performed multiple times so as to essentially completely dissect the molecular sequence of a sample.

If there are two or more targets of similar molecular mass, or if a single amplification reaction results in a product which has the same mass as two or more bioagent reference standards, they can be distinguished by using mass-modifying "tags." In this embodiment of the invention, a nucleotide analog or "tag" is incorporated during amplification (e.g., a 5-(trifluoromethyl) deoxythymidine triphosphate) which has a different molecular weight than the unmodified base so as to improve distinction of masses. Such tags are described in, for example, PCT WO97/33000, which is incorporated herein by reference in its entirety. This further limits the number of possible base compositions consistent with any mass. For example, 5-(trifluoromethyl)deoxythymidine triphosphate can be used in place of dTTP in a separate nucleic acid amplification reaction. Measurement of the mass shift between a conventional amplification product and the tagged product is used to quantitate the number of thymidine nucleotides in each of the single strands. Because the strands are complementary, the number of adenosine nucleotides in each strand is also determined.

In another amplification reaction, the number of G and C residues in each strand is determined using, for example, the cytidine analog 5-methylcytosine (5-meC) or propyne C. The combination of the A/T reaction and G/C reaction, followed by molecular weight determination, provides a unique base composition. This method is summarized in FIG. 4 and Table 1.

TABLE-US-00001 TABLE 1 Total Total Total Base Base base base mass info info comp. comp. Double strand Single strand this this other Top Bottom Mass tag sequence Sequence strand strand strand strand strand T*mass T*ACGT*ACGT* T*ACGT*ACGT* 3x 3T 3A 3T 3A (T* - T) = x AT*GCAT*GCA 2A 2T 2C 2G 2G 2C AT*GCAT*GCA 2x 2T 2A C*mass TAC*GTAC*GT TAC*GTAC*GT 2x 2C 2G (C* - C) = y ATGC*ATGC*A ATGC*ATGC*A 2x 2C 2G

The mass tag phosphorothioate A (A*) was used to distinguish a Bacillus anthracis cluster. The B. anthracis(A.sub.14G.sub.9C.sub.14T.sub.9) had an average MW of 14072.26, and the B. anthracis(A.sub.1A*.sub.13G.sub.9C.sub.14T.sub.9) had an average molecular weight of 14281.11 and the phosphorothioate A had an average molecular weight of +16.06 as determined by ESI-TOF MS. The deconvoluted spectra are shown in FIG. 5.

In another example, assume the measured molecular masses of each strand are 30,000.115 Da and 31,000.115 Da respectively, and the measured number of dT and dA residues are (30,28) and (28,30). If the molecular mass is accurate to 100 ppm, there are 7 possible combinations of dG+dC possible for each strand. However, if the measured molecular mass is accurate to 10 ppm, there are only 2 combinations of dG+dC, and at 1 ppm accuracy there is only one possible base composition for each strand.

Signals from the mass spectrometer may be input to a maximum-likelihood detection and classification algorithm such as is widely used in radar signal processing. The detection processing uses matched filtering of BCS observed in mass-basecount space and allows for detection and subtraction of signatures from known, harmless organisms, and for detection of unknown bioagent threats. Comparison of newly observed bioagents to known bioagents is also possible, for estimation of threat level, by comparing their BCS to those of known organisms and to known forms of pathogenicity enhancement, such as insertion of antibiotic resistance genes or toxin genes.

Processing may end with a Bayesian classifier using log likelihood ratios developed from the observed signals and average background levels. The program emphasizes performance predictions culminating in probability-of-detection versus probability-of-false-alarm plots for conditions involving complex backgrounds of naturally occurring organisms and environmental contaminants. Matched filters consist of a priori expectations of signal values given the set of primers used for each of the bioagents. A genomic sequence database (e.g. GenBank) is used to define the mass basecount matched filters. The database contains known threat agents and benign background organisms. The latter is used to estimate and subtract the signature produced by the background organisms. A maximum likelihood detection of known background organisms is implemented using matched filters and a running-sum estimate of the noise covariance. Background signal strengths are estimated and used along with the matched filters to form signatures which are then subtracted, the maximum likelihood process is applied to this "cleaned up" data in a similar manner employing matched filters for the organisms and a running-sum estimate of the noise-covariance for the cleaned up data.

F. Base Composition Signatures as Indices of Bioagent Identifying Amplicons

Although the molecular mass of amplification products obtained using intelligent primers provides a means for identification of bioagents, conversion of molecular mass data to a base composition signature is useful for certain analyses. As used herein, a "base composition signature" (BCS) is the exact base composition determined from the molecular mass of a bioagent identifying amplicon. In one embodiment, a BCS provides an index of a specific gene in a specific organism.

Base compositions, like sequences, vary slightly from isolate to isolate within species. It is possible to manage this diversity by building "base composition probability clouds" around the composition constraints for each species. This permits identification of organisms in a fashion similar to sequence analysis. A "pseudo four-dimensional plot" can be used to visualize the concept of base composition probability clouds (FIG. 18). Optimal primer design requires optimal choice of bioagent identifying amplicons and maximizes the separation between the base composition signatures of individual bioagents. Areas where clouds overlap indicate regions that may result in a misclassification, a problem which is overcome by selecting primers that provide information from different bioagent identifying amplicons, ideally maximizing the separation of base compositions. Thus, one aspect of the utility of an analysis of base composition probability clouds is that it provides a means for screening primer sets in order to avoid potential misclassifications of BCS and bioagent identity. Another aspect of the utility of base composition probability clouds is that they provide a means for predicting the identity of a bioagent whose exact measured BCS was not previously observed and/or indexed in a BCS database due to evolutionary transitions in its nucleic acid sequence.

It is important to note that, in contrast to probe-based techniques, mass spectrometry determination of base composition does not require prior knowledge of the composition in order to make the measurement, only to interpret the results. In this regard, the present invention provides bioagent classifying information similar to DNA sequencing and phylogenetic analysis at a level sufficient to detect and identify a given bioagent. Furthermore, the process of determination of a previously unknown BCS for a given bioagent (for example, in a case where sequence information is unavailable) has downstream utility by providing additional bioagent indexing information with which to populate BCS databases. The process of future bioagent identification is thus greatly improved as more BCS indexes become available in the BCS databases.

Another embodiment of the present invention is a method of surveying bioagent samples that enables detection and identification of all bacteria for which sequence information is available using a set of twelve broad-range intelligent PCR primers. Six of the twelve primers are "broad range survey primers" herein defined as primers targeted to broad divisions of bacteria (for example, the Bacillus/Clostridia group or gamma-proteobacteria). The other six primers of the group of twelve primers are "division-wide" primers herein defined as primers which provide more focused coverage and higher resolution. This method enables identification of nearly 100% of known bacteria at the species level. A further example of this embodiment of the present invention is a method herein designated "survey/drill-down" wherein a subspecies characteristic for detected bioagents is obtained using additional primers. Examples of such a subspecies characteristic include but are not limited to: antibiotic resistance, pathogenicity island, virulence factor, strain type, sub-species type, and clade group. Using the survey/drill-down method, bioagent detection, confirmation and a subspecies characteristic can be provided within hours. Moreover, the survey/drill-down method can be focused to identify bioengineering events such as the insertion of a toxin gene into a bacterial species that does not normally make the toxin.

G. Fields of Application of the Present Invention

The present methods allow extremely rapid and accurate detection and identification of bioagents compared to existing methods. Furthermore, this rapid detection and identification is possible even when sample material is impure. The methods leverage ongoing biomedical research in virulence, pathogenicity, drug resistance and genome sequencing into a method which provides greatly improved sensitivity, specificity and reliability compared to existing methods, with lower rates of false positives. Thus, the methods are useful in a wide variety of fields, including, but not limited to, those fields discussed below.

1. Identification Of Pathogens In Humans And Animals

In other embodiments of the invention, the methods disclosed herein can identify infectious agents in biological samples. At least a first biological sample containing at least a first unidentified infectious agent is obtained. An identification analysis is carried out on the sample, whereby the first infectious agent in the first biological sample is identified. More particularly, a method of identifying an infectious agent in a biological entity is provided. An identification analysis is carried out on a first biological sample obtained from the biological entity, whereby at least one infectious agent in the biological sample from the biological entity is identified. The obtaining and the performing steps are, optionally, repeated on at least one additional biological sample from the biological entity.

The present invention also provides methods of identifying an infectious agent that is potentially the cause of a health condition in a biological entity. An identification analysis is carried out on a first test sample from a first infectious agent differentiating area of the biological entity, whereby at least one infectious agent is identified. The obtaining and the performing steps are, optionally, repeated on an additional infectious agent differentiating area of the biological entity.

Biological samples include, but are not limited to, hair, mucosa, skin, nail, blood, saliva, rectal, lung, stool, urine, breath, nasal, ocular sample, or the like. In some embodiments, one or more biological samples are analyzed by the methods described herein. The biological sample(s) contain at least a first unidentified infectious agent and may contain more than one infectious agent. The biological sample(s) are obtained from a biological entity. The biological sample can be obtained by a variety of manners such as by biopsy, swabbing, and the like. The biological samples may be obtained by a physician in a hospital or other health care environment. The physician may then perform the identification analysis or send the biological sample to a laboratory to carry out the analysis.

Biological entities include, but are not limited to, a mammal, a bird, or a reptile. The biological entity may be a cow, horse, dog, cat, or a primate. The biological entity can also be a human. The biological entity may be living or dead.

An infectious agent differentiating area is any area or location within a biological entity that can distinguish between a harmful versus normal health condition. An infectious agent differentiating area can be a region or area of the biological entity whereby an infectious agent is more likely to predominate from another region or area of the biological entity. For example, infectious agent differentiating areas may include the blood vessels of the heart (heart disease, coronary artery disease, etc.), particular portions of the digestive system (ulcers, Crohn's disease, etc.), liver (hepatitis infections), and the like. In some embodiments, one or more biological samples from a plurality of infectious agent differentiating areas is analyzed the methods described herein.

Infectious agents of the invention may potentially cause a health condition in a biological entity. Health conditions include any condition, syndrome, illness, disease, or the like, identified currently or in the future by medical personnel. Infectious agents include, but are not limited to, bacteria, viruses, parasites, fungi, and the like.

In other embodiments of the invention, the methods disclosed herein can be used to screen blood and other bodily fluids and tissues for pathogenic and non-pathogenic bacteria, viruses, parasites, fungi and the like. Animal samples, including but not limited to, blood and other bodily fluid and tissue samples, can be obtained from living animals, who are either known or not known to or suspected of having a disease, infection, or condition. Alternately, animal samples such as blood and other bodily fluid and tissue samples can be obtained from deceased animals. Blood samples can be further separated into plasma or cellular fractions and further screened as desired. Bodily fluids and tissues can be obtained from any part of the animal or human body. Animal samples can be obtained from, for example, mammals and humans.

Clinical samples are analyzed for disease causing bioagents and biowarfare pathogens simultaneously with detection of bioagents at levels as low as 100-1000 genomic copies in complex backgrounds with throughput of approximately 100-300 samples with simultaneous detection of bacteria and viruses. Such analyses provide additional value in probing bioagent genomes for unanticipated modifications. These analyses are carried out in reference labs, hospitals and the LRN laboratories of the public health system in a coordinated fashion, with the ability to report the results via a computer network to a common data-monitoring center in real time. Clonal propagation of specific infectious agents, as occurs in the epidemic outbreak of infectious disease, can be tracked with base composition signatures, analogous to the pulse field gel electrophoresis fingerprinting patterns used in tracking the spread of specific food pathogens in the Pulse Net system of the CDC (Swaminathan, B., et al., Emerging Infectious Diseases, 2001, 7, 382-389). The present invention provides a digital barcode in the form of a series of base composition signatures, the combination of which is unique for each known organism. This capability enables real-time infectious disease monitoring across broad geographic locations, which may be essential in a simultaneous outbreak or attack in different cities.

In other embodiments of the invention, the methods disclosed herein can be used for detecting the presence of pathogenic and non-pathogenic bacteria, viruses, parasites, fungi and the like in organ donors and/or in organs from donors. Such examination can result in the prevention of the transfer of, for example, viruses such as West Nile virus, hepatitis viruses, human immunodeficiency virus, and the like from a donor to a recipient via a transplanted organ. The methods disclosed herein can also be used for detection of host versus graft or graft versus host rejection issues related to organ donors by detecting the presence of particular antigens in either the graft or host known or suspected of causing such rejection. In particular, the bioagents in this regard are the antigens of the major histocompatibility complex, such as the HLA antigens. The present methods can also be used to detect and track emerging infectious diseases, such as West Nile virus infection, HIV-related diseases.

In other embodiments of the invention, the methods disclosed herein can be used for pharmacogenetic analysis and medical diagnosis including, but not limited to, cancer diagnosis based on mutations and polymorphisms, drug resistance and susceptibility testing, screening for and/or diagnosis of genetic diseases and conditions, and diagnosis of infectious diseases and conditions. In context of the present invention, pharmacogenetics is defined as the study of variability in drug response due to genetic factors. Pharmacogenetic investigations are often based on correlating patient outcome with variations in genes involved in the mode of action of a given drug. For example, receptor genes, or genes involved in metabolic pathways. The methods of the present invention provide a means to analyze the DNA of a patient to provide the basis for pharmacogenetic analysis.

The present method can also be used to detect single nucleotide polymorphisms (SNPs), or multiple nucleotide polymorphisms, rapidly and accurately. A SNP is defined as a single base pair site in the genome that is different from one individual to another. The difference can be expressed either as a deletion, an insertion or a substitution, and is frequently linked to a disease state. Because they occur every 100-1000 base pairs, SNPs are the most frequently bound type of genetic marker in the human genome.

For example, sickle cell anemia results from an A-T transition, which encodes a valine rather than a glutamic acid residue. Oligonucleotide primers may be designed such that they bind to sequences that flank a SNP site, followed by nucleotide amplification and mass determination of the amplified product. Because the molecular masses of the resulting product from an individual who does not have sickle cell anemia is different from that of the product from an individual who has the disease, the method can be used to distinguish the two individuals. Thus, the method can be used to detect any known SNP in an individual and thus diagnose or determine increased susceptibility to a disease or condition.

In one embodiment, blood is drawn from an individual and peripheral blood mononuclear cells (PBMC) are isolated and simultaneously tested, such as in a high-throughput screening method, for one or more SNPs using appropriate primers based on the known sequences which flank the SNP region. The National Center for Biotechnology Information maintains a publicly available database of SNPs on the world wide web of the Internet at, for example, "ncbi.nlm.nih.gov/SNP/."

The method of the present invention can also be used for blood typing. The gene encoding A, B or 0 blood type can differ by four single nucleotide polymorphisms. If the gene contains the sequence CGTGGTGACCCTT (SEQ ID NO:5), antigen A results. If the gene contains the sequence CGTCGTCACCGCTA (SEQ ID NO:6) antigen B results. If the gene contains the sequence CGTGGT-ACCCCTT (SEQ ID NO:7), blood group 0 results ("-"indicates a deletion). These sequences can be distinguished by designing a single primer pair which flanks these regions, followed by amplification and mass determination.

The method of the present invention can also be used for detection and identification of blood-borne pathogens such as Staphylococcus aureus for example. The method of the present invention can also be used for strain typing of respiratory pathogens in epidemic surveillance. Group A streptococci (GAS), or Streptococcus pyogenes, is one of the most consequential causes of respiratory infections because of prevalence and ability to cause disease with complications such as acute rheumatic fever and acute glomerulonephritis. GAS also causes infections of the skin (impetigo) and, in rare cases, invasive disease such as necrotizing fasciitis and toxic shock syndrome. Despite many decades of study, the underlying microbial ecology and natural selection that favors enhanced virulence and explosive GAS outbreaks is still poorly understood. The ability to detect GAS and multiple other pathogenic and non-pathogenic bacteria and viruses in patient samples would greatly facilitate our understanding of GAS epidemics. It is also essential to be able to follow the spread of virulent strains of GAS in populations and to distinguish virulent strains from less virulent or avirulent streptococci that colonize the nose and throat of asymptomatic individuals at a frequency ranging from 5-20% of the population (Bisno, A. L. (1995) in Principles and Practice of Infectious Diseases, eds. Mandell, G. L., Bennett, J. E. & Dolin, R. (Churchill Livingston, New York), Vol. 2, pp. 1786-1799). Molecular methods have been developed to type GAS based upon the sequence of the emm gene that encodes the M-protein virulence factor (Beall, B., Facklam, R. & Thompson, T. (1996) J. Clin. Micro. 34, 953-958; Beall, B., et al. (1997) J. Clin. Micro. 35, 1231-1235; Facklam, R., et al. (1999) Emerging Infectious Diseases 5, 247-253). Using this molecular classification, over 150 different emm-types are defined and correlated with phenotypic properties of thousands of GAS isolates (see the world wide web of the internet at "cdc.gov/ncidod/biotech/strep/strepindex") (Facklam, R., et al. (2002) Clinical Infectious Diseases 34, 28-38). Recently, a strategy known as Multi Locus Sequence Typing (MLST) was developed to follow the molecular Epidemiology of GAS (13). In MLST, internal fragments of seven housekeeping genes are amplified, sequenced, and compared to a database of previously studied isolates (see the world wide web of the internet at "test.mlst.net").

The present invention enables an emm-typing process to be carried out directly from throat swabs for a large number of samples within 12 hours, allowing strain tracking of an ongoing epidemic, even if geographically dispersed, on a larger scale than ever before achievable.

In another embodiment, the present invention can be employed in the serotyping of viruses including, but not limited to, adenoviruses. Adenoviruses are DNA viruses that cause over 50% of febrile respiratory illnesses in military recruits. Human adenoviruses are divided into six major serogroups (A through F), each containing multiple strain types. Despite the prevalence of adenoviruses, there are no rapid methods for detecting and serotyping adenoviruses.

In another embodiment, the present invention can be employed in distinguishing between members of the Orthopoxvirus genus. Smallpox is caused by the Variola virus. Other members of the genus include Vaccinia, Monkeypox, Camelpox, and Cowpox. All are capable of infecting humans, thus, a method capable of identifying and distinguishing among members of the Orthopox genus is a worthwhile objective.

In another embodiment, the present invention can be employed in distinguishing between viral agents of viral hemorrhagic fevers (VHF). VHF agents include, but are not limited to, Filoviridae (Marburg virus and Ebola virus), Arenaviridae (Lassa, Junin, Machupo, Sabia, and Guanarito viruses), Bunyaviridae (Crimean-Congo hemorrhagic fever virus (CCHFV), Rift Valley fever virus, and Hanta viruses), and Flaviviridae (yellow fever virus and dengue virus). Infections by VHF viruses are associated with a wide spectrum of clinical manifestations such as diarrhea, myalgia, cough, headache, pneumonia, encephalopathy, and hepatitis. Filoviruses, arenaviruses, and CCHFV are of particular relevance because they can be transmitted from human to human, thus causing epidemics with high mortality rates (Khan, A. S., et al., Am. J. Trop. Med. Hyg., 1997, 57, 519-525). In the absence of bleeding or organ manifestation, VHF is clinically difficult to diagnose, and the various etiologic agents can hardly be distinguished by clinical tests. Current approaches to PCR detection of these agents are time-consuming, as they include a separate cDNA synthesis step prior to PCR, agarose gel analysis of PCR products, and in some instances a second round of nested amplification or Southern hybridization. PCRs for different pathogens have to be run assay by assay due to differences in cycling conditions, which complicate broad-range testing in a short period. Moreover, post-PCR processing or nested PCR steps included in currently used assays increase the risk of false positive results due to carryover contamination (Kwok, S. and R. Higuchi, Nature 1989, 339, 237-238).

In another embodiment, the present invention, can be employed in the diagnosis of a plurality of etiologic agents of a disease. An "etiologic agent" is herein defined as a pathogen acting as the causative agent of a disease. Diseases may be caused by a plurality of etiologic agents. For example, recent studies have implicated both human herpesvirus 6 (HHV-6) and the obligate intracellular bacterium Chlamydia pneumoniae in the etiology of multiple sclerosis (Swanborg, R. H. Microbes and Infection 2002, 4, 1327-1333). The present invention can be applied to the identification of multiple etiologic agents of a disease by, for example, the use of broad range bacterial intelligent primers and division-wide primers (if necessary) for the identification of bacteria such as Chlamydia pneumoniae followed by primers directed to viral housekeeping genes for the identification of viruses such as HHV-6, for example.

In other embodiments of the invention, the methods disclosed herein can be used for detection and identification of pathogens in livestock. Livestock includes, but is not limited to, cows, pigs, sheep, chickens, turkeys, goats, horses and other farm animals. For example, conditions classified by the California Department of Food and Agriculture as emergency conditions in livestock (see the world wide web of the internet at "cdfa.ca.gov/ahfss/ah/pdfs/CA_repor-table_disease_list.sub.-05292002.p- df") include, but are not limited to: Anthrax (Bacillus anthracis), Screwworm myiasis (Cochliomyia hominivorax or Chrysomya bezziana), African trypanosomiasis (Tsetse fly diseases), Bovine babesiosis (piroplasmosis), Bovine spongiform encephalopathy (Mad Cow), Contagious bovine pleuropneumonia (Mycoplasma mycoides mycoides small colony), Foot-and-mouth disease (Hoof-and-mouth), Heartwater (Cowdria ruminantium), Hemorrhagic septicemia (Pasteurella multocida serotypes B:2 or E:2), Lumpy skin disease, Malignant catarrhal fever (African type), Rift Valley fever, Rinderpest (Cattle plague), Theileriosis (Corridor disease, East Coast fever), Vesicular stomatitis, Contagious agalactia (Mycoplasma species), Contagious caprine pleuropneumonia (Mycoplasma capricolum capripneumoniae), Nairobi sheep disease, Peste des petits ruminants (Goat plague), Pulmonary adenomatosis (Viral neoplastic pneumonia), Salmonella abortus ovis, Sheep and goat pox, African swine fever, Classical swine fever (Hog cholera), Japanese encephalitis, Nipah virus, Swine vesicular disease, Teschen disease (Enterovirus encephalomyelitis), Vesicular exanthema, Exotic Newcastle disease (Viscerotropic velogenic Newcastle disease), Highly pathogenic avian influenza (Fowl plague), African horse sickness, Dourine (Trypanosoma equiperdum), Epizootic lymphangitis (equine blastomycosis, equine histoplasmosis), Equine piroplasmosis (Babesia equi, B. caballi), Glanders (Farcy) (Pseudomonas mallei), Hendra virus (Equine morbillivirus), Horse pox, Surra (Trypanosoma evansi), Venezuelan equine encephalomyelitis, West Nile Virus, Chronic wasting disease in cervids, and Viral hemorrhagic disease of rabbits (calicivirus)

Conditions classified by the California Department of Food and Agriculture as regulated conditions in livestock include, but are not limited to: rabies, Bovine brucellosis (Brucella abortus), Bovine tuberculosis (Mycobacterium bovis), Cattle scabies (multiple types), Trichomonosis (Tritrichomonas fetus), Caprine and ovine brucellosis (excluding Brucella ovis), Scrapie, Sheep scabies (Body mange) (Psoroptes ovis), Porcine brucellosis (Brucella suis), Pseudorabies (Aujeszky's disease), Ornithosis (Psittacosis or avian chlamydiosis) (Chlamydia psittaci), Pullorum disease (Fowl typhoid) (Salmonella gallinarum and pullorum), Contagious equine metritis (Taylorella equigenitalis), Equine encephalomyelitis (Eastern and Western equine encephalitis), Equine infectious anemia (Swamp fever), Duck viral enteritis (Duck plague), and Tuberculosis in cervids.

Additional conditions monitored by the California Department of Food and Agriculture include, but are not limited to: Avian tuberculosis (Mycobacterium avium), Echinococcosis/Hydatidosis (Echinococcus species), Leptospirosis, Anaplasmosis (Anaplasma marginale or A. centrale), Bluetongue, Bovine cysticercosis (Taenia saginata in humans), Bovine genital campylobacteriosis (Campylobacter fetus venerealis), Dermatophilosis (Streptothricosis, mycotic dermatitis) (Dermatophilus congolensis), Enzootic bovine leukosis (Bovine leukemia virus), Infectious bovine rhinotracheitis (Bovine herpesvirus-1), Johne's disease (Paratuberculosis) (Mycobacterium avium paratuberculosis), Malignant catarrhal fever (North American), Q Fever (Coxiella burnetii), Caprine (contagious) arthritis/encephalitis, Enzootic abortion of ewes (Ovine chlamydiosis) (Chlamydia psittaci), Maedi-Visna (Ovine progressive pneumonia), Atrophic rhinitis (Bordetella bronchiseptica, Pasteurella multocida), Porcine cysticercosis (Taenia solium in humans), Porcine reproductive and respiratory syndrome, Transmissible gastroenteritis (coronavirus), Trichinellosis (Trichinella spiralis), Avian infectious bronchitis, Avian infectious laryngotracheitis, Duck viral hepatitis, Fowl cholera (Pasteurella multocida), Fowl pox, Infectious bursal disease (Gumboro disease), Low pathogenic avian influenza, Marek's disease, Mycoplasmosis (Mycoplasma gallisepticum), Equine influenza Equine rhinopneumonitis (Equine herpesvirus-1), Equine viral arteritis, and Horse mange (multiple types).

2. Identification of Bioagents of Biological Warfare

A key problem in determining that an infectious outbreak is the result of a bioterrorist attack is the sheer variety of organisms that might be used by terrorists. According to a recent review (Taylor, L. H. et al. Philos. Trans. R. Soc. Lond B. Biol. Sci. 2001, 356, 983-989), there are over 1400 organisms infectious to humans; most of these have the potential to be used in a deliberate, malicious attack. These numbers do not include numerous strain variants of each organism, bioengineered versions, or pathogens that infect plants or animals. Paradoxically, most of the new technology being developed for detection of biological weapons incorporates a version of quantitative PCR, which is based upon the use of highly specific primers and probes designed to selectively identify specific pathogenic organisms. This approach requires assumptions about the type and strain of bacteria or virus which is expected to be detected. Although this approach will work for the most obvious organisms, like smallpox and anthrax, experience has shown that it is very difficult to anticipate what a terrorist will do.

The present invention can be used to detect and identify any biological agent, including bacteria, viruses, fungi and toxins without prior knowledge of the organism being detected and identified. As one example, where the agent is a biological threat, the information obtained such as the presence of toxin genes, pathogenicity islands and antibiotic resistance genes for example, is used to determine practical information needed for countermeasures. In addition, the methods can be used to identify natural or deliberate engineering events including chromosome fragment swapping, molecular breeding (gene shuffling) and emerging infectious diseases. The present invention provides broad-function technology that may be the only practical means for rapid diagnosis of disease caused by a biowarfare or bioterrorist attack, especially an attack that might otherwise be missed or mistaken for a more common infection.

Bacterial biological warfare agents capable of being detected by the present methods include, but are not limited to, Bacillus anthracis(anthrax), Yersinia pestis (pneumonic plague), Franciscella tularensis (tularemia), Brucella suis, Brucella abortus, Brucella melitensis (undulant fever), Burkholderia mallei (glanders), Burkholderia pseudomalleii (melioidosis), Salmonella typhi (typhoid fever), Rickettsia typhii (epidemic typhus), Rickettsia prowasekii (endemic typhus) and Coxiella burnetii (Q fever), Rhodobacter capsulatus, Chlamydia pneumoniae, Escherichia coli, Shigella dysenteriae, Shigellaflexneri, Bacillus cereus, Clostridium botulinum, Coxiella burnetti, Pseudomonas aeruginosa, Legionella pneumophila, and Vibrio cholerae.

Besides 16S and 23S rRNA, other target regions suitable for use in the present invention for detection of bacteria include, but are not limited to, 5S rRNA and RNase P (FIG. 3).

Fungal biowarfare agents include, but are not limited to, Coccidioides immitis (Coccidioidomycosis), and Magnaporthe grisea.

Biological warfare toxin genes capable of being detected by the methods of the present invention include, but are not limited to, botulinum toxin, T-2 mycotoxins, ricin, staph enterotoxin B, shigatoxin, abrin, aflatoxin, Clostridium perfringen s epsilon toxin, conotoxins, diacetoxyscirpenol, tetrodotoxin and saxitoxin.

Parasites that could be used in biological warfare include, but are not limited to: Ascaris suum, Giardia lamblia, Cryptosporidium, and Schistosoma.

Biological warfare viral threat agents are mostly RNA viruses (positive-strand and negative-strand), with the exception of smallpox. Every RNA virus is a family of related viruses (quasispecies). These viruses mutate rapidly and the potential for engineered strains (natural or deliberate) is very high. RNA viruses cluster into families that have conserved RNA structural domains on the viral genome (e.g., virion components, accessory proteins) and conserved housekeeping genes that encode core viral proteins including, for single strand positive strand RNA viruses, RNA-dependent RNA polymerase, double stranded RNA helicase, chymotrypsin-like and papain-like proteases and methyltransferases. "Housekeeping genes" refers to genes that are generally always expressed and thought to be involved in routine cellular metabolism.

Examples of (-)-strand RNA viruses include, but are not limited to, arenaviruses (e.g., sabia virus, lassa fever, Machupo, Argentine hemorrhagic fever, flexal virus), bunyaviruses (e.g., hantavirus, nairovirus, phlebovirus, hantaan virus, Congo-crimean hemorrhagic fever, rift valley fever), and mononegavirales (e.g., filovirus, paramyxovirus, ebola virus, Marburg, equine morbillivirus).

Examples of (+)-strand RNA viruses include, but are not limited to, picornaviruses (e.g., coxsackievirus, echovirus, human coxsackievirus A, human echovirus, human enterovirus, human poliovirus, hepatitis A virus, human parechovirus, human rhinovirus), astroviruses (e.g., human astrovirus), calciviruses (e.g., chiba virus, chitta virus, human calcivirus, norwalk virus), nidovirales (e.g., human coronavirus, human torovirus), flaviviruses (e.g., dengue virus 1-4, Japanese encephalitis virus, Kyanasur forest disease virus, Murray Valley encephalitis virus, Rocio virus, St. Louis encephalitis virus, West Nile virus, yellow fever virus, hepatitis c virus) and togaviruses (e.g., Chikugunya virus, Eastern equine encephalitis virus, Mayaro virus, O'nyong-nyong virus, Ross River virus, Venezuelan equine encephalitis virus, Rubella virus, hepatitis E virus). The hepatitis C virus has a 5'-untranslated region of 340 nucleotides, an open reading frame encoding 9 proteins having 3010 amino acids and a 3'-untranslated region of 240 nucleotides. The 5'-UTR and 3'-UTR are 99% conserved in hepatitis C viruses.

In one embodiment, the target gene is an RNA-dependent RNA polymerase or a helicase encoded by (+)-strand RNA viruses, or RNA polymerase from a (-)-strand RNA virus. (+)-strand RNA viruses are double stranded RNA and replicate by RNA-directed RNA synthesis using RNA-dependent RNA polymerase and the positive strand as a template. Helicase unwinds the RNA duplex to allow replication of the single stranded RNA. These viruses include viruses from the family picornaviridae (e.g., poliovirus, coxsackievirus, echovirus), togaviridae (e.g., alphavirus, flavivirus, rubivirus), arenaviridae (e.g., lymphocytic choriomeningitis virus, lassa fever virus), cononaviridae (e.g., human respiratory virus) and Hepatitis A virus. The genes encoding these proteins comprise variable and highly conserved regions which flank the variable regions.

In one embodiment, the method can be used to detect the presence of antibiotic resistance and/or toxin genes in a bacterial species. For example, Bacillus anthraciscomprising a tetracycline resistance plasmid and plasmids encoding one or both anthracis toxins (px01 and/or px02) can be detected by using antibiotic resistance primer sets and toxin gene primer sets. If the B. anthracis is positive for tetracycline resistance, then a different antibiotic, for example quinalone, is used.

While the present invention has been described with specificity in accordance with certain of its embodiments, the following examples serve only to illustrate the invention and are not intended to limit the same.

EXAMPLES

Example 1

Nucleic Acid Isolation and PCR

In one embodiment, nucleic acid is isolated from the organisms and amplified by PCR using standard methods prior to BCS determination by mass spectrometry. Nucleic acid is isolated, for example, by detergent lysis of bacterial cells, centrifugation and ethanol precipitation. Nucleic acid isolation methods are described in, for example, Current Protocols in Molecular Biology (Ausubel et al.) and Molecular Cloning; A Laboratory Manual (Sambrook et al.). The nucleic acid is then amplified using standard methodology, such as PCR, with primers which bind to conserved regions of the nucleic acid which contain an intervening variable sequence as described below.

General Genomic DNA Sample Prep Protocol: Raw samples are filtered using Supor-200 0.2 .mu.m membrane syringe filters (VWR International). Samples are transferred to 1.5 ml eppendorf tubes pre-filled with 0.45 g of 0.7 mm Zirconia beads followed by the addition of 350 .mu.l of ATL buffer (Qiagen, Valencia, Calif.). The samples are subjected to bead beating for 10 minutes at a frequency of 19 l/s in a Retsch Vibration Mill (Retsch). After centrifigation, samples are transferred to an S-block plate (Qiagen) and DNA isolation is completed with a BioRobot 8000 nucleic acid isolation robot (Qiagen).

Swab Sample Protocol. Allegiance S/P brand culture swabs and collection/transport system are used to collect samples. After drying, swabs are placed in 17.times.100 mm culture tubes (VWR International) and the genomic nucleic acid isolation is carried out automatically with a Qiagen Mdx robot and the Qiagen QIAamp DNA Blood BioRobot Mdx genomic preparation kit (Qiagen, Valencia, Calif.).

Example 2

Mass Spectrometry

FTICR Instrumentation: The FTICR instrument is based on a 7 tesla actively shielded superconducting magnet and modified Bruker Daltonics Apex II 70 e ion optics and vacuum chamber. The spectrometer is interfaced to a LEAP PAL autosampler and a custom fluidics control system for high throughput screening applications. Samples are analyzed directly from 96-well or 384-well microtiter plates at a rate of about 1 sample/minute. The Bruker data-acquisition platform is supplemented with a lab-built ancillary NT datastation which controls the autosampler and contains an arbitrary waveform generator capable of generating complex rf-excite waveforms (frequency sweeps, filtered noise, stored waveform inverse Fourier transform (SWIFT), etc.) for sophisticated tandem MS experiments. For oligonucleotides in the 20-30-mer regime typical performance characteristics include mass resolving power in excess of 100,000 (FWHM), low ppm mass measurement errors, and an operable m/z range between 50 and 5000 m/z.

Modified ESI Source. In sample-limited analyses, analyte solutions are delivered at 150 nL/minute to a 30 mm i.d. fused-silica ESI emitter mounted on a 3-D micromanipulator. The ESI ion optics consists of a heated metal capillary, an rf-only hexapole, a skimmer cone, and an auxiliary gate electrode. The 6.2 cm rf-only hexapole is comprised of 1 mm diameter rods and is operated at a voltage of 380 Vpp at a frequency of 5 MHz. A lab-built electro-mechanical shutter can be employed to prevent the electrospray plume from entering the inlet capillary unless triggered to the "open" position via a TTL pulse from the data station. When in the "closed" position, a stable electrospray plume is maintained between the ESI emitter and the face of the shutter. The back face of the shutter arm contains an elastomeric seal that can be positioned to form a vacuum seal with the inlet capillary. When the seal is removed, a 1 mm gap between the shutter blade and the capillary inlet allows constant pressure in the external ion reservoir regardless of whether the shutter is in the open or closed position. When the shutter is triggered, a "time slice" of ions is allowed to enter the inlet capillary and is subsequently accumulated in the external ion reservoir. The rapid response time of the ion shutter (<25 ms) provides reproducible, user defined intervals during which ions can be injected into and accumulated in the external ion reservoir.

Apparatus for Infrared Multiphoton Dissociation: A 25 watt CW CO.sub.2 laser operating at 10.6 .mu.m has been interfaced to the spectrometer to enable infrared multiphoton dissociation (IRMPD) for oligonucleotide sequencing and other tandem MS applications. An aluminum optical bench is positioned approximately 1.5 m from the actively shielded superconducting magnet such that the laser beam is aligned with the central axis of the magnet. Using standard IR-compatible mirrors and kinematic mirror mounts, the unfocused 3 mm laser beam is aligned to traverse directly through the 3.5 mm holes in the trapping electrodes of the FTICR trapped ion cell and longitudinally traverse the hexapole region of the external ion guide finally impinging on the skimmer cone. This scheme allows IRMPD to be conducted in an m/z selective manner in the trapped ion cell (e.g. following a SWIFT isolation of the species of interest), or in a broadband mode in the high pressure region of the external ion reservoir where collisions with neutral molecules stabilize IRMPD-generated metastable fragment ions resulting in increased fragment ion yield and sequence coverage.

Example 3

Identification of Bioagents

Table 2 shows a small cross section of a database of calculated molecular masses for over 9 primer sets and approximately 30 organisms. The primer sets were derived from rRNA alignment. Examples of regions from rRNA consensus alignments are shown in FIGS. 1A-1C. Lines with arrows are examples of regions to which intelligent primer pairs for PCR are designed. The primer pairs are >95% conserved in the bacterial sequence database (currently over 10,000 organisms). The intervening regions are variable in length and/or composition, thus providing the base composition "signature" (BCS) for each organism. Primer pairs were chosen so the total length of the amplified region is less than about 80-90 nucleotides. The label for each primer pair represents the starting and ending base number of the amplified region on the consensus diagram.

Included in the short bacterial database cross-section in Table 2 are many well known pathogens/biowarfare agents (shown in bold/red typeface) such as Bacillus anthracis or Yersinia pestis as well as some of the bacterial organisms found commonly in the natural environment such as Streptomyces. Even closely related organisms can be distinguished from each other by the appropriate choice of primers. For instance, two low G+C organisms, Bacillus anthracis and Staph aureus, can be distinguished from each other by using the primer pair defined by 16S.sub.--1337 or 23S.sub.--855 (.DELTA.M of 4 Da).

TABLE-US-00002 TABLE 2 Cross Section Of A Database Of Calculated Molecular Masses.sup.1 Primer Regions Bug Name 16S_971 16S_1100 16S_1337 16S_1294 16S_1228 23S_1021 23S_855 23S_- 193 23S_115 Acinetobacter calcoaceticus 55619.1 55004 28446.7 35854.9 51295.4 30299 42654 39557.5 5- 4999 55005 54388 28448 35238 51296 30295 42651 39560 56850 Bacillus cereus 55622.1 54387.9 28447.6 35854.9 51296.4 30295 42651 39560.- 5 56850.3 Bordetella bronchiseptica 56857.3 51300.4 28446.7 35857.9 51307.4 30299 42- 653 39559.5 51920.5 Borrelia burgdorferi 56231.2 55621.1 28440.7 35852.9 51295.4 30297 42029.9- 38941.4 52524.6 58098 55011 28448 35854 50683 Campylobacter jejuni 58088.5 54386.9 29061.8 35856.9 50674.3 30294 42032.9 39558.5 4573- 2.5 55000 55007 29063 35855 50676 30295 42036 38941 56230 55006 53767 28445 35855 51291 30300 42656 39562 54999 Clostridium difficile 56855.3 54386.9 28444.7 35853.9 51296.4 30294 41417.8 39556.5 5- 5612.2 Enterococcus faecalis 55620.1 54387.9 28447.6 35858.9 51296.4 30297 42652 39559.5 5684- 9.3 55622 55009 28445 35857 51301 30301 42656 39562 54999 53769 54385 28445 35856 51298 Haemophilus influenzae 55620.1 55006 28444.7 35855.9 51298.4 30298 42656 39560.5 5561- 3.1 Kiebsiella pneumoniae 55622.1 55008 28442.7 35856.9 51297.4 30300 42655 39- 562.5 55000 55618 55626 28446 35857 51303 Mycobacterium avium 54390.9 55631.1 29064.8 35858.9 51915.5 30298 42656 38942.4 56241.2- Mycobacterium leprae 54389.9 55629.1 29064.8 35860.9 51917.5 30298 42656 39559.5 56240.- 2 Mycobacterium tuberculosis 54390.9 55629.1 29064.8 35860.9 51301.4 30299 42656 39560.5 - 56243.2 Mycoplasma genitalium 53143.7 45115.4 29061.8 35854.9 50671.3 30294 43264.- 1 39558.5 56842.4 Mycoplasma pneumoniae 53143.7 45118.4 29061.8 35854.9 50673.3 30294 43264.- 1 39559.5 56843.4 Neisseria gonorrhoeae 55627.1 54389.9 28445.7 35855.9 51302.4 30300 42649 - 39561.5 55000 55623 55010 28443 35858 51301 30298 43272 39558 55619 58093 55621 28448 35853 50677 30293 42650 39559 53139 58094 55623 28448 35853 50679 30293 42648 39559 53755 55622 55005 28445 35857 51301 30301 42658 55623 55009 28444 35857 51301 Staphylococcus aureus 56854.3 54386.9 28443.7 35852.9 51294.4 30298 42655 39559.5 57466.- 4 Streptomyces 54389.9 59341.6 29063.8 35858.9 51300.4 39563.5 56864.3 Treponema pallidum 56245.2 55631.1 28445.7 35851.9 51297.4 30299 42034.9 3- 8939.4 57473.4 55625 55626 28443 35857 52536 29063 30303 35241 50675 Vibrio parahaemolyticus 54384.9 55626.1 28444.7 34620.7 50064.2 55620 55626 28443 35857 51299 .sup.1Molecular mass distribution of PCR amplified regions for a selection of organisms (rows) across various primer pairs (columns). Pathogens are shown in bold. Empty cells indicate presently incomplete or missing data.

FIG. 6 shows the use of ESI-FT-ICR MS for measurement of exact mass. The spectra from 46 mer PCR products originating at position 1337 of the 16S rRNA from S. aureus (upper) and B. anthracis(lower) are shown. These data are from the region of the spectrum containing signals from the [M-8H+].sup.8- charge states of the respective 5'-3' strands. The two strands differ by two (AT.fwdarw.CG) substitutions, and have measured masses of 14206.396 and 14208.373+0.010 Da, respectively. The possible base compositions derived from the masses of the forward and reverse strands for the B. anthracis products are listed in Table 3.

TABLE-US-00003 TABLE 3 Possible base composition for B. anthracis products Calc. Mass Error Base Comp. 14208.2935 0.079520 A1 G17 C10 T18 14208.3160 0.056980 A1 G20 C15 T10 14208.3386 0.034440 A1 G23 C20 T2 14208.3074 0.065560 A6 G11 C3 T26 14208.3300 0.043020 A6 G14 C8 T18 14208.3525 0.020480 A6 G17 C13 T10 14208.3751 0.002060 A6 G20 C18 T2 14208.3439 0.029060 A11 G8 C1 T26 14208.3665 0.006520 A11 G11 C6 T18 14208.3890 0.016020 A11 G14 C11 T10 14208.4116 0.038560 A11 G17 C16 T2 14208.4030 0.029980 A16 G8 C4 T18 14208.4255 0.052520 A16 G11 C9 T10 14208.4481 0.075060 A16 G14 C14 T2 14208.4395 0.066480 A21 G5 C2 T18 14208.4620 0.089020 A21 G8 C7 T10 14079.2624 0.080600 A0 G14 C13 T19 14079.2849 0.058060 A0 G17 C18 T11 14079.3075 0.035520 A0 G20 C23 T3 14079.2538 0.089180 A5 G5 C1 T35 14079.2764 0.066640 A5 G8 C6 T27 14079.2989 0.044100 A5 G11 C11 T19 14079.3214 0.021560 A5 G14 C16 T11 14079.3440 0.000980 A5 G17 C21 T3 14079.3129 0.030140 A10 G5 C4 T27 14079.3354 0.007600 A10 G8 C9 T19 14079.3579 0.014940 A10 G11 C14 T11 14079.3805 0.037480 A10 G14 C19 T3 14079.3494 0.006360 A15 G2 C2 T27 14079.3719 0.028900 A15 G5 C7 T19 14079.3944 0.051440 A15 G8 C12 T11 14079.4170 0.073980 A15 G11 C17 T3 14079.4084 0.065400 A20 G2 C5 T19 14079.4309 0.087940 A20 G5 C10 T13

Among the 16 compositions for the forward strand and the 18 compositions for the reverse strand that were calculated, only one pair (shown in bold) are complementary, corresponding to the actual base compositions of the B. anthracis PCR products.

Example 4

BCS of Region from Bacillus anthracis and Bacillus cereus

A conserved Bacillus region from B. anthracis(A.sub.14G.sub.9C.sub.14T.sub.9) and B. cereus (A.sub.15G.sub.9C.sub.13T.sub.9) having a C to A base change was synthesized and subjected to ESI-TOF MS. The results are shown in FIG. 7 in which the two regions are clearly distinguished using the method of the present invention (MW=14072.26 vs. 14096.29).

Example 5

Identification of Additional Bioagents

In other examples of the present invention, the pathogen Vibrio cholera can be distinguished from Vibrio parahemolyticus with .DELTA.M>600 Da using one of three 16S primer sets shown in Table 2 (16S.sub.--971, 16S.sub.--1228 or 16s.sup.-1294) as shown in Table 4. The two mycoplasma species in the list (M. genitalium and M pneumoniae) can also be distinguished from each other, as can the three mycobacteriae. While the direct mass measurements of amplified products can identify and distinguish a large number of organisms, measurement of the base composition signature provides dramatically enhanced resolving power for closely related organisms. In cases such as Bacillus anthracis and Bacillus cereus that are virtually indistinguishable from each other based solely on mass differences, compositional analysis or fragmentation patterns are used to resolve the differences. The single base difference between the two organisms yields different fragmentation patterns, and despite the presence of the ambiguous/unidentified base N at position 20 in B. anthracis, the two organisms can be identified.

Tables 4a-b show examples of primer pairs from Table 1 which distinguish pathogens from background.

TABLE-US-00004 TABLE 4a Organism name 23S_855 16S_1337 23S_1021 Bacillus anthracis 42650.98 28447.65 30294.98 Staphylococcus aureus 42654.97 28443.67 30297.96

TABLE-US-00005 TABLE 4b Organism name 16S_971 16S_1294 16S_1228 Vibrio cholerae 55625.09 35856.87 52535.59 Vibrio parahaemolyticus 54384.91 34620.67 50064.19

Table 5 shows the expected molecular weight and base composition of region 16S.sub.--1100-1188 in Mycobacterium avium and Streptomyces sp.

TABLE-US-00006 TABLE 5 Organism Molecular Region name Length weight Base comp. 16S.sub.-- Mycobacterium 82 25624.1728 A.sub.16G.sub.32C.sub.18T.sub.16 1100-1188 avium 16S.sub.-- Streptomyces 96 29904.871 A.sub.17G.sub.38C.sub.27T.sub.14 1100-1188 sp.

Table 6 shows base composition (single strand) results for 16S.sub.--1100-1188 primer amplification reactions different species of bacteria. Species which are repeated in the table (e.g., Clostridium botulinum) are different strains which have different base compositions in the 16S.sub.--1100-1188 region.

TABLE-US-00007 TABLE 6 Organism name Base comp. Mycobacterium avium A.sub.16G.sub.32C.sub.18T.sub.16 Streptomyces sp. A.sub.17G.sub.38C.sub.27T.sub.14 Ureaplasma urealyticum A.sub.18G.sub.30C.sub.17T.sub.17 Streptomyces sp. A.sub.19G.sub.36C.sub.24T.sub.18 Mycobacterium leprae A.sub.20G.sub.32C.sub.22T.sub.16 A.sub.20G.sub.33C.sub.21T.sub.16 A.sub.20G.sub.33C.sub.21T.sub.16 Fusobacterium necroforum A.sub.21G.sub.26C.sub.22T.sub.16 Listeria monocytogenes A.sub.21G.sub.27C.sub.19T.sub.19 Clostridium botulinum A.sub.21G.sub.27C.sub.19T.sub.21 Neisseria gonorrhoeae A.sub.21G.sub.28C.sub.21T.sub.18 Bartonella quintana A.sub.21G.sub.30C.sub.22T.sub.16 Enterococcus faecalis A.sub.22G.sub.27C.sub.20T.sub.19 Bacillus megaterium A.sub.22G.sub.28C.sub.20T.sub.18 Bacillus subtilis A.sub.22G.sub.28C.sub.21T.sub.17 Pseudomonas aeruginosa A.sub.22G.sub.29C.sub.23T.sub.15 Legionella pneumophila A.sub.22G.sub.32C.sub.20T.sub.16 Mycoplasma pneumoniae A.sub.23G.sub.20C.sub.14T.sub.16 Clostridium botulinum A.sub.23G.sub.26C.sub.20T.sub.19 Enterococcus faecium A.sub.23G.sub.26C.sub.21T.sub.18 Acinetobacter calcoaceti A.sub.23G.sub.26C.sub.21T.sub.19 A.sub.23G.sub.26C.sub.24T.sub.15 A.sub.23G.sub.26C.sub.24T.sub.15 Clostridium perfringens A.sub.23G.sub.27C.sub.19T.sub.19 A.sub.23G.sub.27C.sub.20T.sub.18 A.sub.23G.sub.27C.sub.20T.sub.18 A.sub.23G.sub.27C.sub.20T.sub.18 Aeromonas hydrophila A.sub.23G.sub.29C.sub.21T.sub.16 Escherichia coli A.sub.23G.sub.29C.sub.21T.sub.16 Pseudomonas putida A.sub.23G.sub.29C.sub.21T.sub.17 A.sub.23G.sub.29C.sub.22T.sub.15 A.sub.23G.sub.29C.sub.22T.sub.15 Vibrio cholerae A.sub.23G.sub.30C.sub.21T.sub.16 A.sub.23G.sub.31C.sub.21T.sub.15 A.sub.23G.sub.31C.sub.21T.sub.15 Mycoplasma genitalium A.sub.24G.sub.19C.sub.12T.sub.18 Clostridium botulinum A.sub.24G.sub.25C.sub.18T.sub.20 Bordetella bronchiseptica A.sub.24G.sub.26C.sub.19T.sub.14 Francisella tularensis A.sub.24G.sub.26C.sub.19T.sub.19 A.sub.24G.sub.26C.sub.20T.sub.18 A.sub.24G.sub.26C.sub.20T.sub.18 A.sub.24G.sub.26C.sub.20T.sub.18 Helicobacter pylori A.sub.24G.sub.26C.sub.20T.sub.19 Helicobacter pylori A.sub.24G.sub.26C.sub.21T.sub.18 Moraxella catarrhalis A.sub.24G.sub.26C.sub.23T.sub.16 Haemophilus influenzae Rd A.sub.24G.sub.28C.sub.20T.sub.17 A.sub.24G.sub.28C.sub.21T.sub.16 A.sub.24G.sub.28C.sub.21T.sub.16 A.sub.24G.sub.28C.sub.21T.sub.16 Pseudomonas putida A.sub.24G.sub.29C.sub.21T.sub.16 A.sub.24G.sub.30C.sub.21T.sub.15 A.sub.24G.sub.30C.sub.21T.sub.15 A.sub.24G.sub.30C.sub.21T.sub.15 Clostridium botulinum A.sub.25G.sub.24C.sub.18T.sub.21 Clostridium tetani A.sub.25G.sub.25C.sub.18T.sub.20 Francisella tularensis A.sub.25G.sub.25C.sub.19T.sub.19 Acinetobacter calcoacetic A.sub.25G.sub.26C.sub.20T.sub.19 Bacteriodes fragilis A.sub.25G.sub.27C.sub.16T.sub.22 Chlamydophila psittaci A.sub.25G.sub.27C.sub.21T.sub.16 Borrelia burgdorferi A.sub.25G.sub.29C.sub.17T.sub.19 Streptobacillus monilifor A.sub.26G.sub.26C.sub.20T.sub.16 Rickettsia prowazekii A.sub.26G.sub.28C.sub.18T.sub.18 Rickettsia rickettsii A.sub.26G.sub.28C.sub.20T.sub.16 Mycoplasma mycoides A.sub.28G.sub.23C.sub.16T.sub.20

The same organism having different base compositions are different strains. Groups of organisms which are highlighted or in italics have the same base compositions in the amplified region. Some of these organisms can be distinguished using multiple primers. For example, Bacillus anthracis can be distinguished from Bacillus cereus and Bacillus thuringiensis using the primer 16S.sub.--971-1062 (Table 7). Other primer pairs which produce unique base composition signatures are shown in Table 6 (bold). Clusters containing very similar threat and ubiquitous non-threat organisms (e.g. anthracis cluster) are distinguished at high resolution with focused sets of primer pairs. The known biowarfare agents in Table 6 are Bacillus anthracis, Yersinia pestis, Francisella tularensis and Rickettsia prowazekii.

TABLE-US-00008 TABLE 7 Organism 16S_971-1062 16S_1228-1310 16S_1100-1188 Aeromonas hydrophila A.sub.21G.sub.29C.sub.22T.sub.20 A.sub.22G.sub.27C.su- b.21T.sub.13 A.sub.23G.sub.31C.sub.21T.sub.15 Aeromonas salmonicida A.sub.21G.sub.29C.sub.22T.sub.20 A.sub.22G.sub.27C.s- ub.21T.sub.13 A.sub.23G.sub.31C.sub.21T.sub.15 Bacillus anthracis A.sub.21G.sub.27C.sub.22T.sub.22 A.sub.24G.sub.22C.sub.- 19T.sub.18 A.sub.23G.sub.27C.sub.20T.sub.18 Bacillus cereus A.sub.22G.sub.27C.sub.21T.sub.22 A.sub.24G.sub.22C.sub.19T- .sub.18 A.sub.23G.sub.27C.sub.20T.sub.18 Bacillus thuringiensis A.sub.22G.sub.27C.sub.21T.sub.22 A.sub.24G.sub.22C.- sub.19T.sub.18 A.sub.23G.sub.27C.sub.20T.sub.18 Chlamydia trachomatis A.sub.22G.sub.26C.sub.20T.sub.23 A.sub.24G.sub.23C.s- ub.19T.sub.16 A.sub.24G.sub.28C.sub.21T.sub.16 Chlamydia pneumoniae AR39 A.sub.26G.sub.23C.sub.20T.sub.22 A.sub.26G.sub.22C.sub.16T.sub.18 A.- sub.24G.sub.28C.sub.21T.sub.16 Leptospira borgpetersenii A.sub.22G.sub.26C.sub.20T.sub.21 A.sub.22G.sub.2- 5C.sub.21T.sub.15 A.sub.23G.sub.26C.sub.24T.sub.15 Leptospira interrogans A.sub.22G.sub.26C.sub.20T.sub.21 A.sub.22G.sub.25C.- sub.21T.sub.15 A.sub.23G.sub.26C.sub.24T.sub.15 Mycoplasma genitalium A.sub.28G.sub.23C.sub.15T.sub.22 A.sub.30G.sub.18C.s- ub.15T.sub.19 A.sub.24G.sub.19C.sub.12T.sub.18 Mycoplasma pneumoniae A.sub.28G.sub.23C.sub.15T.sub.22 A.sub.27G.sub.19C.s- ub.16T.sub.20 A.sub.23G.sub.20C.sub.14T.sub.16 Escherichia coli A.sub.22G.sub.28C.sub.20T.sub.22 A.sub.24G.sub.25C.sub.21T.sub.13 A.- sub.23G.sub.29C.sub.22T.sub.15 Shigella dysenteriae A.sub.22G.sub.28C.sub.21T.sub.21 A.sub.24G.sub.25C.su- b.21T.sub.13 A.sub.23G.sub.29C.sub.22T.sub.15 Proteus vulgaris A.sub.23G.sub.26C.sub.22T.sub.21 A.sub.26G.sub.24C.sub.19- T.sub.14 A.sub.24G.sub.30C.sub.21T.sub.15 Yersinia pestis A.sub.24G.sub.25C.sub.21T.sub.22 A.sub.25G.sub.24C.sub.20T- .sub.14 A.sub.24G.sub.30C.sub.21T.sub.15 Yersinia pseudotuberculosis A.sub.24G.sub.25C.sub.21T.sub.22 A.sub.25G.sub- .24C.sub.20T.sub.14 A.sub.24G.sub.30C.sub.21T.sub.15 Francisella tularensis A.sub.20G.sub.25C.sub.21T.sub.23 A.sub.23G.sub.26C.sub.17T.sub- .17 A.sub.24G.sub.26C.sub.19T.sub.19 Rickettsia prowazekii A.sub.21G.sub.26C.sub.24T.sub.25 A.sub.24G.sub.23C.s- ub.16T.sub.19 A.sub.26G.sub.28C.sub.18T.sub.18 Rickettsia rickettsii A.sub.21G.sub.26C.sub.25T.sub.24 A.sub.24G.sub.24C.s- ub.17T.sub.17 A.sub.26G.sub.28C.sub.20T.sub.16

The sequence of B. anthracis and B. cereus in region 16S.sub.--971 is shown below. Shown in bold is the single base difference between the two species which can be detected using the methods of the present invention. B. anthracis has an ambiguous base at position 20.

TABLE-US-00009 B.anthracis_16S_971 GCGAAGAACCUUACCAGGUNUUGACAUCCUCUGACAA (SEQ ID NO:1) CCCUAGAGAUAGGGCUUCUCCUUCGGGAGCAGAGUGA CAGGUGGUGCAUGGUU B.cereus_16S_971 GCGAAGAACCUUACCAGGUCUUGACAUCCUCUGAAA (SEQ ID NO:2) ACCCUAGAGAUAGGGCUUCUCCUUCGGGAGCAGAGU GACAGGUGGUGCAUGGUU

Example 6

ESI-TOF MS of sspE 56-mer Plus Calibrant

The mass measurement accuracy that can be obtained using an internal mass standard in the ESI-MS study of PCR products is shown in FIG. 8. The mass standard was a 20-mer phosphorothioate oligonucleotide added to a solution containing a 56-mer PCR product from the B. anthracis spore coat protein sspE. The mass of the expected PCR product distinguishes B. anthracis from other species of Bacillus such as B. thuringiensis and B. cereus.

Example 7

B. anthracis ESI-TOF Synthetic 16S.sub.--1228 Duplex

An ESI-TOF MS spectrum was obtained from an aqueous solution containing 5 .mu.M each of synthetic analogs of the expected forward and reverse PCR products from the nucleotide 1228 region of the B. anthracis16S rRNA gene. The results (FIG. 9) show that the molecular weights of the forward and reverse strands can be accurately determined and easily distinguish the two strands. The [M-21H.sup.+].sup.21- and [M-20H.sup.+].sup.20- charge states are shown.

Example 8

ESI-FTICR-MS of Synthetic B. anthracis16S 1337 46 Base Pair Duplex

An ESI-FTICR-MS spectrum was obtained from an aqueous solution containing 5 .mu.M each of synthetic analogs of the expected forward and reverse PCR products from the nucleotide 1337 region of the B. anthracis16S rRNA gene. The results (FIG. 10) show that the molecular weights of the strands can be distinguished by this method. The [M-16H.sup.+].sup.16-through [M-10H.sup.+].sup.10-charge states are shown. The insert highlights the resolution that can be realized on the FTICR-MS instrument, which allows the charge state of the ion to be determined from the mass difference between peaks differing by a single 13C substitution.

Example 9

ESI-TOF MS of 56-mer Oligonucleotide from saspB Gene of B. anthracis with Internal Mass Standard

ESI-TOF MS spectra were obtained on a synthetic 56-mer oligonucleotide (5 .mu.M) from the saspB gene of B. anthracis containing an internal mass standard at an ESI of 1.7 .mu.L/min as a function of sample consumption. The results (FIG. 11) show that the signal to noise is improved as more scans are summed, and that the standard and the product are visible after only 100 scans.

Example 10

ESI-TOF MS of an Internal Standard with Tributylammonium (TBA)-trifluoroacetate (TFA) Buffer

An ESI-TOF-MS spectrum of a 20-mer phosphorothioate mass standard was obtained following addition of 5 mM TBA-TFA buffer to the solution. This buffer strips charge from the oligonucleotide and shifts the most abundant charge state from [M-8H.sup.+].sup.8 to [M-3H.sup.+].sup.3-(FIG. 12).

Example 11

Master Database Comparison

The molecular masses obtained through Examples 1-10 are compared to molecular masses of known bioagents stored in a master database to obtain a high probability matching molecular mass.

Example 12

Master Data Base Interrogation over the Internet

The same procedure as in Example 11 is followed except that the local computer did not store the Master database. The Master database is interrogated over an internet connection, searching for a molecular mass match.

Example 13

Master Database Updating

The same procedure as in example 11 is followed except the local computer is connected to the internet and has the ability to store a master database locally. The local computer system periodically, or at the user's discretion, interrogates the Master database, synchronizing the local master database with the global Master database. This provides the current molecular mass information to both the local database as well as to the global Master database. This further provides more of a globalized knowledge base.

Example 14

Global Database Updating

The same procedure as in example 13 is followed except there are numerous such local stations throughout the world. The synchronization of each database adds to the diversity of information and diversity of the molecular masses of known bioagents.

Various modifications of the invention, in addition to those described herein, will be apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. Each reference cited in the present application is incorporated herein by reference in its entirety.

Example 15

Demonstration of Detection and Identification of Five Species of Bacteria in a Mixture

Broad range intelligent primers were chosen following analysis of a large collection of curated bacterial 16S rRNA sequences representing greater than 4000 species of bacteria. Examples of primers capable of priming from greater than 90% of the organisms in the collection include, but are not limited to, those exhibited in Table 8 wherein Tp=5' propynylated uridine and Cp=5' propynylated cytidine.

TABLE-US-00010 TABLE 8 Intelligent Primer Pairs for Identification of Bacteria Forward Reverse Primer Forward Primer SEQ ID Reverse Primer SEQ ID Pair Name Sequence NO: Sequence NO: 16S_EC_107 GTGAGATGTTGGGTTAAGTCCCGTAACGAG 8 GACGTCATCCCCACCTTCCTC 9 7_1195 16S_EC_108 ATGTTGGGTTAAGTCCCGCAACGAG 10 TTGACGTCATCCCCACCTTCCTC 11 2_1197 16S_EC_109 TTAAGTCCCGCAACGATCGCAA 12 TGACGTCATCCCCACCTTCCTC 13 0_1196 16S_EC_122 GCTACACACGTGCTACAATG 14 CGAGTTGCAGACTGCGATCCG 15 2_1323 16S_EC_133 AAGTCGGAATCGCTAGTAATCG 16 GACGGGCGGTGTGTACAAG 17 2_1407 16S_EC_30_ TGAACGCTGGTGGCATGCTTAACAC 18 TACGCATTACTCACCCGTCCGC 19 126 16S_EC_38_ GTGGCATGCCTAATACATGCAAGTCG 20 TTACTCACCCGTCCGCCGCT 21 120 16S_EC_49_ TAACACATGCAAGTCGAACG 22 TTACTCACCCGTCCGCC 23 120 16S_EC_683_ GTGTAGCGGTGAAATGCG 24 GTATCTAATCCTGTTTGCTCCC 25 795 16S_EC_713_ AGAACACCGATGGCGAAGGC 26 CGTGGACTACCAGGGTATCTA 27 809 16S_EC_785_ GGATTAGAGACCCTGGTAGTCC 28 GGCCGTACTCCCCAGGCG 29 897 16S_EC_785_ GGATTAGATACCCTGGTAGTCCACGC 30 GGCCGTACTCCCCAGGCG 31 897_2 16S_EC_789_ TAGATACCCTGGTAGTCCACGC 32 CGTACTCCCCAGGCG 33 894 16S_EC_960_ TTCGATGCAACGCGAAGAACCT 34 ACGAGCTGACGACAGCCATG 35 1073 16S_EC_969_ ACGCGAAGAACCTTACC 36 ACGACACGAGCTGACGAC 37 1078 23S_EC_182 CTGACACCTGCCCGGTGC 38 GACCGTTATAGTTACGGCC 39 6_1924 23S_EC_264 TCTGTCCCTAGTACGAGAGGACCGG 40 TGCTTAGATGCTTTCAGC 41 5_2761 23S_EC_264 CTGTCCCTAGTACGAGAGGACCGG 42 GTTTCATGCTTAGATGCTTTCAGC 43 5_2767 23S_ECS_493_ GGGGAGTGAAAGAGATCCTGAAACCG 44 ACAAAAGGTACGCCGTCACCC 45 571 23S_EC_493_ GGGGAGTGAAAGAGATCCTGAAACCG 46 ACAAAAGGCACGCCATCACCC 47 571_2 23S_EC_971_ CGAGAGGGAAACAACCCAGACC 48 TGGCTGCTTCTAAGCCAAC 49 1077 INFB_EC_13 TGCTCGTGGTGCACAAGTAACGGATATTA 50 TGCTGCTTTCGCATGGTTAATTGCTTCAA - 51 65_1467 RPOC_EC_10 CAAAACTTATTAGGTAAGCGTGTTGACT 52 TCAAGCGCCATTTCTTTTGGTAAACCACAT - 53 18_1124 RPOC_EC_10 CAAAACTTATTAGGTAAGCGTGTTGACT 54 TCAAGCGCCATCTCTTTCGGTAATCCACAT - 55 18_1124_2 RPOC_EC_11 TAAGAAGCCGGAAACCATCAACTACCG 56 GGCGCTTGTACTTACCGCAC 57 4_232 RPOC_EC_21 TGATTCTGGTGCCCGTGGT 58 TTGGCCATCAGGCCACGCATAC 59 78_2246 RPOC_EC_21 TGATTCCGGTGCCCGTGGT 60 TTGGCCATCAGACCACGCATAC 61 78_2246_2 RPOC_EC_22 CTGGCAGGTATGCGTGGTCTGATG 62 CGCACCGTGGTTGAGATGAAGTAC 63 18_2337 RPOC_EC_22 CTTGCTGGTATGCGTGGTCTGATG 64 CGCACCATGCGTAGAGATGAAGTAC 65 18_2337_2 RPOC_EC_80 CGTCGGGTGATTAACCGTAACAACCG 66 GTTTTTCGTTGCGTACGATGATGTC 67 8_889 RPOC_EC_80 CGTCGTGTAATTAACCGTAACAACCG 68 ACGTTTTTCGTTTTGAACGATAATGCT 69 8_891 RPOC_EC_99 CAAAGGTAAGCAAGGTCGTTTCCGTCA 70 CGAACGGCCTGAGTAGTCAACACG 71 3_1059 RPOC_EC_99 CAAAGGTAAGCAAGGACGTTTCCGTCA 72 CGAACGGCCAGAGTAGTCAACACG 73 3_1059_2 TUFB_EC_23 TAGACTGCCCAGGACACGCTG 74 GCCGTCCATCTGAGCAGCACC 75 9_303 TUFB_EC_23 TTGACTGCCCAGGTCACGCTG 76 GCCGTCCATTTGAGCAGCACC 77 9_303_2 TUFB_EC_97 AACTACCGTCCGCAGTTCTACTTCC 78 GTTGTCGCCAGGCATAACCATTTC 79 6_1068 TUFB_EC_97 AACTACCGTCCTCAGTTCTACTTCC 80 GTTGTCACCAGGCATTACCATTTC 81 6_1068_2 TUFB_EC_98 CCACAGTTCTACTTCCGTACTACTGACG 82 TCCAGGCATTACCATTTCTACTCCTTCTGG - 83 5_1062 RPLB_EC_65 GACCTACAGTAAGAGGTTCTGTAATGAACC 84 TCCAAGTGCTGGTTTACCCCATGG 85 0_762 RPLB_EC_68 CATCCACACGGTGGTGGTGAAGG 86 GTGCTGGTTTACCCCATGGAGT 87 8_757 RPOC_EC_10 CGTGTTGACTATTCGGGGCGTTCAG 88 ATTCAAGAGCCATTTCTTTTGGTAAACCAC 89 36_1126 RPOB_EC_37 TCAACAACCTCTTGGAGGTAAAGCTCAGT 90 TTTCTTGAAGAGTATGAGCTGCTCCGTAAG- 91 62_3865 RPLB_EC_68 CATCCACACGGTGGTGGTGAAGG 92 TGTTTTGTATCCAAGTGCTGGTTTACCCC 93 8_771 VALS_EC_11 CGTGGCGGCGTGGTTATCGA 94 CGGTACGAACTGGATGTCGCCGTT 95 05_1218 RPOB_EC_18 TATCGCTCAGGCGAACTCCAAC 96 GCTGGATTCGCCTTTGCTACG 97 45_1929 RPLB_EC_66 TGTAATGAACCCTAATGACCATCCACACGG 98 CCAAGTGCTGGTTTACCCCATGGAGTA 9- 9 9_761 RPLB_EC_67 TAATGAACCCTAATGACCATCCACACGGTG 100 TCCAAGTGCTGGTTTACCCCATGGAG 1- 01 1_762 RPOB_EC_37 CTTGGAGGTAAGTCTCATTTTGGTGGGCA 102 CGTATAAGCTGCACCATAAGCTTGTAATG- C 103 75_3858 VALS_EC_18 CGACGCGCTGCGCTTCAC 104 GCGTTCCACAGCTTGTTGCAGAAG 105 33_1943 RPOB_EC_13 GACCACCTCGGCAACCGT 106 TTCGCTCTCGGCCTGGCC 107 36_1455 TUFB_EC_22 GCACTATGCACACGTAGATTGTCCTGG 108 TATAGCACCATCCATCTGAGCGGCAC 109 5_309 DNAK_EC_42 CGGCGTACTTCAACGACAGCCA 110 CGCGGTCGGCTCGTTGATGA 111 8_522 VALS_EC_19 CTTCTGCAACAAGCTGTGGAACGC 112 TCGCAGTTCATCAGCACGAAGCG 113 20_1970 TUFB_EC_75 AAGACGACCTGCACGGGC 114 GCGCTCCACGTCTTCACGC 115 7_867 23S_EC_264 CTGTTCTTAGTACGAGAGGACC 116 TTCGTGCTTAGATGCTTTCAG 117 6_2765 16S_EC_969_ ACGCGAAGAACCTTACpC 118 ACGACACGAGCpTpGACGAC 119 1078_3P 16S_EC_972_ CGAAGAACpCpTTACC 120 ACACGAGCpTpGAC 121 1075_4P 16S_EC_972_ CGAAGAACCTTACC 122 ACACGAGCTGAC 123 1075 23S_EC_- CCTGATAAGGGTGAGGTCG 124 ACGTCCTTCATCGCCTCTGA 125 347_59 23S_EC_- GTTGTGAGGTTAAGCGACTAAG 126 CTATCGGTCAGTCAGGAGTAT 127 7_450 23S_EC_- GTTGTGAGGTTAAGCGACTAAG 128 TTGCATCGGGTTGGTAAGTC 129 7_910 23S_EC_430_ ATACTCCTGACTGACCGATAG 130 AACATAGCCTTCTCCGTCC 131 1442 23S_EC_891_ GACTTACCAACCCGATGCAA 132 TACCTTAGGACCGTTATAGTTACG 133 1931 23S_EC_142 GGACGGAGAAGGCTATGTT 134 CCAAACACCGCCGTCGATAT 135 4_2494 23S_EC_190 CGTAACTATAACGGTCCTAAGGTA 136 GCTTACACACCCGGCCTATC 137 8_2852 23S_EC_247 ATATCGACGGCGGTGTTTGG 138 GCGTGACAGGCAGGTATTC 139 5_3209 16S_EC_- AGTCTCAAGAGTGAACACGTAA 140 GCTGCTGGCACGGAGTTA 141 60_525 16S_EC_326_ GACACGGTCCAGACTCCTAC 142 CCATGCAGCACCTGTCTC 143 1058 16S_EC_705_ GATCTGGAGGAATACCGGTG 144 ACGGTTACCTTGTTACGACT 145 1512 16S_EC_126 GAGAGCAAGCGGACCTCATA 146 CCTCCTGCGTGCAAAGC 147 8_1775 GROL_EC_94 TGGAAGATCTGGGTCAGGC 148 CAATCTGCTGACGGATCTGAGC 149 1_1060 INFB_EC_11 GTCGTGAAAACGAGCTGGAAGA 150 CATGATGGTCACAACCGG 151 03_1191 HFLB_EC_10 TGGCGAACCTGGTGAACGAAGC 152 CTTTCGCTTTCTCGAACTCAACCAT 153 82_1168 INFB_EC_19 CGTCAGGGTAAATTCCGTGAAGTTAA 154 AACTTCGCCTTCGGTCATGTT 155 69_2058 GROL_EC_21 GGTGAAAGAAGTTGCCTCTAAAGC 156 TTCAGGTCCATCGGGTTCATGCC 157 9_350 VALS_EC_11 CGTGGCGGCGTGGTTATCGA 158 ACGAACTGGATGTCGCCGTT 159 05_1214 16S_EC_556_ CGGAATTACTGGGCGTAAAG 160 CGCATTTCACCGCTACAC 161 700 RPOC_EC_12 ACCCAGTGCTGCTGAACCGTGC 162 GTTCAAATGCCTGGATACCCA 163 56_1315 16S_EC_774_ GGGAGCAAACAGGATTAGATAC 164 CGTACTCCCCAGGCG 165 894 RPOC_EC_15 TGGCCCGAAAGAAGCTGAGCG 166 ACGCGGGCATGCAGAGATGCC 167 84_1643 16S_EC_108 ATGTTGGGTTAAGTCCCGC 168 TGACGTCATCCCCACCTTCC 169 2_1196 16S_EC_138 CTTGTACACACCGCCCGTC 170 AAGGAGGTGATCCAGCC 171 9_1541 16S_EC_130 CGGATTGGAGTCTGCAACTCG 172 GACGGGCGGTGTGTACAAG 173 3_1407 23S_EC_23_ GGTGGATGCCTTGCC 174 GGGTTTCCCCATTCGG 175 130 23_EC_187_ GGGAACTGAAACATCTAAGTA 176 TTCGCTCGCCGCTAC 177 256 23S_EC_160 TACCCCAAACCGACACAGG 178 CCTTCTCCCGAAGTTACG 179 2_1703 23S_EC_168 CCGTAACTTCGGGAGAAGG 180 CACCGGGCAGGCGTC 181 5_1842 23S_EC_182 GACGCCTGCCCGGTGC 182 CCGACAAGGAATTTCGCTACC 183 7_1949 23S_EC_243 AAGGTACTCCGGGGATAACAGGC 184 AGCCGACATCGAGGTGCCAAAC 185 4_2511 23S_EC_259 GACAGTTCGGTCCCTATC 186 CCGGTCCTCTCGTACTA 187 9_2669 23S_EC_265 TAGTACGAGAGGACCGG 188 TTAGATGCTTTCAGCACTTATC 189 3_2758 23S_BS_- AAACTAGATAACAGTAGACATCAC 190 GTGCGCCCTTTCTAACTT 191 68_21 16S_EC_8_3 AGAGTTTGATCATGGCTCAG 192 ACTGCTGCCTCCCGTAG 193 58 16S_EC_314_ CACTGGAACTGAGACACGG 194 CTTTACGCCCAGTAATTCCG 195 575 16S_EC_518_ CCAGCAGCCGCGGTAATAC 196 GTATCTAATCCTGTTTGCTCCC 197 795 16S_EC_683_ GTGTAGCGGTGAAATGCG 198 GGTAAGGTTCTTCGCGTTG 199 985 16S_EC_937_ AAGCGGTGGAGCATGTGG 200 ATTGTAGCACGTGTGTAGCCC 201 1240 16S_EC_119 CAAGTCATCATGGCCCTTA 202 AAGGAGGTGATCCAGCC 203 5_1541 16S_EC_8_1 AGAGTTTGATCATCGCTCAG 204 AAGGAGGTGATCCAGCC 205 541 23S_EC_183 ACCTGCCCAGTGCTGGAAG 206 TCGCTACCTTAGGACCGT 207 1_1936 16S_EC_138 GCCTTGTACACACCTCCCGTC 208 CACGGCTACCTTGTTACGAC 209 7_1513 16S_EC_139 TTGTACACACCGCCCGTCATAC 210 CCTTGTTACGACTTCACCCC 211 0_1505 16S_EC_136 TACGGTGAATACGTTCCCGGG 212 ACCTTGTTACGACTTCACCCCA 213 7_1506 16S_EC_804_ ACCACGCCGTAAACGATGA 214 CCCCCGTCAATTCCTTTGAGT 215 929 16S_EC_791_ GATACCCTGGTAGTCCACACCG 216 GCCTTGCGACCGTACTCCC 217 904 16S_EC_789_ TAGATACCCTGGTAGTCCACGC 218 GCGACCGTACTCCCCAGG 219 899 16S_EC_109 TAGTCCCGCAACGAGCGC 220 GACGTCATCCCCACCTTCCTCC 221 2_1195 23S_EC_258 TAGAACGTCGCGAGACAGTTCG 222 AGTCCATCCCGGTCCTCTCG 223 6_2677 HEXAMER_EC_ GAGGAAAGTCCGGGCTC 224 ATAAGCCGGGTTCTGTCG 225 61_362 RNASEP_BS_ GAGGAAAGTCCATGCTCGC 226 GTAAGCCATGTTTTGTTCCATC 227 43_384 RNASEP_EC_ GAGGAAAGTCCGGGCTC 228 ATAAGCCGGGTTCTGTCG 229 61_362 YAED_TRNA_ GCGGGATCCTCTAGAGGTGTTA 230 GCGGGATCCTCTAGAAGACCTC 231 ALA- AATAGCCTGGCAG CTGCGTGCAAAGC RRNH_EC_51 3_49 RNASEP_SA_ GAGGAAAGTCCATGCTCAC 232 ATAAGCCATGTTCTGTTCCATC 233 31_379 16S_EC_108 ATGTTGGGTTAAGTCCCGC 234 AAGGAGGTGATCCAGCC 235 2_1541 16S_EC_556_ CGGAATTACTGGGCGTAAAG 236 GTATCTAATCCTGTTTGCTCCC 237 795 16S_EC_108 ATGTTGGGTTAAGTCCCGC 238 TGACGTCATGCCCACCTTCC 239 2_1196_10G 16S_EC_108 ATGTTGGGTTAAGTCCCGC 240 TGACGTCATGGCCACCTTCC 241

2_1196_10G_ 11G TRNA_ILERR GCGGGATCCTCTAGACCTGATA 242 GCGGGATCCTCTAGAGCGTGAC 243 NH_ASPRRNH_ AGGGTGAGGTCG AGGCAGGTATTC EC_32_41 16S_EC_969_ ACGCGAAGAACCTTACC 244 GACGGGCGGTGTGTACAAG 245 1407 16S_EC_683_ GTGTAGCGGTGAAATGCG 246 CGAGTTGCAGACTGCGATCCG 247 1323 16S_EC_49_ TAACACATGCAAGTCGAACG 248 CGTACTCCCCAGGCG 249 894 16S_EC_49_ TAACACATGCAAGTCGAACG 250 ACGACACGAGCTGACGAC 251 1078 CYA_BA_134 ACAACGAAGTACAATACAAGAC 252 CTTCTACATTTTTAGCCATCAC 253 9_1447 16S_EC_109 TTAAGTCCCGCAACGAGCGCAA 254 TGACGTCATCCCCACCTTCCTC 255 0_1196_2 16S_EC_405_ TGAGTGATGAAGGCCTTAGGGTTGTAAA 256 CGGCTGCTGGCACGAAGTTAG 257 527 GROL_EC_49 ATGGACAAGGTTGGCAAGGAAGG 258 TAGCCGCGGTCGAATTGCAT 259 6_596 GROL_EC_51 AAGGAAGGCGTGATCACCGTTGAAGA 260 CCGCGGTCGAATTGCATGCCTTC 261 1_593 VALS_EC_18 ACGCGCTGCGCTTCAC 262 TTGCAGAAGTTGCGGTAGCC 263 35_1928 RPOB_EC_13 TCGACCACCTGGGCAACC 264 ATCAGGTCGTGCGGCATCA 265 34_1478 DNAK_EC_42 CACGGTGCCGGCGTACT 266 GCGGTCGGCTCGTTGATGAT 267 0_521 RPOB_EC_37 TTGGAGGTAAGTCTCATTTTGGTGG 268 AAGCTGCACCATAAGCTTGTAATGC 269 76_3853 RPOB_EC_38 CAGCGTTTCGGCGAAATGGA 270 CGACTTGACGGTTAACATTTCCTG 271 02_3885 RPOB_EC_37 GGGCAGCGTTTCGGCGAAATGGA 272 GTCCGACTTGACGGTCAACATTTCCTG 273 99_3888 RPOC_EC_21 CAGGAGTCGTTCAACTCGATCTACATGAT 274 ACGCCATCAGGCCACGCAT 275 46_2245 ASPS_EC_40 GCACAACCTGCGGCTGCG 276 ACGGCACGAGGTAGTCGC 277 5_538 RPOC_EC_13 CGCCGACTTCGACGGTGACC 278 GAGCATCAGCGTGCGTGCT 279 74_1455 TUFB_EC_95 CCACACGCCGTTCTTCAACAACT 280 GGCATCACCATTTCCTTGTCCTTCG 281 7_1058 16S_EC_7 GAGAGTTTGATCCTGGCTCAGAACGAA 282 TGTTACTCACCCGTCTGCCACT 283 22 VALS_EC_61 ACCGAGCAAGGAGACCAGC 284 TATAACGCACATCGTCAGGGTGA 285 0_727

For evaluation in the laboratory, five species of bacteria were selected including three .gamma.-proteobacteria (E. coli, K pneumoniae and P. auergiosa) and two low G+C gram positive bacteria (B. subtilitis and S. aureus). The identities of the organisms were not revealed to the laboratory technicians.

Bacteria were grown in culture, DNA was isolated and processed, and PCR performed using standard protocols. Following PCR, all samples were desalted, concentrated, and analyzed by Fourier Transform Ion Cyclotron Resonance (FTICR) mass spectrometry. Due to the extremely high precision of the FTICR, masses could be measured to within 1 Da and unambiguously deconvoluted to a single base composition. The measured base compositions were compared with the known base composition signatures in our database. As expected when using broad range survey 16S primers, several phylogenetic near-neighbor organisms were difficult to distinguish from our test organisms. Additional non-ribosomal primers were used to triangulate and further resolve these clusters.

An example of the use of primers directed to regions of RNA polymerase B (rpoB) is shown in FIG. 19. This gene has the potential to provide broad priming and resolving capabilities. A pair of primers directed against a conserved region of rpoB provided distinct base composition signatures that helped resolve the tight enterobacteriae cluster. Joint probability estimates of the signatures from each of the primers resulted in the identification of a single organism that matched the identity of the test sample. Therefore a combination of a small number of primers that amplify selected regions of the 16S ribosomal RNA gene and a few additional primers that amplify selected regions of protein encoding genes provide sufficient information to detect and identify all bacterial pathogens.

Example 16

Detection of Staphylococcus aureus in Blood Samples

Blood samples in an analysis plate were spiked with genomic DNA equivalent of 10.sup.3 organisms/ml of Staphylococcus aureus. A single set of 16S rRNA primers was used for amplification. Following PCR, all samples were desalted, concentrated, and analyzed by Fourier Transform Ion Cyclotron Resonance (FTICR) mass spectrometry. In each of the spiked wells, strong signals were detected which are consistent with the expected BCS of the S. aureus amplicon (FIG. 20). Furthermore, there was no robotic carryover or contamination in any of the blood only or water blank wells. Methods similar to this one will be applied for other clinically relevant samples including, but not limited to: urine and throat or nasal swabs.

Example 17

Detection and Serotyping of Viruses

The virus detection capability of the present invention was demonstrated in collaboration with Naval health officers using adenoviruses as an example.

All available genomic sequences for human adenoviruses available in public databases were surveyed. The hexon gene was identified as a candidate likely to have broad specificity across all serotypes. Four primer pairs were selected from a group of primers designed to yield broad coverage across the majority of the adenoviral strain types (Table 9) wherein Tp=5'propynylated uridine and Cp=5'propynylated cytidine.

TABLE-US-00011 TABLE 9 Intelligent Primer Pairs for Serotyping of Adenoviruses Forward Reverse Primer Pair Forward Primer SEQ ID Reverse Primer SEQ ID Name Sequence NO: Sequence NO: HEX_HAD7+4+2 AGACCCAATTACATTGGCTT 286 CCAGTGCTGTTGTAGTACAT 287 1_934_995 HEX_HAD7+4+2 ATGTACTACAACAGTACTGG 288 CAAGTCAACCACAGCATTCA 289 1_976_1050 HEX_HAD7+4+2 GGGCTTATGTACTACAACAG 290 TCTGTCTTGCAAGTCAACCAC 291 1_970_1059 HEX_HAD7+3_7 GGAATTTTTTGATGGTAGAGA 292 TAAAGCACAATTTCAGGCG 293 71_827 HEX_HAD4+16_ TAGATCTGGCTTTCTTTGAC 294 ATATGAGTATCTGGAGTCTGC 295 746_848 HEX_HAD7_509_ GGAAAGACATTACTGCAGACA 296 CCAACTTGAGGCTCTGGCTG 297 578 HEX_HAD4_121 ACAGACACTTACCAGGGTG 298 ACTGTGGTGTCATCTTTCTC 299 6_1289 HEX_HAD21_51 TCACTAAAGACAAAGGTCTTCC 300 GGCTTCGCCGTCTGTAATTTC 301 5_567 HEX_HAD_1342_ CGGATCCAAGCTAATCTTTGG 302 GGTATGTACTCATAGGTGTTGGTG 303 1469 HEX_HAD7+4+2 AGACpCpCAATTpACpATpTGGCTT 304 CpCpAGTGCTGTpTpGTAGTACAT 305 1_934_995P HEX_HAD7+4+2 ATpGTpACTpACAACAGTACpTpGG 306 CAAGTpCpAACCACAGCATpTpCA 307 1_976_1050P HEX_HAD7+4+2 GGGCpTpTATpGTpACTACAACpAG 308 TCTGTpCpTTGCAAGTpCpAACCAC 309 1_970_1059P HEX HAD7+3_7 GGAATTpTpTpTpTGATGGTAGAGA 310 TAAAGCACAATpTpTpCpAGGCG 311 71_827P HEX_HAD4+16_ TAGATCTGGCTpTpTpCpTTTGAC 312 ATATGAGTATpCpTpGGAGTpCpTGC 313 746_848P HEX_HAD_1342_ CGGATpCCAAGCpTAATCpTpTTGG 314 GGTATGTACTCATAGGTGTpTpGGTC 315- 1469P HEX_HAD7+21+ AACAGACCCAATTACATTGGCTT 316 CAGGCACTTGTATGTGGAAAGG 317 3_931_1645 HEX_HAD4+2_9 ATGCCTAACAGACCCAATTACAT 318 TTCATGTAGTCGTAGGTGTTGG 319 25_1469 HEX_HAD7+21+ CGCGCCTAATACATCTCAGTGGAT 320 AAGCCAATGTAATTGGGTCTGTT 321 3_384_953 HEX_HAD4+2_3 CTACTCTGGCACTGCCTACAAC 322 ATGTAATTGGGTCTGTTAGGCAT 323 45_947 HEX_HAD2_772_ CAATCCGTTCTGGTTCCGGATGAA 324 CTTGCCGGTCGTTCAAAGAGGTAG 325 865 HEX_HAD7+4+2 AGTCCGGGTCTGGTGCAG 326 CGGTCGGTGGTCACATC 327 1_73_179 HEX_HAD7+4+2 ATGGCCACCCCATCGATG 328 CTGTCCGGCGATGTGCATG 329 1_1_54 HEX_HAD7+4+2 GGTCGTTATGTGCCTTTCCACAT 330 TCCTTTCTGAAGTTCCACTCATAGG 331 1_1612_1718 HEX_HAD7+4+2 ACAACATTGGCTACCAGGGCTT 332 CCTGCCTGCTCATAGGCTGGAAGTT 333 1_2276_2368

These primers also served to clearly distinguish those strains responsible for most disease (types 3, 4, 7 and 21) from all others. DNA isolated from field samples known to contain adenoviruses were tested using the hexon gene PCR primers, which provided unambiguous strain identification for all samples. A single sample was found to contain a mixture of two viral DNAs belonging to strains 7 and 21.

Test results (FIG. 21) showed perfect concordance between predicted and observed base composition signatures for each of these samples. Classical serotyping results confirmed each of these observations. Processing of viral samples directly from collection material such as throat swabs rather than from isolated DNA, will result in a significant increase in throughput, eliminating the need for virus culture.

Example 18

Broad Rapid Detection and Strain Typing of Respiratory Pathogens for Epidemic Surveillance

Genome preparation. Genomic materials from culture samples or swabs were prepared using a modified robotic protocol using DNeasy.TM. 96 Tissue Kit, Qiagen). Cultures of Streptococcus pyogenes were pelleted and transferred to a 1.5 mL tube containing 0.45 g of 0.7 mm Zirconia beads (Biospec Products, Inc.). Cells were lysed by shaking for 10 minutes at a speed of 19 1/s using a MM300 Vibration Mill (Retsch, Germany). The samples were centrifuged for 5 min and the supernatants transferred to deep well blocks and processed using the manufacture's protocol and a Qiagen 8000 BioRobot.

PCR: PCR reactions were assembled using a Packard MPII liquid handling platform and were performed in 50 .mu.L volume using 1.8 units each of Platinum Taq (Invitrogen) and Hotstart PFU Turbo (Stratagene) polymerases. Cycling was performed on a DNA Engine Dyad (MJ Research) with cycling conditions consisting of an initial 2 min at 95.degree. C. followed by 45 cycles of 20 s at 95.degree. C., 15 s at 58.degree. C., and 15 s at 72.degree. C.

Broad-range primers: PCR primer design for base composition analysis from precise mass measurements is constrained by an upper limit where ionization and accurate deconvolution can be achieved. Currently, this limit is approximately 140 base pairs. Primers designed to broadly conserved regions of bacterial ribosomal RNAs (16 and 23S) and the gene encoding ribosomal protein L3 (rpoC) are shown in Table 10.

TABLE-US-00012 TABLE 10 Broad Range Primer Pairs Target SEQ ID Length of Gene Direction Primer NO Amplicon 16S_1 F GGATTAGAGACCCTGGTAGTCC 334 116 16S_1 R GGCCGTACTCCCCAGGCG 335 116 16S_2 F TTCGATGCAACGCGAAGAACCT 336 115 16S_2 R ACGAGCTGACGACAGCCATG 337 115 23S F TCTGTCCCTAGTACGAGAGGACCGG 338 118 23S R TGCTTAGATGCTTTCAGC 339 118 rpoC F CTGGCAGGTATGCGTGGTCTGATG 340 121 rpoC R CGCACCGTGGGTTGAGATGAAGTAC 341 121

Emm-typing primers: The allelic profile of a GAS strain by Multilocus Sequencing Technique (MLST) can be obtained by sequencing the internal fragments of seven housekeeping genes. The nucleotide sequences for each of these housekeeping genes, for 212 isolates of GAS (78 distinct emm types), are available (on the world wide web of the Internet at "mlst.net"). This corresponds to one hundred different allelic profiles or unique sequence types, referred to by Enright et al. as ST1-ST100(Enright, M. C., et al., Infection and Immunity 2001, 69, 2416-2427). For each sequence type, we created a virtual transcript by concatenating sequences appropriate to their allelic profile from each of the seven genes. MLST primers were designed using these sequences and were constrained to be within each gene loci. Twenty-four primer pairs were initially designed and tested against the sequenced GAS strain 700294. A final subset of six primer pairs Table 11 was chosen based on a theoretical calculation of minimal number of primer pairs that maximized resolution of between emm types.

TABLE-US-00013 TABLE 11 Drill-Down Primer Pairs Used in Determining emm-type Target SEQ ID Length of Gene Direction Primer NO Amplicon gki F GGGGATTCAGCCATCAAAGCAGCTATTGAC 342 116 gki R CCAACCTTTTCCACAACAGAATCAGC 343 116 gtr F CCTTACTTCGAACTATGAATCTTTTGGAAG 344 115 gtr R CCCATTTTTTCACGCATGCTGAAAATATC 345 115 murI F CGCAAAAAAATCCAGCTATTAGC 346 118 murI R AAACTATTTTTTTAGCTATACTCGAACAC 347 118 mutS F ATGATTACAATTCAAGAAGGTCGTCACGC 348 121 mutS R TTGGACCTGTAATCAGCTGAATACTGG 349 121 xpt F GATGACTTTTTAGCTAATGGTCAGGCAGC 350 122 xpt R AATCGACGACCATCTTGGAAAGATTTCTC 351 122 yqiL F GCTTCAGGAATCAATGATGGAGCAG 352 119 yqiL R GGGTCTACACCTGCACTTGCATAAC 353 119

Microbiology: GAS isolates were identified from swabs on the basis of colony morphology and beta-hemolysis on blood agar plates, gram stain characteristics, susceptibility to bacitracin, and positive latex agglutination reactivity with group A-specific antiserum.

Sequencing: Bacterial genomic DNA samples of all isolates were extracted from freshly grown GAS strains by using QIAamp DNA Blood Mini Kit (Qiagen, Valencia, Calif.) according to the procedures described by the manufacture. Group A streptococcal cells were subjected to PCR and sequence analysis using emm-gene specific PCR as previously described (Beall, B., et al. J. Clin. Micro., 1996, 34, 953-958; Facklam, R., et al. Emerg. Infect. Dis. 1999, 5, 247-253). Homology searches on DNA sequences were conducted against known emm sequences present in (on the world wide web of the Internet at "cdc.gov/ncidod/biotech/infotech_hp"). For MLST analysis, internal fragments of seven housekeeping genes, were amplified by PCR and analyzed as previously described (Enright, M. C., et al., Infection and Immunity 2001, 69, 2416-2427). The emm-type was determined from comparison to the MLST database.

Broad Range Survey/Drill-Down Process (100): For Streptococcus pyogenes, the objective was the identification of a signature of the virulent epidemic strain and determination of its emm-type. Emm-type information is useful both for treatment considerations and epidemic surveillance. A total of 51 throat swabs were taken both from healthy recruits and from hospitalized patients in December 2002, during the peak of a GAS outbreak at a military training camp. Twenty-seven additional isolates from previous infections ascribed to GAS were also examined. Initially, isolated colonies were examined both from throat culture samples and throat swabs directly without the culture step. The latter path can be completed within 6-12 hours providing information on a significant number of samples rapidly enough to be useful in managing an ongoing epidemic.

The process of broad range survey/drill-down (200) is shown in FIG. 22. A clinical sample such as a throat swab is first obtained from an individual (201). Broad range survey primers are used to obtain amplification products from the clinical sample (202) which are analyzed to determine a BCS (203) from which a species is identified (204). Drill-down primers are then employed to obtain PCR products (205) from which specific information is obtained about the species (such as Emm-type) (206).

Broad Range Survey Priming: Genomic regions targeted by the broad range survey primers were selected for their ability to allow amplification of virtually all known species of bacteria and for their capability to distinguish bacterial species from each other by base composition analysis. Initially, four broad-range PCR target sites were selected and the primers were synthesized and tested. The targets included universally conserved regions of 16S and 23S rRNA, and the gene encoding ribosomal protein L3 (rpoC).

While there was no special consideration of Streptococcus pyogenes in the selection of the broad range survey primers (which were optimized for distinguishing all important pathogens from each other), analysis of genomic sequences showed that the base compositions of these regions distinguished Streptococcus pyogenes from other respiratory pathogens and normal flora, including closely related species of streptococci, staphylococci, and bacilli (FIG. 23).

Drill Down Priming (Emm-Typing). In order to obtain strain-specific information about the epidemic, a strategy was designed to measure the base compositions of a set of fast clock target genes to generate strain-specific signatures and simultaneously correlate with emm-types. In classic MLST analysis, internal fragments of seven housekeeping genes (gki, gtr, muri, mutS, recP, xpt, yqiL) are amplified, sequenced and compared to a database of previously studied isolates whose emm-types have been determined (Homer, M. J.,et al. Fundamental and Applied Toxicology, 1997, 36, 147). Since the analysis enabled by the present embodiment of the present invention provides base composition data rather than sequence data, the challenge was to identify the target regions that provide the highest resolution of species and least ambiguous emm-classification. The data set from Table 2 of Enright et al. (Enright, M. C., et al. Infection and Immunity, 2001, 69, 2416-2427) to bioinformatically construct an alignment of concatenated alleles of the seven housekeeping genes from each of 212 previously emm-typed strains, of which 101 were unique sequences that represented 75 distinct emm-types. This alignment was then analyzed to determine the number and location of the optimal primer pairs that would maximize strain discrimination strictly on base composition data.

An example of assignment of BCSs of PCR products is shown in FIG. 24 where PCR products obtained using the gtr primer (a drill-down emm-typing primer) from two different swab samples were analyzed (sample 12--top and sample 10--bottom). The deconvoluted ESI-FCTIR spectra provide accurate mass measurements of both strands of the PCR products, from which a series of candidate BCSs were calculated from the measured mass (and within the measured mass uncertainty). The identification of complementary candidate BCSs from each strand provides a means for unambiguous assignment of the BCS of the PCR product. BCSs and molecular masses for each strand of the PCR product from the two different samples are also shown in FIG. 24. In this case, the determination of BCSs for the two samples resulted in the identification of the emm-type of Streptococcus pyogenes--sample 12 was identified as emm-type 3 and sample 10 was identified as emm-type 6.

The results of the composition analysis using the six primer pairs, 5'-emm gene sequencing and MLST gene sequencing method for the GAS epidemic at a military training facility are compared in FIG. 25. The base composition results for the six primer pairs showed a perfect concordance with 5'-emm gene sequencing and MLST sequencing methods. Of the 51 samples taken during the peak of the epidemic, all but three had identical compositions and corresponded to emm-type 3. The three outliers, all from healthy individuals, probably represent non-epidemic strains harbored by asymptomatic carriers. Samples 52-80, which were archived from previous infections from Marines at other naval training facilities, showed a much greater heterogeneity of composition signatures and emm-types.

Example 19

Base Composition Probability Clouds

FIG. 18 illustrates the concept of base composition probability clouds via a pseudo-four dimensional plot of base compositions of enterobacteria including Y. pestis, Y psuedotuberculosis, S. typhimurium, S. typhi, Y. enterocolitica, E. coli K12, and E. coli O157:H7. In the plot of FIG. 18, A, C and G compositions correspond to the x, y and z axes respectively whereas T compositions are represented by the size of the sphere at the junction of the x, y and z coordinates. There is no absolute requirement for having a particular nucleobase composition associated with a particular axis. For example, a plot could be designed wherein G, T and C compositions correspond to the x, y and z axes respectively whereas the A composition corresponds to the size of the sphere at the junction of the x, y and z coordinates. Furthermore, a different representation can be made of the "pseudo fourth" dimension i.e.: other than the size of the sphere at junction of the x, y and z coordinates. For example, a symbol having vector information such as an arrow or a cone can be rotated at an angle which varies proportionally with the composition of the nucleobase corresponding to the pseudo fourth dimension. The choice of axes and pseudo fourth dimensional representation is typically made with the aim of optimal visualization of the data being presented.

A similar base composition probability cloud analysis has been presented for a series of viruses in U.S. provisional patent application Serial No. 60/431,319, which is commonly owned and incorporated herein by reference in its entirety. In this base composition probability cloud analysis, the closely related Dengue virus types 1-4 are clearly distinguishable from each other. This example is indicative of a challenging scenario for species identification based on BCS analysis because RNA viruses have a high mutation rate, it would be expected to be difficult to resolve closely related species. However, as this example illustrates, BCS analysis, aided by base composition probability cloud analysis is capable of resolution of closely related viral species.

A base composition probability cloud can also be represented as a three dimensional plot instead of a pseudo-four dimensional plot. An example of such a three dimensional plot is a plot of G, A and C compositions correspond to the x, y and z axes respectively, while the composition of T is left out of the plot. Another such example is a plot where the compositions of all four nucleobases is included: G, A and C+T compositions correspond to the x, y and z axes respectively. As for the pseudo-four dimensional plots, the choice of axes for a three dimensional plot is typically made with the aim of optimal visualization of the data being presented.

Example 20

Biochemical Processing of Large Amplification Products for Analysis by Mass Spectrometry

In the example illustrated in FIG. 26, a primer pair which amplifies a 986 bp region of the 16S ribosomal gene in E. coli (K12) was digested with a mixture of 4 restriction enzymes: BstN1, BsmF1, Bfa1, and Nco1. FIG. 26(a) illustrates the complexity of the resulting ESI-FTICR mass spectrum which contains multiple charge states of multiple restriction fragments. Upon mass deconvolution to neutral mass, the spectrum is significantly simplified and discrete oligonucleotide pairs are evident (FIG. 26b). When base compositions are derived from the masses of the restriction fragments, perfect agreement is observed for the known sequence of nucleotides 1-856 (FIG. 26c); the batch of Nco1 enzyme used in this experiment was inactive and resulted in a missed cleavage site and a 197-mer fragment went undetected as it is outside the mass range of the mass spectrometer under the conditions employed. Interestingly however, both a forward and reverse strand were detected for each fragment measured (solid and dotted lines in, respectively) within 2 ppm of the predicted molecular weights resulting in unambiguous determination of the base composition of 788 nucleotides of the 985 nucleotides in the amplicon. The coverage map offers redundant coverage as both 5' to 3' and 3' to 5' fragments are detected for fragments covering the first 856 nucleotides of the amplicon.

This approach is in many ways analogous to those widely used in MS-based proteomics studies in which large intact proteins are digested with trypsin, or other proteolytic enzyme(s), and the identity of the protein is derived by comparing the measured masses of the tryptic peptides with theoretical digests. A unique feature of this approach is that the precise mass measurements of the complementary strands of each digest product allow one to derive a de novo base composition for each fragment, which can in turn be "stitched together" to derive a complete base composition for the larger amplicon. An important distinction between this approach and a gel-based restriction mapping strategy is that, in addition to determination of the length of each fragment, an unambiguous base composition of each restriction fragment is derived. Thus, a single base substitution within a fragment (which would not be resolved on a gel) is readily observed using this approach. Because this study was performed on a 7 Tesla ESI-FTICR mass spectrometer, better than 2 ppm mass measurement accuracy was obtained for all fragments. Interestingly, calculation of the mass measurement accuracy required to derive unambiguous base compositions from the complementary fragments indicates that the highest mass measurement accuracy actually required is only 15 ppm for the 139 bp fragment (nucleotides 525-663). Most of the fragments were in the 50-70 bp size-range which would require mass accuracy of only .about.50 ppm for unambiguous base composition determination. This level of performance is achievable on other more compact, less expensive MS platforms such as the ESI-TOF suggesting that the methods developed here could be widely deployed in a variety of diagnostic and human forensic arenas.

This example illustrates an alternative approach to derive base compositions from larger PCR products. Because the amplicons of interest cover many strain variants, for some of which complete sequences are not known, each amplicon can be digested under several different enzymatic conditions to ensure that a diagnostically informative region of the amplicon is not obscured by a "blind spot" which arises from a mutation in a restriction site. The extent of redundancy required to confidently map the base composition of amplicons from different markers, and determine which set of restriction enzymes should be employed and how they are most effectively used as mixtures can be determined. These parameters will be dictated by the extent to which the area of interest is conserved across the amplified region, the compatibility of the various restriction enzymes with respect to digestion protocol (buffer, temperature, time) and the degree of coverage required to discriminate one amplicon from another.

Example 21

Identification of Members of the Viral Genus Orthopoxvirus

Primer sites were identified on three essential viral genes --the DNA-dependent polymerase (DdDp), and two sub-units of DNA-dependent RNA polymerases A and B (DdRpA and DdRpB). These intelligent primers designed to identify members of the viral genus Orthopoxvirus are shown in Table 12 wherein Tp=5'propynylated uridine and Cp=5'propynylated cytidine.

TABLE-US-00014 TABLE 12 Intelligent Primer Pairs for Identification of members of the Viral Genus Orthopoxvirus Forward Reverse Primer Pair Forward Primer SEQ ID Reverse Primer SEQ ID Name Sequence NO: Sequence NO: A25L_NC00161 GTACTGAATCCGCCTAAG 354 GTGAATAAAGTATCGCCCTAATA 355 1_28_127 A18R_NC00161 GAAGTTGAACCGGGATCA 356 ATTATCGGTCGTTGTTAATGT 357 1_100_207 A18R_NC00161 CTGTCTGTAGATAAACTAGGATT 358 CGTTCTTCTCTGGAGGAT 359 1_1348_1445 E9L_NC001611_ CGATACTACGGACGC 360 CTTTATGAATTACTTTACATAT 361 1119_1222 K8R_NC001611_ CTCCTCCATCACTAGGAA 362 CTATAACATTCAAAGCTTATTG 363 221_311 A24R_NC00161 CGCGATAATAGATAGTGCTAAAC 364 GCTTCCACCAGGTCATTAA 365 1_795_878 A25L_NC00161 GTACpTpGAATpCpCpGCpCpTAAG 366 GTGAATAAAGTATpCpGCpCpCpTpAATA 3- 67 1_28_127P A18R_NC00161 GAAGTpTpGAACpCpGGGATCA 368 ATTATCGGTpCpGTpTpGTpTpAATGT 369 1_100_207P A18R_NC00161 CTGTpCpTpGTAGATAAACpTpAGGATT 370 CGTTCpTpTpCpTpCpTpGGAGGAT 37- 1 1_1348_1445P E9L_NC001611_ CGATACpTpACpGGACGC 372 CTTTATGAATpTpACpTpTpTpACATAT 373 1119_1222P K8R_NC001611_ CTpCpCpTCpCpATCACpTpAGGAA 374 CTATAACATpTpCpAAAGCpTpTpATTG 3- 75 221_311P A24R_NC00161 CGCGATpAATpAGATAGTpGCpTpAAAC 376 GCTTCpCpACpCAGGTpCATpTAA 377- 1_795_878P

As illustrated in FIG. 27, members of the Orthopoxvirus genus group can be identified, distinguished from one another, and distinguished from other members of the Poxvirus family using a single pair of primers designed against the DdRpB gene.

Since the primers were designed across regions of high conservation within this genus, the likelihood of missed detection due to sequence variations at these sites is minimized. Further, none of the primers is expected to amplify other viruses or any other DNA, based on the data available in GenBank. This method can be used for all families of viral threat agents and is not limited to members of the Orthopoxvirus genus.

Example 22

Identification of Viruses that Cause Viral Hemorrhagic Fevers

In accordance with the present invention an approach of broad PCR priming across several different viral species is employed using conserved regions in the various viral genomes, amplifying a small, yet highly informative region in these organisms, and then analyzing the resultant amplicons with mass spectrometry and data analysis. These regions will be tested with live agents, or with genomic constructs thereof.

Detection of RNA viruses will necessitate a reverse transcription (RT) step prior to the PCR amplification of the TIGER reporter amplicon. To maximize throughput and yield while minimizing the handling of the samples, commercial one-step reverse transcription polymerase chain reaction (RT-PCR) kits will be evaluated for use. If necessary, a one-step RT-PCR mix using our selected DNA polymerase for the PCR portion of the reaction will be developed. To assure there is no variation in our reagent performance all new lots of enzymes, nucleotides and buffers will be individually tested prior to use.

Various modifications of the invention, in addition to those described herein, will be apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. Each reference cited in the present application is incorporated herein by reference in its entirety

SEQUENCE LISTINGS

1

SEQUENCE LISTING <160> NUMBER OF SEQ ID NOS: 382 <210> SEQ ID NO 1 <211> LENGTH: 90 <212> TYPE: RNA <213> ORGANISM: Bacillus anthracis <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (20)..(20) <223> OTHER INFORMATION: N = A, U, G or C <400> SEQUENCE: 1 gcgaagaacc uuaccaggun uugacauccu cugacaaccc uagagauagg gcuucuccuu 60 cgggagcaga gugacaggug gugcaugguu 90 <210> SEQ ID NO 2 <211> LENGTH: 90 <212> TYPE: RNA <213> ORGANISM: Bacillus cereus <400> SEQUENCE: 2 gcgaagaacc uuaccagguc uugacauccu cugaaaaccc uagagauagg gcuucuccuu 60 cgggagcaga gugacaggug gugcaugguu 90 <210> SEQ ID NO 3 <211> LENGTH: 1542 <212> TYPE: RNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <221> NAME/KEY: misc_feature <223> OTHER INFORMATION: 16S rRNA consensus sequence <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1)..(7) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (19)..(19) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (28)..(30) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (43)..(45) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (48)..(48) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (50)..(50) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (52)..(52) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (66)..(66) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (69)..(100) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (103)..(103) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (107)..(108) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (121)..(122) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (124)..(124) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (126)..(129) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (131)..(132) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (134)..(134) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (137)..(145) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (148)..(148) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (150)..(150) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (152)..(158) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (163)..(169) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (177)..(178) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (181)..(194) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (199)..(226) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (229)..(237) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (239)..(242) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (245)..(245) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (248)..(248) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (250)..(250) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (257)..(258) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (264)..(264) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (268)..(269) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (276)..(276) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (278)..(280) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (283)..(286) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (291)..(291) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (293)..(294) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (303)..(304) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (306)..(307) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (309)..(309) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (316)..(316) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (320)..(320) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (328)..(328) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (333)..(333) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (337)..(337) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (359)..(360) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (366)..(366) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (369)..(371) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (378)..(379) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (381)..(381) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (384)..(385) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (390)..(392) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE:

<221> NAME/KEY: misc_feature <222> LOCATION: (396)..(396) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (398)..(399) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (407)..(409) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (412)..(412) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (415)..(415) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (418)..(419) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (421)..(423) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (425)..(425) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (427)..(427) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (433)..(435) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (438)..(438) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (440)..(446) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (449)..(449) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (452)..(479) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (484)..(485) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (488)..(494) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (496)..(497) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (501)..(503) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (508)..(508) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (513)..(513) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (538)..(538) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (542)..(543) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (546)..(546) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (553)..(555) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (560)..(560) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (562)..(562) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (564)..(564) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (576)..(576) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (578)..(580) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (582)..(582) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (586)..(586) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (589)..(596) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (599)..(603) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (606)..(606) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (610)..(616) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (620)..(620) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (624)..(633) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (635)..(641) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (644)..(650) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (653)..(653) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (657)..(662) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (665)..(665) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (668)..(673) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (679)..(682) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (689)..(689) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (694)..(694) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (698)..(698) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (701)..(701) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (705)..(705) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (708)..(709) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (711)..(711) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (713)..(713) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (717)..(717) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (721)..(722) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (724)..(724) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (733)..(738) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (743)..(748) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (755)..(755) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (758)..(758) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (760)..(763) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (771)..(771) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (776)..(776) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (780)..(780) <223> OTHER INFORMATION: N= A, U, G or C

<220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (808)..(808) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (811)..(812) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (819)..(819) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (822)..(826) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (828)..(831) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (833)..(835) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (837)..(859) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (861)..(863) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (868)..(870) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (874)..(878) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (895)..(896) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (903)..(904) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (906)..(906) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (916)..(916) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (929)..(929) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (932)..(932) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (941)..(941) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (943)..(943) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (948)..(948) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (955)..(955) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (965)..(965) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (967)..(968) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (974)..(974) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (976)..(976) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (986)..(990) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (998)..(1012) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1015)..(1015) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1017)..(1043) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1051)..(1051) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1059)..(1059) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1075)..(1076) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1082)..(1082) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1100)..(1100) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1115)..(1123) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1127)..(1127) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1129)..(1129) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1131)..(1131) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1133)..(1141) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1143)..(1143) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1145)..(1145) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1150)..(1156) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1163)..(1165) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1167)..(1168) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1171)..(1173) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1183)..(1183) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1189)..(1189) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1198)..(1198) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1201)..(1201) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1207)..(1207) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1214)..(1214) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1216)..(1219) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1225)..(1225) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1231)..(1231) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1233)..(1233) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1243)..(1247) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1251)..(1252) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1254)..(1254) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1256)..(1257) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1260)..(1260) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1262)..(1265) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1267)..(1268) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1270)..(1274) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1278)..(1278)

<223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1281)..(1281) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1283)..(1286) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1290)..(1294) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1297)..(1298) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1302)..(1302) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1308)..(1308) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1310)..(1313) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1324)..(1327) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1329)..(1329) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1335)..(1336) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1340)..(1340) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1354)..(1356) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1362)..(1362) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1364)..(1364) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1366)..(1368) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1383)..(1383) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1388)..(1388) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1409)..(1411) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1414)..(1414) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1416)..(1417) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1420)..(1428) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1431)..(1432) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1436)..(1447) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1449)..(1454) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1456)..(1465) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1467)..(1467) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1469)..(1469) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1472)..(1481) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1484)..(1484) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1489)..(1491) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1508)..(1508) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1511)..(1511) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1514)..(1516) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1520)..(1521) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1524)..(1524) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1527)..(1527) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1542)..(1542) <223> OTHER INFORMATION: N= A, U, G or C <400> SEQUENCE: 3 nnnnnnnaga guuugaucnu ggcucagnnn gaacgcuggc ggnnngcnun anacaugcaa 60 gucgancgnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn agnggcnnac gggugaguaa 120 nncnunnnna nnunccnnnn nnnnnggnan annnnnnnga aannnnnnnu aauaccnnau 180 nnnnnnnnnn nnnnaaagnn nnnnnnnnnn nnnnnnnnnn nnnnnngann nnnnnnngnn 240 nnaunagnun guuggunngg uaanggcnna ccaagncnnn gannnnuagc ngnncugaga 300 ggnngnncng ccacanuggn acugaganac ggnccanacu ccuacgggag gcagcagunn 360 ggaaunuunn ncaauggnng naanncugan nnagcnannc cgcgugnnng anganggnnu 420 nnngnungua aannncunun nnnnnngang annnnnnnnn nnnnnnnnnn nnnnnnnnnu 480 gacnnuannn nnnnannaag nnncggcnaa cuncgugcca gcagccgcgg uaauacgnag 540 gnngcnagcg uunnncggan unanugggcg uaaagngnnn gnaggnggnn nnnnnngunn 600 nnngunaaan nnnnnngcun aacnnnnnnn nnncnnnnnn nacnnnnnnn cungagnnnn 660 nnagnggnnn nnngaauunn nnguguagng gugnaauncg naganaunng nangaanacc 720 nnungcgaag gcnnnnnncu ggnnnnnnac ugacncunan nnncgaaagc nugggnagcn 780 aacaggauua gauacccugg uaguccangc nnuaaacgnu gnnnnnunnn ngnnngnnnn 840 nnnnnnnnnn nnnnnnnnna nnnaacgnnn uaannnnncc gccuggggag uacgnncgca 900 agnnunaaac ucaaangaau ugacggggnc cngcacaagc ngnggagnau guggnuuaau 960 ucgangnnac gcgnanaacc uuaccnnnnn uugacaunnn nnnnnnnnnn nnganannnn 1020 nnnnnnnnnn nnnnnnnnnn nnnacaggug nugcauggnu gucgucagcu cgugnnguga 1080 gnuguugggu uaagucccgn aacgagcgca acccnnnnnn nnnguuncna ncnnnnnnnn 1140 ngngnacucn nnnnnnacug ccnnngnnaa nnnggaggaa ggnggggang acgucaanuc 1200 nucaugnccc uuangnnnng ggcuncacac nuncuacaau ggnnnnnaca nngngnngcn 1260 annnngnnan nnnnagcnaa ncnnnnaaan nnnnucnnag uncggaungn nnncugcaac 1320 ucgnnnncnu gaagnnggan ucgcuaguaa ucgnnnauca gnangnnncg gugaauacgu 1380 ucncgggncu uguacacacc gcccgucann ncangnnagn nnnnnnnncc nnaagnnnnn 1440 nnnnnnncnn nnnngnnnnn nnnnncnang gnnnnnnnnn nganugggnn naagucguaa 1500 caagguancc nuannngaan nugnggnugg aucaccuccu un 1542 <210> SEQ ID NO 4 <211> LENGTH: 2904 <212> TYPE: RNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <221> NAME/KEY: misc_feature <223> OTHER INFORMATION: 23S rRNA consensus sequence <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1)..(4) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (8)..(12) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (16)..(16) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (18)..(22) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (34)..(34) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (38)..(43) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (46)..(46) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (50)..(50) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (57)..(57) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (59)..(65)

<223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (67)..(68) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (70)..(72) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (74)..(75) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (77)..(79) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (82)..(83) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (86)..(87) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (89)..(96) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (98)..(102) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (104)..(104) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (107)..(109) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (111)..(111) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (113)..(113) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (125)..(125) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (131)..(148) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (150)..(177) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (179)..(181) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (184)..(188) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (192)..(192) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (203)..(203) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (208)..(212) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (218)..(218) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (224)..(225) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (228)..(231) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (236)..(236) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (238)..(241) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (246)..(246) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (257)..(259) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (261)..(261) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (263)..(264) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (267)..(267) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (269)..(293) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (295)..(297) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (301)..(305) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (309)..(309) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (313)..(321) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (323)..(325) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (329)..(329) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (331)..(331) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (333)..(334) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (337)..(337) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (341)..(344) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (348)..(370) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (375)..(377) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (379)..(382) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (384)..(384) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (387)..(387) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (389)..(390) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (392)..(395) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (398)..(399) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (403)..(405) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (407)..(410) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (416)..(421) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (425)..(425) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (435)..(441) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (446)..(446) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (451)..(451) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (453)..(453) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (455)..(456) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (462)..(462) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (467)..(467) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (475)..(475) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (482)..(482) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature

<222> LOCATION: (487)..(491) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (493)..(493) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (504)..(504) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (507)..(508) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (518)..(522) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (524)..(524) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (527)..(527) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (530)..(532) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (535)..(537) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (540)..(553) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (557)..(558) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (563)..(563) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (571)..(571) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (573)..(574) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (578)..(580) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (582)..(582) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (584)..(584) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (587)..(587) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (590)..(593) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (595)..(599) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (602)..(602) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (605)..(605) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (610)..(618) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (620)..(620) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (623)..(623) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (626)..(626) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (629)..(629) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (634)..(634) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (640)..(642) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (645)..(646) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (648)..(648) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (652)..(654) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (658)..(662) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (664)..(667) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (672)..(672) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (677)..(677) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (679)..(681) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (686)..(686) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (690)..(692) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (696)..(697) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (702)..(702) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (708)..(712) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (717)..(717) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (719)..(723) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (730)..(730) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (737)..(744) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (753)..(758) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (765)..(766) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (771)..(772) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (774)..(774) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (776)..(776) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (779)..(779) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (784)..(785) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (787)..(787) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (790)..(790) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (792)..(792) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (796)..(798) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (800)..(801) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (815)..(816) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (822)..(825) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (832)..(835) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (838)..(838) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (840)..(854) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE:

<221> NAME/KEY: misc_feature <222> LOCATION: (857)..(857) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (870)..(879) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (882)..(894) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (898)..(899) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (901)..(908) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (914)..(914) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (920)..(920) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (923)..(938) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (940)..(940) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (943)..(944) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (946)..(947) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (949)..(951) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (953)..(953) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (955)..(955) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (957)..(957) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (961)..(962) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (964)..(964) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (966)..(968) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (971)..(972) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (974)..(974) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (979)..(979) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (984)..(984) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (991)..(991) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (993)..(994) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (996)..(998) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1004)..(1004) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1008)..(1008) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1011)..(1018) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1026)..(1026) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1030)..(1030) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1033)..(1033) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1037)..(1042) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1044)..(1045) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1047)..(1047) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1051)..(1053) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1058)..(1058) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1078)..(1078) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1080)..(1080) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1083)..(1083) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1089)..(1090) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1097)..(1097) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1106)..(1107) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1110)..(1110) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1113)..(1119) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1124)..(1124) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1127)..(1128) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1131)..(1131) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1134)..(1134) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1139)..(1139) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1144)..(1151) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1157)..(1162) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1164)..(1185) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1191)..(1192) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1199)..(1211) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1216)..(1222) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1224)..(1225) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1227)..(1233) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1238)..(1246) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1251)..(1251) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1253)..(1253) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1257)..(1258) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1260)..(1261) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1264)..(1264) <223> OTHER INFORMATION: N= A, U, G or C

<220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1269)..(1269) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1273)..(1280) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1285)..(1285) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1287)..(1288) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1290)..(1294) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1296)..(1296) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1300)..(1300) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1302)..(1304) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1306)..(1306) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1311)..(1311) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1316)..(1321) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1323)..(1323) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1325)..(1325) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1327)..(1328) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1331)..(1336) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1341)..(1341) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1347)..(1349) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1356)..(1357) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1361)..(1361) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1363)..(1363) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1366)..(1366) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1368)..(1368) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1370)..(1371) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1375)..(1376) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1382)..(1383) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1385)..(1387) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1391)..(1392) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1400)..(1402) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1405)..(1425) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1430)..(1435) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1437)..(1454) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1457)..(1564) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1566)..(1567) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1573)..(1599) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1606)..(1607) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1622)..(1622) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1624)..(1627) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1629)..(1630) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1634)..(1634) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1636)..(1637) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1639)..(1640) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1644)..(1644) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1646)..(1648) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1650)..(1653) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1656)..(1663) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1672)..(1673) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1679)..(1679) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1681)..(1684) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1690)..(1690) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1697)..(1697) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1699)..(1699) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1704)..(1707) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1709)..(1749) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1751)..(1754) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1756)..(1758) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1760)..(1762) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1764)..(1770) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1772)..(1772) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1781)..(1782) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1793)..(1794) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1796)..(1797) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1801)..(1801) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1804)..(1805)

<223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1808)..(1808) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1812)..(1813) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1816)..(1816) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1822)..(1822) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1825)..(1826) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1831)..(1831) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1839)..(1839) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1844)..(1845) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1855)..(1856) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1858)..(1866) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1868)..(1872) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1874)..(1884) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1886)..(1888) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1895)..(1896) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1899)..(1899) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1908)..(1909) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1921)..(1922) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1963)..(1963) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1971)..(1971) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1974)..(1974) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1976)..(1976) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1979)..(1979) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1982)..(1989) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (1997)..(2005) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2007)..(2007) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2009)..(2009) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2011)..(2011) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2015)..(2015) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2018)..(2019) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2021)..(2021) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2023)..(2026) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2029)..(2029) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2037)..(2040) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2042)..(2042) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2044)..(2044) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2048)..(2052) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2067)..(2068) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2070)..(2070) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2072)..(2072) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2080)..(2081) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2083)..(2085) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2087)..(2089) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2091)..(2091) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2094)..(2108) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2112)..(2113) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2116)..(2116) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2123)..(2123) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2128)..(2128) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2130)..(2132) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2135)..(2142) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2145)..(2146) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2149)..(2155) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2160)..(2160) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2162)..(2166) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2169)..(2170) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2175)..(2175) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2178)..(2178) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2181)..(2194) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2201)..(2211) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2213)..(2213) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2215)..(2223) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2228)..(2228) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature

<222> LOCATION: (2231)..(2233) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2235)..(2236) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2240)..(2240) <223> OTHER INFORMATION: = A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2246)..(2246) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2258)..(2259) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2265)..(2265) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2269)..(2270) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2281)..(2281) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2283)..(2284) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2286)..(2286) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2292)..(2294) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2297)..(2297) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2299)..(2302) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2305)..(2306) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2309)..(2310) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2314)..(2321) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2325)..(2326) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2329)..(2330) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2332)..(2332) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2334)..(2334) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2338)..(2340) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2343)..(2343) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2345)..(2345) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2350)..(2351) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2354)..(2357) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2360)..(2363) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2371)..(2373) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2380)..(2381) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2384)..(2386) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2398)..(2398) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2402)..(2407) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2414)..(2414) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2418)..(2418) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2437)..(2437) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2441)..(2441) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2443)..(2443) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2458)..(2458) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2461)..(2464) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2474)..(2474) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2477)..(2477) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2486)..(2489) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2513)..(2513) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2516)..(2516) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2530)..(2530) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2533)..(2534) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2547)..(2548) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2560)..(2561) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2568)..(2568) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2571)..(2571) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2575)..(2575) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2586)..(2586) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2588)..(2588) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2606)..(2606) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2617)..(2617) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2619)..(2620) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2622)..(2622) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2624)..(2624) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2626)..(2626) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2628)..(2630) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2633)..(2635) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2640)..(2642) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2644)..(2646) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2649)..(2650) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE:

<221> NAME/KEY: misc_feature <222> LOCATION: (2652)..(2652) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2670)..(2674) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2677)..(2678) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2680)..(2680) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2682)..(2682) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2689)..(2691) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2693)..(2693) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2699)..(2701) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2706)..(2708) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2712)..(2713) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2716)..(2716) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2718)..(2719) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2726)..(2727) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2729)..(2730) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2733)..(2736) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2742)..(2743) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2750)..(2750) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2760)..(2762) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2766)..(2766) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2768)..(2770) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2772)..(2775) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2779)..(2780) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2783)..(2785) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2788)..(2788) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2790)..(2809) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2812)..(2814) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2816)..(2820) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2824)..(2825) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2827)..(2830) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2833)..(2833) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2840)..(2842) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2844)..(2846) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2849)..(2849) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2853)..(2856) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2858)..(2859) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2861)..(2864) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2866)..(2867) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2870)..(2872) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2875)..(2877) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2885)..(2888) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2890)..(2895) <223> OTHER INFORMATION: N= A, U, G or C <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: (2899)..(2904) <223> OTHER INFORMATION: N= A, U, G or C <400> SEQUENCE: 4 nnnnaagnnn nnaagngnnn nngguggaug ccunggcnnn nnnagncgan gaaggangnn 60 nnnnncnncn nnanncnnng gnnagnngnn nnnnnncnnn nnanccnnng nunuccgaau 120 ggggnaaccc nnnnnnnnnn nnnnnnnnan nnnnnnnnnn nnnnnnnnnn nnnnnnngnn 180 nacnnnnnga anugaaacau cunaguannn nnaggaanag aaannaannn ngauuncnnn 240 nguagnggcg agcgaannng nannagncnn nnnnnnnnnn nnnnnnnnnn nnnannngaa 300 nnnnnuggna agnnnnnnnn nannngguna nannccngua nnnnaaannn nnnnnnnnnn 360 nnnnnnnnnn aguannncnn nncncgngnn annnngunng aannngnnnn gaccannnnn 420 naagncuaaa uacunnnnnn ngaccnauag ngnannagua cngugangga aaggngaaaa 480 gnacccnnnn nangggagug aaanagnncc ugaaaccnnn nncnuanaan nngunnnagn 540 nnnnnnnnnn nnnuganngc gunccuuuug nannaugnnn cngnganuun nnnunnnnng 600 cnagnuuaan nnnnnnnngn agncgnagng aaancgagun nnaanngngc gnnnagunnn 660 nngnnnnaga cncgaancnn ngugancuan nnaugnncag gnugaagnnn nnguaanann 720 nnnuggaggn ccgaacnnnn nnnnguugaa aannnnnngg augannugug nnungnggng 780 aaanncnaan cnaacnnngn nauagcuggu ucucnncgaa annnnuuuag gnnnngcnun 840 nnnnnnnnnn nnnnggnggu agagcacugn nnnnnnnnng gnnnnnnnnn nnnnuacnna 900 nnnnnnnnaa acuncgaaun ccnnnnnnnn nnnnnnnngn agnnanncnn ngngngnuaa 960 nnuncnnngu nnanagggna acancccaga ncnncnnnua aggncccnaa nnnnnnnnua 1020 aguggnaaan gangugnnnn nncnnanaca nnnaggangu uggcuuagaa gcagccancn 1080 uunaaagann gcguaanagc ucacunnucn agnnnnnnng cgcngannau nuancgggnc 1140 uaannnnnnn nccgaannnn nngnnnnnnn nnnnnnnnnn nnnnngguag nngagcgunn 1200 nnnnnnnnnn ngaagnnnnn nngnnannnn nnnuggannn nnnnnnagug ngnaugnngn 1260 naunaguanc gannnnnnnn gugananncn nnnncnccgn annncnaagg nuuccnnnnn 1320 nangnunnuc nnnnnngggu nagucgnnnc cuaagnngag ncnganangn nuagnngaug 1380 gnnannnggu nnauauuccn nnacnnnnnn nnnnnnnnnn nnnnngacgn nnnnngnnnn 1440 nnnnnnnnnn nnnnggnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1500 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1560 nnnncnngaa aannnnnnnn nnnnnnnnnn nnnnnnnnnc guaccnnaaa ccgacacagg 1620 ungnnnngnn gagnanncnn aggngnnngn nnnaannnnn nnnaaggaac unngcaaanu 1680 nnnnccguan cuucggnana aggnnnncnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1740 nnnnnnnnng nnnnannnan nngnnnnnnn cnacuguuua nnaaaaacac agnncnnugc 1800 naanncgnaa gnnganguau anggnnugac nccugcccng ugcnngaagg uuaanngnnn 1860 nnnnnngnnn nngnnnnnnn nnnnannnaa gcccnnguna acggcggnng uaacuauaac 1920 nnuccuaagg uagcgaaauu ccuugucggg uaaguuccga ccngcacgaa nggngnaang 1980 annnnnnnnc ugucucnnnn nnnnncncng ngaanuunna nunnnnguna agaugcnnnn 2040 uncncgcnnn nngacggaaa gaccccnngn ancuuuacun nannnunnna nugnnnnnnn 2100 nnnnnnnnug unnagnauag gunggagncn nngannnnnn nncgnnagnn nnnnnggagn 2160 cnnnnnugnn auacnacncu nnnnnnnnnn nnnnucuaac nnnnnnnnnn nancnnnnnn 2220 nnngacanug nnngnngggn aguuunacug gggcggunnc cuccnaaann guaacggagg 2280 ngnncnaagg unnncunann nnggnnggnn aucnnnnnnn nagunnaann gnanaagnnn 2340 gcnunacugn nagnnnnacn nnncgagcag nnncgaaagn nggnnnuagu gauccggngg 2400 unnnnnnugg aagngccnuc gcucaacgga uaaaagnuac ncnggggaua acaggcunau 2460

nnnncccaag aguncanauc gacggnnnng uuuggcaccu cgaugucggc ucnucncauc 2520 cuggggcugn agnngguccc aagggunngg cuguucgccn nuuaaagngg nacgngagcu 2580 ggguunanaa cgucgugaga caguungguc ccuaucngnn gngngngnnn gannnuugan 2640 nngnnnugnn cnuaguacga gaggaccggn nngnacnnan cncuggugnn ncnguugunn 2700 ngccannngc anngcngnnu agcuannunn ggnnnngaua anngcugaan gcaucuaagn 2760 nngaancnnn cnnnnagann agnnnucncn nnnnnnnnnn nnnnnnnnna gnnncnnnnn 2820 agannannnn gungauaggn nngnnnugna agnnnngnna nnnnunnagn nnacnnnuac 2880 uaaunnnncn nnnnncuunn nnnn 2904 <210> SEQ ID NO 5 <211> LENGTH: 13 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <221> NAME/KEY: misc_feature <223> OTHER INFORMATION: Primer <400> SEQUENCE: 5 cgtggtgacc ctt 13 <210> SEQ ID NO 6 <211> LENGTH: 14 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <221> NAME/KEY: misc_feature <223> OTHER INFORMATION: Primer <400> SEQUENCE: 6 cgtcgtcacc gcta 14 <210> SEQ ID NO 7 <211> LENGTH: 13 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <221> NAME/KEY: misc_feature <223> OTHER INFORMATION: Primer <400> SEQUENCE: 7 cgtggtaccc ctt 13 <210> SEQ ID NO 8 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 8 gtgagatgtt gggttaagtc ccgtaacgag 30 <210> SEQ ID NO 9 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 9 gacgtcatcc ccaccttcct c 21 <210> SEQ ID NO 10 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 10 atgttgggtt aagtcccgca acgag 25 <210> SEQ ID NO 11 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 11 ttgacgtcat ccccaccttc ctc 23 <210> SEQ ID NO 12 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 12 ttaagtcccg caacgatcgc aa 22 <210> SEQ ID NO 13 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 13 tgacgtcatc cccaccttcc tc 22 <210> SEQ ID NO 14 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 14 gctacacacg tgctacaatg 20 <210> SEQ ID NO 15 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 15 cgagttgcag actgcgatcc g 21 <210> SEQ ID NO 16 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 16 aagtcggaat cgctagtaat cg 22 <210> SEQ ID NO 17 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 17 gacgggcggt gtgtacaag 19 <210> SEQ ID NO 18 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 18 tgaacgctgg tggcatgctt aacac 25 <210> SEQ ID NO 19 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 19 tacgcattac tcacccgtcc gc 22 <210> SEQ ID NO 20 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 20 gtggcatgcc taatacatgc aagtcg 26 <210> SEQ ID NO 21 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 21 ttactcaccc gtccgccgct 20 <210> SEQ ID NO 22 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 22 taacacatgc aagtcgaacg 20 <210> SEQ ID NO 23 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 23 ttactcaccc gtccgcc 17 <210> SEQ ID NO 24 <211> LENGTH: 18

<212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 24 gtgtagcggt gaaatgcg 18 <210> SEQ ID NO 25 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 25 gtatctaatc ctgtttgctc cc 22 <210> SEQ ID NO 26 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 26 agaacaccga tggcgaaggc 20 <210> SEQ ID NO 27 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 27 cgtggactac cagggtatct a 21 <210> SEQ ID NO 28 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 28 ggattagaga ccctggtagt cc 22 <210> SEQ ID NO 29 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 29 ggccgtactc cccaggcg 18 <210> SEQ ID NO 30 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 30 ggattagata ccctggtagt ccacgc 26 <210> SEQ ID NO 31 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 31 ggccgtactc cccaggcg 18 <210> SEQ ID NO 32 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 32 tagataccct ggtagtccac gc 22 <210> SEQ ID NO 33 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 33 cgtactcccc aggcg 15 <210> SEQ ID NO 34 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 34 ttcgatgcaa cgcgaagaac ct 22 <210> SEQ ID NO 35 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 35 acgagctgac gacagccatg 20 <210> SEQ ID NO 36 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 36 acgcgaagaa ccttacc 17 <210> SEQ ID NO 37 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 37 acgacacgag ctgacgac 18 <210> SEQ ID NO 38 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 38 ctgacacctg cccggtgc 18 <210> SEQ ID NO 39 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 39 gaccgttata gttacggcc 19 <210> SEQ ID NO 40 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 40 tctgtcccta gtacgagagg accgg 25 <210> SEQ ID NO 41 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 41 tgcttagatg ctttcagc 18 <210> SEQ ID NO 42 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 42 ctgtccctag tacgagagga ccgg 24 <210> SEQ ID NO 43 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 43 gtttcatgct tagatgcttt cagc 24 <210> SEQ ID NO 44 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 44 ggggagtgaa agagatcctg aaaccg 26 <210> SEQ ID NO 45

<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 45 acaaaaggta cgccgtcacc c 21 <210> SEQ ID NO 46 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 46 ggggagtgaa agagatcctg aaaccg 26 <210> SEQ ID NO 47 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 47 acaaaaggca cgccatcacc c 21 <210> SEQ ID NO 48 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 48 cgagagggaa acaacccaga cc 22 <210> SEQ ID NO 49 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 49 tggctgcttc taagccaac 19 <210> SEQ ID NO 50 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 50 tgctcgtggt gcacaagtaa cggatatta 29 <210> SEQ ID NO 51 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 51 tgctgctttc gcatggttaa ttgcttcaa 29 <210> SEQ ID NO 52 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 52 caaaacttat taggtaagcg tgttgact 28 <210> SEQ ID NO 53 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 53 tcaagcgcca tttcttttgg taaaccacat 30 <210> SEQ ID NO 54 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 54 caaaacttat taggtaagcg tgttgact 28 <210> SEQ ID NO 55 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 55 tcaagcgcca tctctttcgg taatccacat 30 <210> SEQ ID NO 56 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 56 taagaagccg gaaaccatca actaccg 27 <210> SEQ ID NO 57 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 57 ggcgcttgta cttaccgcac 20 <210> SEQ ID NO 58 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 58 tgattctggt gcccgtggt 19 <210> SEQ ID NO 59 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 59 ttggccatca ggccacgcat ac 22 <210> SEQ ID NO 60 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 60 tgattccggt gcccgtggt 19 <210> SEQ ID NO 61 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 61 ttggccatca gaccacgcat ac 22 <210> SEQ ID NO 62 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 62 ctggcaggta tgcgtggtct gatg 24 <210> SEQ ID NO 63 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 63 cgcaccgtgg gttgagatga agtac 25 <210> SEQ ID NO 64 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 64 cttgctggta tgcgtggtct gatg 24 <210> SEQ ID NO 65 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 65 cgcaccatgc gtagagatga agtac 25

<210> SEQ ID NO 66 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 66 cgtcgggtga ttaaccgtaa caaccg 26 <210> SEQ ID NO 67 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 67 gtttttcgtt gcgtacgatg atgtc 25 <210> SEQ ID NO 68 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 68 cgtcgtgtaa ttaaccgtaa caaccg 26 <210> SEQ ID NO 69 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 69 acgtttttcg ttttgaacga taatgct 27 <210> SEQ ID NO 70 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 70 caaaggtaag caaggtcgtt tccgtca 27 <210> SEQ ID NO 71 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 71 cgaacggcct gagtagtcaa cacg 24 <210> SEQ ID NO 72 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 72 caaaggtaag caaggacgtt tccgtca 27 <210> SEQ ID NO 73 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 73 cgaacggcca gagtagtcaa cacg 24 <210> SEQ ID NO 74 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 74 tagactgccc aggacacgct g 21 <210> SEQ ID NO 75 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 75 gccgtccatc tgagcagcac c 21 <210> SEQ ID NO 76 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 76 ttgactgccc aggtcacgct g 21 <210> SEQ ID NO 77 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 77 gccgtccatt tgagcagcac c 21 <210> SEQ ID NO 78 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 78 aactaccgtc cgcagttcta cttcc 25 <210> SEQ ID NO 79 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 79 gttgtcgcca ggcataacca tttc 24 <210> SEQ ID NO 80 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 80 aactaccgtc ctcagttcta cttcc 25 <210> SEQ ID NO 81 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 81 gttgtcacca ggcattacca tttc 24 <210> SEQ ID NO 82 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 82 ccacagttct acttccgtac tactgacg 28 <210> SEQ ID NO 83 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 83 tccaggcatt accatttcta ctccttctgg 30 <210> SEQ ID NO 84 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 84 gacctacagt aagaggttct gtaatgaacc 30 <210> SEQ ID NO 85 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 85 tccaagtgct ggtttacccc atgg 24 <210> SEQ ID NO 86 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 86 catccacacg gtggtggtga agg 23

<210> SEQ ID NO 87 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 87 gtgctggttt accccatgga gt 22 <210> SEQ ID NO 88 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 88 cgtgttgact attcggggcg ttcag 25 <210> SEQ ID NO 89 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 89 attcaagagc catttctttt ggtaaaccac 30 <210> SEQ ID NO 90 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 90 tcaacaacct cttggaggta aagctcagt 29 <210> SEQ ID NO 91 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 91 tttcttgaag agtatgagct gctccgtaag 30 <210> SEQ ID NO 92 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 92 catccacacg gtggtggtga agg 23 <210> SEQ ID NO 93 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 93 tgttttgtat ccaagtgctg gtttacccc 29 <210> SEQ ID NO 94 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 94 cgtggcggcg tggttatcga 20 <210> SEQ ID NO 95 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 95 cggtacgaac tggatgtcgc cgtt 24 <210> SEQ ID NO 96 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 96 tatcgctcag gcgaactcca ac 22 <210> SEQ ID NO 97 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 97 gctggattcg cctttgctac g 21 <210> SEQ ID NO 98 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 98 tgtaatgaac cctaatgacc atccacacgg 30 <210> SEQ ID NO 99 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 99 ccaagtgctg gtttacccca tggagta 27 <210> SEQ ID NO 100 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 100 taatgaaccc taatgaccat ccacacggtg 30 <210> SEQ ID NO 101 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 101 tccaagtgct ggtttacccc atggag 26 <210> SEQ ID NO 102 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 102 cttggaggta agtctcattt tggtgggca 29 <210> SEQ ID NO 103 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 103 cgtataagct gcaccataag cttgtaatgc 30 <210> SEQ ID NO 104 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 104 cgacgcgctg cgcttcac 18 <210> SEQ ID NO 105 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 105 gcgttccaca gcttgttgca gaag 24 <210> SEQ ID NO 106 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 106 gaccacctcg gcaaccgt 18 <210> SEQ ID NO 107 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 107 ttcgctctcg gcctggcc 18

<210> SEQ ID NO 108 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 108 gcactatgca cacgtagatt gtcctgg 27 <210> SEQ ID NO 109 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 109 tatagcacca tccatctgag cggcac 26 <210> SEQ ID NO 110 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 110 cggcgtactt caacgacagc ca 22 <210> SEQ ID NO 111 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 111 cgcggtcggc tcgttgatga 20 <210> SEQ ID NO 112 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 112 cttctgcaac aagctgtgga acgc 24 <210> SEQ ID NO 113 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 113 tcgcagttca tcagcacgaa gcg 23 <210> SEQ ID NO 114 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 114 aagacgacct gcacgggc 18 <210> SEQ ID NO 115 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 115 gcgctccacg tcttcacgc 19 <210> SEQ ID NO 116 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 116 ctgttcttag tacgagagga cc 22 <210> SEQ ID NO 117 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 117 ttcgtgctta gatgctttca g 21 <210> SEQ ID NO 118 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 118 acgcgaagaa ccttacc 17 <210> SEQ ID NO 119 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 119 acgacacgag ctgacgac 18 <210> SEQ ID NO 120 <211> LENGTH: 14 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 120 cgaagaacct tacc 14 <210> SEQ ID NO 121 <211> LENGTH: 12 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 121 acacgagctg ac 12 <210> SEQ ID NO 122 <211> LENGTH: 14 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 122 cgaagaacct tacc 14 <210> SEQ ID NO 123 <211> LENGTH: 12 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 123 acacgagctg ac 12 <210> SEQ ID NO 124 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 124 cctgataagg gtgaggtcg 19 <210> SEQ ID NO 125 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 125 acgtccttca tcgcctctga 20 <210> SEQ ID NO 126 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 126 gttgtgaggt taagcgacta ag 22 <210> SEQ ID NO 127 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 127 ctatcggtca gtcaggagta t 21 <210> SEQ ID NO 128 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 128

gttgtgaggt taagcgacta ag 22 <210> SEQ ID NO 129 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 129 ttgcatcggg ttggtaagtc 20 <210> SEQ ID NO 130 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 130 atactcctga ctgaccgata g 21 <210> SEQ ID NO 131 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 131 aacatagcct tctccgtcc 19 <210> SEQ ID NO 132 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 132 gacttaccaa cccgatgcaa 20 <210> SEQ ID NO 133 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 133 taccttagga ccgttatagt tacg 24 <210> SEQ ID NO 134 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 134 ggacggagaa ggctatgtt 19 <210> SEQ ID NO 135 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 135 ccaaacaccg ccgtcgatat 20 <210> SEQ ID NO 136 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 136 cgtaactata acggtcctaa ggta 24 <210> SEQ ID NO 137 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 137 gcttacacac ccggcctatc 20 <210> SEQ ID NO 138 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 138 atatcgacgg cggtgtttgg 20 <210> SEQ ID NO 139 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 139 gcgtgacagg caggtattc 19 <210> SEQ ID NO 140 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 140 agtctcaaga gtgaacacgt aa 22 <210> SEQ ID NO 141 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 141 gctgctggca cggagtta 18 <210> SEQ ID NO 142 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 142 gacacggtcc agactcctac 20 <210> SEQ ID NO 143 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 143 ccatgcagca cctgtctc 18 <210> SEQ ID NO 144 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 144 gatctggagg aataccggtg 20 <210> SEQ ID NO 145 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 145 acggttacct tgttacgact 20 <210> SEQ ID NO 146 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 146 gagagcaagc ggacctcata 20 <210> SEQ ID NO 147 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 147 cctcctgcgt gcaaagc 17 <210> SEQ ID NO 148 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 148 tggaagatct gggtcaggc 19 <210> SEQ ID NO 149 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 149

caatctgctg acggatctga gc 22 <210> SEQ ID NO 150 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 150 gtcgtgaaaa cgagctggaa ga 22 <210> SEQ ID NO 151 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 151 catgatggtc acaaccgg 18 <210> SEQ ID NO 152 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 152 tggcgaacct ggtgaacgaa gc 22 <210> SEQ ID NO 153 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 153 ctttcgcttt ctcgaactca accat 25 <210> SEQ ID NO 154 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 154 cgtcagggta aattccgtga agttaa 26 <210> SEQ ID NO 155 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 155 aacttcgcct tcggtcatgt t 21 <210> SEQ ID NO 156 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 156 ggtgaaagaa gttgcctcta aagc 24 <210> SEQ ID NO 157 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 157 ttcaggtcca tcgggttcat gcc 23 <210> SEQ ID NO 158 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 158 cgtggcggcg tggttatcga 20 <210> SEQ ID NO 159 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 159 acgaactgga tgtcgccgtt 20 <210> SEQ ID NO 160 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 160 cggaattact gggcgtaaag 20 <210> SEQ ID NO 161 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 161 cgcatttcac cgctacac 18 <210> SEQ ID NO 162 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 162 acccagtgct gctgaaccgt gc 22 <210> SEQ ID NO 163 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 163 gttcaaatgc ctggataccc a 21 <210> SEQ ID NO 164 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 164 gggagcaaac aggattagat ac 22 <210> SEQ ID NO 165 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 165 cgtactcccc aggcg 15 <210> SEQ ID NO 166 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 166 tggcccgaaa gaagctgagc g 21 <210> SEQ ID NO 167 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 167 acgcgggcat gcagagatgc c 21 <210> SEQ ID NO 168 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 168 atgttgggtt aagtcccgc 19 <210> SEQ ID NO 169 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 169 tgacgtcatc cccaccttcc 20 <210> SEQ ID NO 170 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer

<400> SEQUENCE: 170 cttgtacaca ccgcccgtc 19 <210> SEQ ID NO 171 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 171 aaggaggtga tccagcc 17 <210> SEQ ID NO 172 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 172 cggattggag tctgcaactc g 21 <210> SEQ ID NO 173 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 173 gacgggcggt gtgtacaag 19 <210> SEQ ID NO 174 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 174 ggtggatgcc ttggc 15 <210> SEQ ID NO 175 <211> LENGTH: 16 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 175 gggtttcccc attcgg 16 <210> SEQ ID NO 176 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 176 gggaactgaa acatctaagt a 21 <210> SEQ ID NO 177 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 177 ttcgctcgcc gctac 15 <210> SEQ ID NO 178 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 178 taccccaaac cgacacagg 19 <210> SEQ ID NO 179 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 179 ccttctcccg aagttacg 18 <210> SEQ ID NO 180 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 180 ccgtaacttc gggagaagg 19 <210> SEQ ID NO 181 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 181 caccgggcag gcgtc 15 <210> SEQ ID NO 182 <211> LENGTH: 16 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 182 gacgcctgcc cggtgc 16 <210> SEQ ID NO 183 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 183 ccgacaagga atttcgctac c 21 <210> SEQ ID NO 184 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 184 aaggtactcc ggggataaca ggc 23 <210> SEQ ID NO 185 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 185 agccgacatc gaggtgccaa ac 22 <210> SEQ ID NO 186 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 186 gacagttcgg tccctatc 18 <210> SEQ ID NO 187 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 187 ccggtcctct cgtacta 17 <210> SEQ ID NO 188 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 188 tagtacgaga ggaccgg 17 <210> SEQ ID NO 189 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 189 ttagatgctt tcagcactta tc 22 <210> SEQ ID NO 190 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 190 aaactagata acagtagaca tcac 24 <210> SEQ ID NO 191 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer

<400> SEQUENCE: 191 gtgcgccctt tctaactt 18 <210> SEQ ID NO 192 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 192 agagtttgat catggctcag 20 <210> SEQ ID NO 193 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 193 actgctgcct cccgtag 17 <210> SEQ ID NO 194 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 194 cactggaact gagacacgg 19 <210> SEQ ID NO 195 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 195 ctttacgccc agtaattccg 20 <210> SEQ ID NO 196 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 196 ccagcagccg cggtaatac 19 <210> SEQ ID NO 197 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 197 gtatctaatc ctgtttgctc cc 22 <210> SEQ ID NO 198 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 198 gtgtagcggt gaaatgcg 18 <210> SEQ ID NO 199 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 199 ggtaaggttc ttcgcgttg 19 <210> SEQ ID NO 200 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 200 aagcggtgga gcatgtgg 18 <210> SEQ ID NO 201 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 201 attgtagcac gtgtgtagcc c 21 <210> SEQ ID NO 202 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 202 caagtcatca tggccctta 19 <210> SEQ ID NO 203 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 203 aaggaggtga tccagcc 17 <210> SEQ ID NO 204 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 204 agagtttgat catggctcag 20 <210> SEQ ID NO 205 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 205 aaggaggtga tccagcc 17 <210> SEQ ID NO 206 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 206 acctgcccag tgctggaag 19 <210> SEQ ID NO 207 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 207 tcgctacctt aggaccgt 18 <210> SEQ ID NO 208 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 208 gccttgtaca cacctcccgt c 21 <210> SEQ ID NO 209 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 209 cacggctacc ttgttacgac 20 <210> SEQ ID NO 210 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 210 ttgtacacac cgcccgtcat ac 22 <210> SEQ ID NO 211 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 211 ccttgttacg acttcacccc 20 <210> SEQ ID NO 212 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE:

<223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 212 tacggtgaat acgttcccgg g 21 <210> SEQ ID NO 213 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 213 accttgttac gacttcaccc ca 22 <210> SEQ ID NO 214 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 214 accacgccgt aaacgatga 19 <210> SEQ ID NO 215 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 215 cccccgtcaa ttcctttgag t 21 <210> SEQ ID NO 216 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 216 gataccctgg tagtccacac cg 22 <210> SEQ ID NO 217 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 217 gccttgcgac cgtactccc 19 <210> SEQ ID NO 218 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 218 tagataccct ggtagtccac gc 22 <210> SEQ ID NO 219 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 219 gcgaccgtac tccccagg 18 <210> SEQ ID NO 220 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 220 tagtcccgca acgagcgc 18 <210> SEQ ID NO 221 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 221 gacgtcatcc ccaccttcct cc 22 <210> SEQ ID NO 222 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 222 tagaacgtcg cgagacagtt cg 22 <210> SEQ ID NO 223 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 223 agtccatccc ggtcctctcg 20 <210> SEQ ID NO 224 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 224 gaggaaagtc cgggctc 17 <210> SEQ ID NO 225 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 225 ataagccggg ttctgtcg 18 <210> SEQ ID NO 226 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 226 gaggaaagtc catgctcgc 19 <210> SEQ ID NO 227 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 227 gtaagccatg ttttgttcca tc 22 <210> SEQ ID NO 228 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 228 gaggaaagtc cgggctc 17 <210> SEQ ID NO 229 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 229 ataagccggg ttctgtcg 18 <210> SEQ ID NO 230 <211> LENGTH: 35 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 230 gcgggatcct ctagaggtgt taaatagcct ggcag 35 <210> SEQ ID NO 231 <211> LENGTH: 35 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 231 gcgggatcct ctagaagacc tcctgcgtgc aaagc 35 <210> SEQ ID NO 232 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 232 gaggaaagtc catgctcac 19 <210> SEQ ID NO 233 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence

<220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 233 ataagccatg ttctgttcca tc 22 <210> SEQ ID NO 234 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 234 atgttgggtt aagtcccgc 19 <210> SEQ ID NO 235 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 235 aaggaggtga tccagcc 17 <210> SEQ ID NO 236 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 236 cggaattact gggcgtaaag 20 <210> SEQ ID NO 237 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 237 gtatctaatc ctgtttgctc cc 22 <210> SEQ ID NO 238 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 238 atgttgggtt aagtcccgc 19 <210> SEQ ID NO 239 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 239 tgacgtcatg cccaccttcc 20 <210> SEQ ID NO 240 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 240 atgttgggtt aagtcccgc 19 <210> SEQ ID NO 241 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 241 tgacgtcatg gccaccttcc 20 <210> SEQ ID NO 242 <211> LENGTH: 34 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 242 gcgggatcct ctagacctga taagggtgag gtcg 34 <210> SEQ ID NO 243 <211> LENGTH: 34 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 243 gcgggatcct ctagagcgtg acaggcaggt attc 34 <210> SEQ ID NO 244 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 244 acgcgaagaa ccttacc 17 <210> SEQ ID NO 245 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 245 gacgggcggt gtgtacaag 19 <210> SEQ ID NO 246 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 246 gtgtagcggt gaaatgcg 18 <210> SEQ ID NO 247 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 247 cgagttgcag actgcgatcc g 21 <210> SEQ ID NO 248 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 248 taacacatgc aagtcgaacg 20 <210> SEQ ID NO 249 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 249 cgtactcccc aggcg 15 <210> SEQ ID NO 250 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 250 taacacatgc aagtcgaacg 20 <210> SEQ ID NO 251 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 251 acgacacgag ctgacgac 18 <210> SEQ ID NO 252 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 252 acaacgaagt acaatacaag ac 22 <210> SEQ ID NO 253 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 253 cttctacatt tttagccatc ac 22 <210> SEQ ID NO 254 <211> LENGTH: 22 <212> TYPE: DNA

<213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 254 ttaagtcccg caacgagcgc aa 22 <210> SEQ ID NO 255 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 255 tgacgtcatc cccaccttcc tc 22 <210> SEQ ID NO 256 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 256 tgagtgatga aggccttagg gttgtaaa 28 <210> SEQ ID NO 257 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 257 cggctgctgg cacgaagtta g 21 <210> SEQ ID NO 258 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 258 atggacaagg ttggcaagga agg 23 <210> SEQ ID NO 259 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 259 tagccgcggt cgaattgcat 20 <210> SEQ ID NO 260 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 260 aaggaaggcg tgatcaccgt tgaaga 26 <210> SEQ ID NO 261 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 261 ccgcggtcga attgcatgcc ttc 23 <210> SEQ ID NO 262 <211> LENGTH: 16 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 262 acgcgctgcg cttcac 16 <210> SEQ ID NO 263 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 263 ttgcagaagt tgcggtagcc 20 <210> SEQ ID NO 264 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 264 tcgaccacct gggcaacc 18 <210> SEQ ID NO 265 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 265 atcaggtcgt gcggcatca 19 <210> SEQ ID NO 266 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 266 cacggtgccg gcgtact 17 <210> SEQ ID NO 267 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 267 gcggtcggct cgttgatgat 20 <210> SEQ ID NO 268 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 268 ttggaggtaa gtctcatttt ggtgg 25 <210> SEQ ID NO 269 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 269 aagctgcacc ataagcttgt aatgc 25 <210> SEQ ID NO 270 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 270 cagcgtttcg gcgaaatgga 20 <210> SEQ ID NO 271 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 271 cgacttgacg gttaacattt cctg 24 <210> SEQ ID NO 272 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 272 gggcagcgtt tcggcgaaat gga 23 <210> SEQ ID NO 273 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 273 gtccgacttg acggtcaaca tttcctg 27 <210> SEQ ID NO 274 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 274 caggagtcgt tcaactcgat ctacatgat 29 <210> SEQ ID NO 275 <211> LENGTH: 19

<212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 275 acgccatcag gccacgcat 19 <210> SEQ ID NO 276 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 276 gcacaacctg cggctgcg 18 <210> SEQ ID NO 277 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 277 acggcacgag gtagtcgc 18 <210> SEQ ID NO 278 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 278 cgccgacttc gacggtgacc 20 <210> SEQ ID NO 279 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 279 gagcatcagc gtgcgtgct 19 <210> SEQ ID NO 280 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 280 ccacacgccg ttcttcaaca act 23 <210> SEQ ID NO 281 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 281 ggcatcacca tttccttgtc cttcg 25 <210> SEQ ID NO 282 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 282 gagagtttga tcctggctca gaacgaa 27 <210> SEQ ID NO 283 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 283 tgttactcac ccgtctgcca ct 22 <210> SEQ ID NO 284 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 284 accgagcaag gagaccagc 19 <210> SEQ ID NO 285 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 285 tataacgcac atcgtcaggg tga 23 <210> SEQ ID NO 286 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 286 agacccaatt acattggctt 20 <210> SEQ ID NO 287 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 287 ccagtgctgt tgtagtacat 20 <210> SEQ ID NO 288 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 288 atgtactaca acagtactgg 20 <210> SEQ ID NO 289 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 289 caagtcaacc acagcattca 20 <210> SEQ ID NO 290 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 290 gggcttatgt actacaacag 20 <210> SEQ ID NO 291 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 291 tctgtcttgc aagtcaacca c 21 <210> SEQ ID NO 292 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 292 ggaatttttt gatggtagag a 21 <210> SEQ ID NO 293 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 293 taaagcacaa tttcaggcg 19 <210> SEQ ID NO 294 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 294 tagatctggc tttctttgac 20 <210> SEQ ID NO 295 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 295 atatgagtat ctggagtctg c 21 <210> SEQ ID NO 296

<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 296 ggaaagacat tactgcagac a 21 <210> SEQ ID NO 297 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 297 ccaacttgag gctctggctg 20 <210> SEQ ID NO 298 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 298 acagacactt accagggtg 19 <210> SEQ ID NO 299 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 299 actgtggtgt catctttgtc 20 <210> SEQ ID NO 300 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 300 tcactaaaga caaaggtctt cc 22 <210> SEQ ID NO 301 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 301 ggcttcgccg tctgtaattt c 21 <210> SEQ ID NO 302 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 302 cggatccaag ctaatctttg g 21 <210> SEQ ID NO 303 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 303 ggtatgtact cataggtgtt ggtg 24 <210> SEQ ID NO 304 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 304 agacccaatt acattggctt 20 <210> SEQ ID NO 305 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 305 ccagtgctgt tgtagtacat 20 <210> SEQ ID NO 306 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 306 atgtactaca acagtactgg 20 <210> SEQ ID NO 307 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 307 caagtcaacc acagcattca 20 <210> SEQ ID NO 308 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 308 gggcttatgt actacaacag 20 <210> SEQ ID NO 309 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 309 tctgtcttgc aagtcaacca c 21 <210> SEQ ID NO 310 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 310 ggaatttttt gatggtagag a 21 <210> SEQ ID NO 311 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 311 taaagcacaa tttcaggcg 19 <210> SEQ ID NO 312 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 312 tagatctggc tttctttgac 20 <210> SEQ ID NO 313 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 313 atatgagtat ctggagtctg c 21 <210> SEQ ID NO 314 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 314 cggatccaag ctaatctttg g 21 <210> SEQ ID NO 315 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 315 ggtatgtact cataggtgtt ggtg 24 <210> SEQ ID NO 316 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 316 aacagaccca attacattgg ctt 23

<210> SEQ ID NO 317 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 317 gaggcacttg tatgtggaaa gg 22 <210> SEQ ID NO 318 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 318 atgcctaaca gacccaatta cat 23 <210> SEQ ID NO 319 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 319 ttcatgtagt cgtaggtgtt gg 22 <210> SEQ ID NO 320 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 320 cgcgcctaat acatctcagt ggat 24 <210> SEQ ID NO 321 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 321 aagccaatgt aattgggtct gtt 23 <210> SEQ ID NO 322 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 322 ctactctggc actgcctaca ac 22 <210> SEQ ID NO 323 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 323 atgtaattgg gtctgttagg cat 23 <210> SEQ ID NO 324 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 324 caatccgttc tggttccgga tgaa 24 <210> SEQ ID NO 325 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 325 cttgccggtc gttcaaagag gtag 24 <210> SEQ ID NO 326 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 326 agtccgggtc tggtgcag 18 <210> SEQ ID NO 327 <211> LENGTH: 17 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 327 cggtcggtgg tcacatc 17 <210> SEQ ID NO 328 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 328 atggccaccc catcgatg 18 <210> SEQ ID NO 329 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 329 ctgtccggcg atgtgcatg 19 <210> SEQ ID NO 330 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 330 ggtcgttatg tgcctttcca cat 23 <210> SEQ ID NO 331 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 331 tcctttctga agttccactc atagg 25 <210> SEQ ID NO 332 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 332 acaacattgg ctaccagggc tt 22 <210> SEQ ID NO 333 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 333 cctgcctgct cataggctgg aagtt 25 <210> SEQ ID NO 334 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 334 ggattagaga ccctggtagt cc 22 <210> SEQ ID NO 335 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 335 ggccgtactc cccaggcg 18 <210> SEQ ID NO 336 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 336 ttcgatgcaa cgcgaagaac ct 22 <210> SEQ ID NO 337 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 337 acgagctgac gacagccatg 20

<210> SEQ ID NO 338 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 338 tctgtcccta gtacgagagg accgg 25 <210> SEQ ID NO 339 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 339 tgcttagatg ctttcagc 18 <210> SEQ ID NO 340 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 340 ctggcaggta tgcgtggtct gatg 24 <210> SEQ ID NO 341 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 341 cgcaccgtgg gttgagatga agtac 25 <210> SEQ ID NO 342 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 342 ggggattcag ccatcaaagc agctattgac 30 <210> SEQ ID NO 343 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 343 ccaacctttt ccacaacaga atcagc 26 <210> SEQ ID NO 344 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 344 ccttacttcg aactatgaat cttttggaag 30 <210> SEQ ID NO 345 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 345 cccatttttt cacgcatgct gaaaatatc 29 <210> SEQ ID NO 346 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 346 cgcaaaaaaa tccagctatt agc 23 <210> SEQ ID NO 347 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 347 aaactatttt tttagctata ctcgaacac 29 <210> SEQ ID NO 348 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 348 atgattacaa ttcaagaagg tcgtcacgc 29 <210> SEQ ID NO 349 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 349 ttggacctgt aatcagctga atactgg 27 <210> SEQ ID NO 350 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 350 gatgactttt tagctaatgg tcaggcagc 29 <210> SEQ ID NO 351 <211> LENGTH: 29 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 351 aatcgacgac catcttggaa agatttctc 29 <210> SEQ ID NO 352 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 352 gcttcaggaa tcaatgatgg agcag 25 <210> SEQ ID NO 353 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 353 gggtctacac ctgcacttgc ataac 25 <210> SEQ ID NO 354 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 354 gtactgaatc cgcctaag 18 <210> SEQ ID NO 355 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 355 gtgaataaag tatcgcccta ata 23 <210> SEQ ID NO 356 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 356 gaagttgaac cgggatca 18 <210> SEQ ID NO 357 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 357 attatcggtc gttgttaatg t 21 <210> SEQ ID NO 358 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 358 ctgtctgtag ataaactagg att 23

<210> SEQ ID NO 359 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 359 cgttcttctc tggaggat 18 <210> SEQ ID NO 360 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 360 cgatactacg gacgc 15 <210> SEQ ID NO 361 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 361 ctttatgaat tactttacat at 22 <210> SEQ ID NO 362 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 362 ctcctccatc actaggaa 18 <210> SEQ ID NO 363 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 363 ctataacatt caaagcttat tg 22 <210> SEQ ID NO 364 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 364 cgcgataata gatagtgcta aac 23 <210> SEQ ID NO 365 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 365 gcttccacca ggtcattaa 19 <210> SEQ ID NO 366 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 366 gtactgaatc cgcctaag 18 <210> SEQ ID NO 367 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 367 gtgaataaag tatcgcccta ata 23 <210> SEQ ID NO 368 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 368 gaagttgaac cgggatca 18 <210> SEQ ID NO 369 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 369 attatcggtc gttgttaatg t 21 <210> SEQ ID NO 370 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 370 ctgtctgtag ataaactagg att 23 <210> SEQ ID NO 371 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 371 cgttcttctc tggaggat 18 <210> SEQ ID NO 372 <211> LENGTH: 15 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 372 cgatactacg gacgc 15 <210> SEQ ID NO 373 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 373 ctttatgaat tactttacat at 22 <210> SEQ ID NO 374 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 374 ctcctccatc actaggaa 18 <210> SEQ ID NO 375 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 375 ctataacatt caaagcttat tg 22 <210> SEQ ID NO 376 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 376 cgcgataata gatagtgcta aac 23 <210> SEQ ID NO 377 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: PCR Primer <400> SEQUENCE: 377 gcttccacca ggtcattaa 19 <210> SEQ ID NO 378 <211> LENGTH: 375 <212> TYPE: RNA <213> ORGANISM: Bacterial Ribosomal RNA <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 73 <223> OTHER INFORMATION: n = A,T,C or G <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: 77, 78, 79, 81, 82, 85, 86, 87, 90, 91, 92, 94, 98, 99, 100, 102, 103, 104, 105, 106, 107, 108, 110, 111, 113, 114, 115, 116, 117, 121, 125, 127, 134, 136, 137, 138, 139, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156 <223> OTHER INFORMATION: n = A,T,C or G

<220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 170, 178, 181, 184, 185, 186, 187, 195, 196, 202, 203, 204, 205, 206, 207, 208, 209, 211, 212, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 225, 226, 229, 237, 238, 239, 240 <223> OTHER INFORMATION: n = A,T,C or G <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: 242, 249, 250, 251, 252, 253, 254, 255, 256, 257, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, 275, 276, 278, 279, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 292, 294, 295, 296, 297, 301 <223> OTHER INFORMATION: n = A,T,C or G <220> FEATURE: <221> NAME/KEY: misc_feature <222> LOCATION: 305, 306, 307, 308, 309, 310, 311, 313, 314, 316, 317, 318, 319, 320, 321, 322, 325, 329, 330, 331, 335, 336, 337, 338, 339, 340, 342, 343, 344, 351, 357, 360, 361, 362, 363, 364, 365, 366, 367, 368, 369, 370, 371, 372, 373, 374, 375 <223> OTHER INFORMATION: n = A,T,C or G <400> SEQUENCE: 378 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnng 60 aggaaagucc ggncucnnna nncannnugn nngnuaannn cnnnnnnngn nannnnngac 120 naguncnaca gagngnnnnc cgccnnnnnn nnnnnnnnnn nnnnnnnggn aagggugnaa 180 nggnnnngua agagnncacc gnnnnnnnng nnannnnnnn nnncnnggna aacuccnnnn 240 gnagcaagnn nnnnnnngnn nnnnnnnnnn nnngnncnnn nnnnnnnnnn nnannnngcu 300 ngagnnnnnn ngnnannnnn nnccnagann naugnnnnnn cnnnacagaa nccggcnuan 360 nnnnnnnnnn nnnnn 375 <210> SEQ ID NO 379 <211> LENGTH: 9 <212> TYPE: DNA <213> ORGANISM: Double stranded nucleic acid <400> SEQUENCE: 379 tacgtacgt 9 <210> SEQ ID NO 380 <211> LENGTH: 9 <212> TYPE: DNA <213> ORGANISM: Double stranded nucleic acid <400> SEQUENCE: 380 atgcatgca 9 <210> SEQ ID NO 381 <211> LENGTH: 65 <212> TYPE: RNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthetic oligonucleotide <400> SEQUENCE: 381 gacccauggu cgcucgcucc ucuccuacuu ggauaacugu gguaauucua gagcuaauac 60 augcc 65 <210> SEQ ID NO 382 <211> LENGTH: 48 <212> TYPE: RNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthetic oligonucleotide <400> SEQUENCE: 382 gccauaugga gggggauaac uacuggaaac gguagcuaau accgcaua 48

* * * * *

Current U.S. Class:	435/6.12; 435/91.2; 536/24.33; 435/6.18
Current CPC Class:	C12Q 1/686 (20130101); C12Q 1/689 (20130101); C12Q 1/686 (20130101); C12Q 2565/627 (20130101); Y10T 436/24 (20150115)
Current International Class:	C12Q 1/68 (20060101); C07H 21/04 (20060101); C12P 19/34 (20060101)